Recombinant_DT murine_NN and_CC human_IN TCF-1_NN recognized_JJ the_DT same_DT sequence_NN motif_CD in_VBG the_VBG CD3-epsilon_VBG enhancer_VBG as_VBG judged_VBG by_VBG gel_VBG retardation_VBG and_VBG methylation_VBG interference_VBG assays_VBG ._VBG
p50B_DT is_VBZ able_RB to_VBG form_IN heteromeric_JJ kappa_NN B-binding_VBG complexes_NNS with_IN RelB_NNS ,_VBG as_VBG well_JJ as_VBG with_DT p65_NN and_CC p50_RB ,_VBG the_VBG two_VBG subunits_VBG of_VBG NF-kappa_VBG B_VBG ._VBG
The_VBG constitutively_VBG active_VBG type_VBG of_VBG the_VBG CN_VBG A_VBG subunit_VBG ,_VBG which_VBG lacks_VBG the_VBG auto-inhibitory_VBG and_VBG calmodulin-binding_VBG domains_VBG ,_VBG acts_VBG in_VBG synergy_VBG with_VBG PMA_VBG to_VBG activate_VBG transcription_VBG from_VBG the_VBG GM-CSF_VBG promoter_VBG ._VBG
This_DT high-affinity_JJ site_NN has_NN been_VBN conserved_NN in_VBG the_VBG promoters_VBG of_VBG both_VBG human_VBG and_VBG mouse_VBG CD19_VBG genes_VBG and_VBG was_VBG furthermore_VBG shown_VBG to_VBG confer_VBG B-cell_VBG specificity_VBG to_VBG a_VBG beta-globin_VBG reporter_VBG gene_VBG in_VBG transient_VBG transfection_VBG experiments_VBG ._VBG
N-acetyl-L-cysteine_VBG NP_VBG ,_VBG a_VBG well_VBG characterized_VBG antioxidant_VBG which_VBG counteracts_VBG the_VBG effects_VBG of_VBG reactive_VBG oxygen_VBG intermediates_VBG ROI_VBG in_VBG living_VBG cells_VBG ,_VBG prevented_VBG the_VBG activation_VBG of_VBG NF-kappa_VBG B_VBG by_VBG H2O2_VBG ._VBG
Total_NN RNA_NN isolated_JJ from_VBG the_VBG index_VBG subject_VBG mononuclear_VBG leukocytes_VBG was_VBG used_VBG to_VBG produce_VBG first_VBG strand_VBG hGR_VBG cDNAs_VBG ,_VBG and_VBG the_VBG entire_VBG hGR_VBG cDNA_VBG was_VBG amplified_VBG in_VBG segments_VBG and_VBG sequenced_VBG ._VBG
The_VBG eukaryotic_VBG transcription_VBG factor_VBG nuclear_VBG factor-kappa_VBG B_VBG NF-kappa_VBG B_VBG participates_VBG in_VBG many_VBG parts_VBG of_VBG the_VBG genetic_VBG program_VBG mediating_VBG T_VBG lymphocyte_VBG activation_VBG and_VBG growth_VBG ._VBG
We_VBG have_VBG cloned_VBG the_VBG latent_VBG membrane_VBG protein_VBG 1_VBG LMP1_VBG homologs_VBG from_VBG the_VBG simian_VBG EBV_VBG naturally_VBG infecting_VBG baboons_VBG cercopithicine_VBG herpesvirus_VBG 12_VBG ,_VBG herpesvirus_VBG papio_VBG and_VBG rhesus_VBG monkeys_VBG cercopithicine_VBG herpesvirus_VBG 15_VBG for_VBG a_VBG comparative_VBG study_VBG with_VBG the_VBG human_VBG EBV_VBG oncogene_VBG ._VBG
To_VBG clarify_VBG the_VBG molecular_VBG mechanisms_VBG involved_VBG in_VBG the_VBG developmental_VBG control_VBG of_VBG hemoglobin-encoding_VBG genes_VBG we_VBG have_VBG been_VBG studying_VBG the_VBG expression_VBG of_VBG these_VBG genes_VBG in_VBG human_VBG cells_VBG in_VBG continuous_VBG culture_VBG ._VBG
We_VBG conclude_VBG that_VBG the_VBG serum_VBG response_VBG of_VBG the_VBG human_VBG TSP_VBG 1_VBG gene_VBG requires_VBG the_VBG coordinated_VBG function_VBG of_VBG an_VBG SRE-_VBG and_VBG NF-Y-binding_VBG site_VBG ._VBG
It_DT is_VBZ concluded_JJ that_VBG adenovirus_VBG may_VBG be_VBG one_VBG cause_VBG of_VBG persistent_VBG or_VBG recurrent_VBG inflammatory_VBG arthritis_VBG ._VBG
To_VBG further_VBG define_VBG the_VBG effects_VBG of_VBG dexamethasone_VBG at_VBG the_VBG molecular_VBG level_VBG ,_VBG we_VBG prepared_VBG a_VBG series_VBG of_VBG deleted_VBG c-jun_VBG promoter_VBG fragments_VBG linked_VBG to_VBG the_VBG chloramphenicol_VBG acetyltransferase_VBG CAT_VBG gene_VBG ._VBG
In_NN nuclear_JJ extracts_VBZ from_VBG monocytes_VBG or_VBG macrophages_VBG ,_VBG induction_VBG of_VBG NF-KB_VBG occurred_VBG only_VBG if_VBG the_VBG cells_VBG were_VBG previously_VBG infected_VBG with_VBG HIV-1_VBG ._VBG
Mutations_DT of_VBG the_DT CRE_NN site_JJ that_VBG result_VBZ in_VBG loss_JJ of_VBG CREB_JJ binding_NN also_RB lead_JJ to_VBG loss_VB of_VBG functional_VBG activity_VBG of_VBG the_VBG bcl-2_VBG promoter_VBG in_VBG transient-transfection_VBG assays_VBG ._VBG
In_VBG line_VBG with_VBG this_VBG conclusion_VBG ,_VBG we_VBG show_VBG that_VBG the_VBG protein_VBG ,_VBG a_VBG transcriptional_VBG repressor_VBG that_VBG inhibits_VBG gpc91-phox_VBG gene_VBG expression_VBG by_VBG preventing_VBG NF-Y_VBG binding_VBG to_VBG the_VBG CAAT_VBG box_VBG ,_VBG is_VBG absent_VBG in_VBG monocytes_VBG ._VBG
The_DT inhibition_CD of_VBG HIV_VBG infection_VBG in_VBG cells_VBG stably_VBG expressing_VBG a_VBG transdominant_VBG Rev_VBG protein_VBG ,_VBG in_VBG the_VBG absence_VBG of_VBG any_VBG deleterious_VBG effect_VBG on_VBG T_VBG cell_VBG function_VBG ,_VBG suggests_VBG that_VBG such_VBG a_VBG strategy_VBG could_VBG provide_VBG a_VBG therapeutic_VBG effect_VBG in_VBG the_VBG T_VBG lymphocytes_VBG of_VBG acquired_VBG immunodeficiency_VBG syndrome_VBG patients_VBG ._VBG
Here_PRP ,_VBG we_VBG show_VBG that_VBG v-erbA_VBG and_VBG c-erbA_VBG bind_VBG directly_VBG to_VBG sequences_VBG within_VBG the_VBG promoter_VBG of_VBG the_VBG erythrocyte-specific_VBG carbonic_VBG anhydrase_VBG II_VBG CAII_VBG ,_VBG a_VBG gene_VBG transcription_VBG is_VBG efficiently_VBG suppressed_VBG by_VBG v-erbA_VBG ._VBG
The_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG NF-AT_VBG 3_VBG is_VBG an_VBG inducible_VBG DNA-binding_VBG protein_VBG that_VBG is_VBG essential_VBG for_VBG transcriptional_VBG induction_VBG of_VBG the_VBG IL-2_VBG gene_VBG during_VBG T_VBG cell_VBG activation_VBG ._VBG
In_VBG contrast_VBG to_VBG the_VBG type_VBG I_VBG receptor_VBG ,_VBG the_VBG type_VBG II_VBG IL-1R_VBG has_VBG a_VBG small_VBG cytoplasmic_VBG tail_VBG ,_VBG and_VBG it_VBG is_VBG not_VBG clear_VBG whether_VBG this_VBG receptor_VBG is_VBG a_VBG signal-transducing_VBG or_VBG a_VBG regulatory_VBG molecule_VBG ._VBG
The_DT presence_NNS of_VBG c-fos_NN had_JJ a_VBG negative_JJ influence_VBP on_VBG GR_VBG function_VBG and_VBG correlated_VBG with_VBG the_VBG cell-specific_VBG synergistic_VBG or_VBG antagonistic_VBG activity_VBG of_VBG Jun_VBG with_VBG respect_VBG to_VBG GR_VBG ;_VBG high_VBG basal_VBG expression_VBG of_VBG c-fos_VBG as_VBG well_VBG as_VBG AP-1_VBG DNA_VBG binding_VBG and_VBG transcriptional_VBG activity_VBG were_VBG observed_VBG in_VBG HeLa_VBG cells_VBG ,_VBG but_VBG not_VBG in_VBG T_VBG cells_VBG ._VBG
One_JJ ,_VBG located_VBD at_VBG -50_NN ,_VBG binds_VBG members_VBG of_VBG the_VBG family_VBG and_VBG the_VBG other_VBG ,_VBG located_VBG at_VBG -20_VBG ,_VBG binds_VBG the_VBG erythroid_VBG factor_VBG GATA-1_VBG ._VBG
Although_JJ sequences_NNS located_VBD between_IN -559_DT and_CC -88_FW of_VBG the_DT zeta_NNS 2_VBG globin_VBG gene_VBG were_VBG dispensable_VBG for_VBG expression_VBG on_VBG enhancerless_VBG plasmids_VBG ,_VBG they_VBG were_VBG required_VBG for_VBG the_VBG HS-40_VBG enhancer-mediated_VBG activity_VBG of_VBG the_VBG zeta_VBG 2_VBG globin_VBG promoter_VBG ._VBG
The_VBG minimal_VBG region_VBG of_VBG the_VBG human_VBG tumor_VBG necrosis_VBG factor_VBG alpha_VBG TNF-alpha_VBG gene_VBG promoter_VBG necessary_VBG for_VBG transcriptional_VBG induction_VBG by_VBG phorbol_VBG esters_VBG PMA_VBG in_VBG human_VBG T_VBG and_VBG B_VBG lymphocyte_VBG cell_VBG lines_VBG has_VBG been_VBG localized_VBG between_VBG -52_VBG and_VBG nucleotides_VBG nt_VBG relative_VBG to_VBG the_VBG gene_VBG transcriptional_VBG start_VBG site_VBG ._VBG
Glucocorticoids_NN and_CC interferon-alpha_VBP in_VBG the_DT acquired_VBD immunodeficiency_NN syndrome_NN ._.
We_VBG tested_VBG the_VBG ability_VBG of_VBG human_VBG TSP_VBG 1-chloramphenicol_VBG acetyltransferase_VBG constructs_VBG to_VBG respond_VBG to_VBG serum_VBG in_VBG stably_VBG transfected_VBG NIH-3T3_VBG cells_VBG ._VBG
Involvement_DT of_VBG mitogen-activated_VBD protein_NN kinase_NN pathways_VBZ in_VBG interleukin-8_VBG production_VBG by_VBG human_VBG monocytes_VBG and_VBG polymorphonuclear_VBG cells_VBG stimulated_VBG with_VBG lipopolysaccharide_VBG or_VBG Mycoplasma_VBG fermentans_VBG membrane_VBG lipoproteins_VBG ._VBG
Nondividing_VBG macrophages_VBG from_VBG normal_VBG individuals_VBG also_VBG expressed_VBG 1,25-LRB-OH-RRB-2D3_VBG receptor_VBG RNA_VBG ._VBG
IFN-gamma_VBG has_VBG potent_VBG antiproliferative_VBG and_VBG apoptotic_VBG effects_VBG in_VBG T_VBG cells_VBG that_VBG are_VBG important_VBG in_VBG determining_VBG T_VBG cell_VBG development_VBG and_VBG polarized_VBG differentiation_VBG ._VBG
The_DT promoters_VBZ and_CC enhancers_CD of_VBG cell_VBG type-specific_VBG genes_VBG are_VBG often_VBG conserved_VBG in_VBG evolution_VBG ,_VBG and_VBG hence_VBG one_VBG might_VBG expect_VBG that_VBG a_VBG given_VBG enhancer_VBG has_VBG evolved_VBG to_VBG work_VBG best_VBG with_VBG own_VBG promoter_VBG ._VBG
The_DT mechanism_CD of_VBG action_IN of_VBG DM_JJ on_VBG IL-2R_VBG alpha_VBG transcription_VBG was_VBG examined_VBG by_VBG determining_VBG the_VBG mRNA_VBG levels_VBG of_VBG the_VBG p50_VBG subunit_VBG of_VBG nuclear_VBG factor_VBG kappa_VBG B_VBG NF-kappa_VBG B_VBG ,_VBG a_VBG transcription_VBG factor_VBG that_VBG stimulates_VBG IL-2R_VBG alpha_VBG gene_VBG expression_VBG ._VBG
Phytohemagglutinin_VBG stimulated_VBG lymphocytes_VBG derived_VBG from_VBG DS_VBG subjects_VBG showed_VBG a_VBG statistically_VBG significant_VBG diminished_VBG proliferation_VBG capacity_VBG in_VBG comparison_VBG with_VBG lymphocytes_VBG derived_VBG from_VBG NCL_VBG and_VBG healthy_VBG individuals_VBG ._VBG
In_JJ previous_JJ transfection_NN analyses_NNS using_JJ the_DT chloramphenicol_JJ acetyltransferase_NN reporter_VBP gene_NN system_IN ,_VBG we_PRP determined_VBP that_VBG linker_VBG substitution_VBG LS_VBG mutations_VBG between_VBG -201_VBG and_VBG -130_VBG relative_VBG to_VBG the_VBG transcription_VBG start_VBG site_VBG of_VBG the_VBG human_VBG immunodeficiency_VBG virus_VBG type_VBG 1_VBG long_VBG terminal_VBG repeat_VBG LTR_VBG caused_VBG moderate_VBG decreases_VBG in_VBG LTR_VBG transcriptional_VBG activity_VBG in_VBG a_VBG T-cell_VBG line_VBG S.L.Zeichner_VBG ,_VBG J.Y.H._VBG Kim_VBG ,_VBG and_VBG J.C.Alwine_VBG ,_VBG J.Virol.65_VBG :_VBG 2436-2444_VBG ,_VBG 1991_VBG ._VBG
Inhibition_IN of_VBG anti-CD3_VBG monoclonal_VBG antibody-induced_VBG T-cell_VBG proliferation_VBG by_VBG dexamethasone_VBG ,_VBG isoproterenol_VBG ,_VBG or_VBG prostaglandin_VBG E2_VBG either_VBG alone_VBG or_VBG in_VBG combination_VBG ._VBG
Additionally_IN ,_VBG infected_VBG T_VBG cells_VBG displayed_VBG lower_VBG levels_VBG of_VBG CD45_VBG on_VBG surfaces_VBG ._VBG
Glucocorticoid_VBG receptor_VBG and_VBG inhibition_VBG of_VBG 3-O-methyl-D-glucose_VBG uptake_VBG by_VBG glucocorticoids_VBG in_VBG peripheral_VBG blood_VBG leukocytes_VBG from_VBG normal_VBG humans_VBG :_VBG correlation_VBG between_VBG receptor_VBG level_VBG and_VBG hormone_VBG effect_VBG in_VBG vitro_VBG ._VBG
Epstein-Barr_VBG virus_VBG nuclear_VBG antigen_VBG 2_VBG and_VBG latent_VBG membrane_VBG protein_VBG independently_VBG transactivate_VBG p53_VBG through_VBG induction_VBG of_VBG NF-kappaB_VBG activity_VBG ._VBG
The_DT T_NN lineage-specific_NN expression_IN and_CC the_DT affinity_VBN for_VBG functional_JJ motifs_VBZ in_VBG the_VBG TCR-alpha_VBG and_VBG CD3-epsilon_VBG enhancers_VBG imply_VBG an_VBG important_VBG role_VBG for_VBG TCF-1_VBG in_VBG the_VBG establishment_VBG of_VBG the_VBG mature_VBG T_VBG cell_VBG phenotype_VBG ._VBG
Cell_VBG type-_VBG and_VBG stage-specific_VBG expression_VBG of_VBG the_VBG antigen_VBG correlates_VBG with_VBG the_VBG activity_VBG of_VBG a_VBG diverged_VBG octamer_VBG DNA_VBG motif_VBG present_VBG in_VBG promoter_VBG ._VBG
We_VBG have_VBG located_VBG the_VBG major_VBG positive_VBG regulatory_VBG region_VBG for_VBG control_VBG of_VBG bcl-2_VBG expression_VBG in_VBG B_VBG cells_VBG in_VBG the_VBG region_VBG ._VBG
IL-10_VBG profoundly_VBG inhibited_VBG release_VBG of_VBG IL-1beta_VBG from_VBG PBMC_VBG stimulated_VBG by_VBG all_VBG three_VBG stimuli_VBG ._VBG
Tat_IN ,_VBG a_VBG potent_VBG activator_VBG of_VBG HIV-1_VBG gene_VBG expression_VBG ,_VBG serves_VBG to_VBG greatly_VBG increase_VBG the_VBG rate_VBG of_VBG transcription_VBG directed_VBG by_VBG the_VBG viral_VBG promoter_VBG ._VBG
From_NN HeLa_NN cells_VBZ ,_VBG two_DT major_JJ proteins_VBZ of_VBG 52_VBG and_NN 45_VBG kilodaltons_NNS kD_NN copurified_VBD with_IN DNA_NNS binding_VBG activity_VBG ,_VBG whereas_VBG from_VBG T-cells_VBG ,_VBG four_VBG proteins_VBG --_VBG a_VBG major_VBG protein_VBG of_VBG 52_VBG kD_VBG and_VBG three_VBG minor_VBG proteins_VBG of_VBG 82_VBG ,_VBG 67_VBG ,_VBG and_VBG 43-47_VBG kD_VBG --_VBG were_VBG purified_VBG ._VBG
Finally_IN ,_VBG we_VBG did_VBG not_VBG observed_VBG either_VBG up-regulation_VBG or_VBG antagonism_VBG of_VBG GcR_VBG by_VBG ketoconazole_VBG treatment_VBG ,_VBG at_VBG the_VBG time_VBG that_VBG cortisol_VBG levels_VBG of_VBG patients_VBG with_VBG Cushing_VBG disease_VBG were_VBG reduced_VBG ._VBG
occurrence_DT is_VBZ considered_VBD to_VBG be_VB extremely_RB rare_VBP ._.
Within_DT this_DT region_RB ,_VBG we_PRP have_VBP identified_JJ several_JJ sequences_VBZ that_VBG are_VBG implicated_VBG in_VBG DNA_VBG protein_VBG interactions_VBG as_VBG shown_VBG in_VBG DNAse_VBG I_VBG footprints_VBG and_VBG gel_VBG mobility_VBG shift_VBG assays_VBG ._VBG
The_VBG regulatory_VBG effect_VBG of_VBG insulin_VBG on_VBG the_VBG specific_VBG binding_VBG power_VBG of_VBG glucocorticoid_VBG receptor_VBG GR_VBG of_VBG human_VBG leukocytes_VBG was_VBG assessed_VBG by_VBG the_VBG unoccupied_VBG receptor_VBG sites_VBG capable_VBG of_VBG combining_VBG with_VBG -LCB-3H-RCB-_VBG labelled_VBG dexamethasone_VBG measured_VBG at_VBG 3_VBG and_VBG 24_VBG h_VBG after_VBG incubation_VBG with_VBG various_VBG concentrations_VBG of_VBG insulin_VBG added_VBG to_VBG the_VBG medium_VBG ._VBG
We_VBG suggest_VBG that_VBG in_VBG young_VBG subjects_VBG Type_VBG II_VBG receptors_VBG are_VBG initially_VBG up-regulated_VBG by_VBG dexamethasone_VBG ,_VBG and_VBG then_VBG down-regulated_VBG ,_VBG while_VBG in_VBG aged_VBG subjects_VBG an_VBG up-regulation_VBG can_VBG not_VBG be_VBG achieved_VBG ,_VBG as_VBG suggested_VBG by_VBG the_VBG higher_VBG values_VBG of_VBG plasma_VBG cortisol_VBG usually_VBG found_VBG in_VBG aging_VBG subjects_VBG
This_VBG function_VBG has_VBG been_VBG attributed_VBG to_VBG the_VBG coordinated_VBG binding_VBG of_VBG subunits_VBG of_VBG NF-kappa_VBG B_VBG to_VBG distinct_VBG regions_VBG of_VBG the_VBG promoter_VBG elements_VBG of_VBG numerous_VBG genes_VBG ,_VBG including_VBG cytokines_VBG ,_VBG growth_VBG factor_VBG receptors_VBG ,_VBG and_VBG adhesion_VBG molecules_VBG ._VBG
The_VBG potential_VBG clinical_VBG usefulness_VBG of_VBG these_VBG CL_VBG assays_VBG was_VBG suggested_VBG by_VBG the_VBG ability_VBG of_VBG both_VBG monocytes_VBG and_VBG IFN-U937_VBG cells_VBG to_VBG respond_VBG to_VBG red_VBG cells_VBG ,_VBG platelets_VBG or_VBG granulocytes_VBG sensitized_VBG with_VBG sera_VBG from_VBG pregnant_VBG women_VBG babies_VBG had_VBG either_VBG haemolytic_VBG disease_VBG of_VBG the_VBG newborn_VBG HDN_VBG ,_VBG alloimmune_VBG thrombocytopenia_VBG or_VBG alloimmune_VBG neutropenia_VBG respectively_VBG ._VBG
These_NN findings_NNS indicate_VBD that_VBG corticosteroid_VBG resistance_VBG in_VBG bronchial_VBG asthma_VBG can_VBG not_VBG be_VBG explained_VBG by_VBG abnormalities_VBG in_VBG corticosteroid_VBG receptor_VBG characteristics_VBG ._VBG
In_VBG conclusion_VBG ,_VBG E-LRB-gre-RRB-_VBG motifs_VBG and_VBG interacting_VBG basic_VBG helix-loop-helix_VBG proteins_VBG are_VBG important_VBG determinants_VBG for_VBG MLV_VBG transcriptional_VBG activity_VBG in_VBG lymphocytic_VBG cell_VBG lines_VBG ._VBG
Characterization_IN of_VBG a_VBG new_VBG isoform_VBG of_VBG the_VBG NFAT_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG gene_VBG family_VBG member_VBG NFATc_VBG published_VBG erratum_VBG appears_VBG in_VBG J_VBG Biol_VBG Chem_VBG 1996_VBG Dec_VBG 27_VBG ;_VBG 271_VBG 52_VBG :_VBG 33705_VBG
The_DT retinoblastoma_NNS gene_NN product_JJ Rb_NN is_NNS a_VBG nuclear_VBG phosphoprotein_VBG that_VBG regulates_VBG cell_VBG cycle_VBG progression_VBG ._VBG
Generation_IN of_VBG dendritic_VBG cells_VBG and_VBG tartrate-resistant_VBG acid_VBG phosphatase-positive_VBG osteoclast-like_VBG multinucleated_VBG giant_VBG cells_VBG from_VBG human_VBG monocytes_VBG ._VBG
To_TO correlate_VB changes_VBZ in_VBG nuclear_JJ factor_NN binding_JJ in_VBG vitro_VBG with_VBG transcriptional_VBG activity_VBG in_VBG vivo_VBG and_VBG define_VBG the_VBG structural_VBG requirements_VBG for_VBG IL-2_VBG promoter_VBG repression_VBG ,_VBG we_VBG used_VBG transient_VBG DNA_VBG transfections_VBG ._VBG
1,25-Dihydroxy_VBG vitamin_VBG D3_VBG and_VBG 12-O-tetradecanoyl_VBG phorbol-13-acetate_VBG synergistically_VBG induce_VBG monocytic_VBG cell_VBG differentiation_VBG :_VBG FOS_VBG and_VBG RB_VBG expression_VBG ._VBG
In_VBG the_VBG bone_VBG marrow_VBG ,_VBG it_VBG is_VBG preferentially_VBG expressed_VBG in_VBG myeloid_VBG cells_VBG ._VBG
TAR-independent_VBG transactivation_VBG by_VBG Tat_VBG in_VBG cells_VBG derived_VBG from_VBG the_VBG CNS_VBG :_VBG a_VBG novel_VBG mechanism_VBG of_VBG HIV-1_VBG gene_VBG regulation_VBG ._VBG
Compared_VBD to_VBG benign_VBG tumor_VBG or_VBG mammary_VBG reduction_VBG test_VBG material_VBG the_VBG eicosanoid_VBG profile_VBG of_VBG tissue_VBG obtained_VBG from_VBG malignant_VBG mammary_VBG tumors_VBG showed_VBG important_VBG differences_VBG ._VBG
Similar_VBG effects_VBG were_VBG obtained_VBG for_VBG the_VBG c-fos_VBG gene_VBG ._VBG
Of_VBG the_VBG 23_VBG cases_VBG ,_VBG 19_VBG were_VBG classified_VBG as_VBG NK-cell_VBG and_VBG 4_VBG as_VBG T-cell_VBG tumours_VBG ._VBG
Therefore_PRP ,_VBG the_VBG successful_VBG generation_VBG of_VBG surrogate_VBG receptors_VBG on_VBG non-T_VBG cells_VBG is_VBG not_VBG associated_VBG with_VBG more_VBG efficient_VBG TG_VBG presentation_VBG of_VBG T_VBG cells_VBG ._VBG
The_VBG IL-2_VBG and_VBG the_VBG IL-2-R_VBG alpha_VBG genes_VBG are_VBG both_VBG expressed_VBG transiently_VBG in_VBG normal_VBG T_VBG lymphocytes_VBG after_VBG Ag_VBG or_VBG mitogen_VBG activation_VBG ._VBG
The_DT inhibition_CD of_VBG c-fos_VBG and_VBG c-jun_VBG expression_VBG by_VBG IL-4_VBG in_VBG LPS-treated_VBG cells_VBG was_VBG shown_VBG to_VBG be_VBG due_VBG to_VBG a_VBG lower_VBG transcription_VBG rate_VBG of_VBG the_VBG c-fos_VBG and_VBG c-jun_VBG genes_VBG ._VBG
No_VBG age-related_VBG differences_VBG were_VBG found_VBG in_VBG the_VBG expression_VBG of_VBG either_VBG of_VBG these_VBG two_VBG proto-oncogenes_VBG by_VBG anti-CD2_VBG activated_VBG T_VBG cells_VBG ._VBG
In_VBG cotransfection_VBG experiments_VBG we_VBG show_VBG that_VBG all_VBG the_VBG isoforms_VBG are_VBG able_VBG to_VBG activate_VBG an_VBG octamer_VBG containing_VBG promoter_VBG element_VBG in_VBG fibroblasts_VBG revealing_VBG an_VBG unexpected_VBG functional_VBG redundancy_VBG ._VBG
In_NN situ_NN hybridizations_VBZ of_VBG adult_DT murine_JJ tissues_NNS demonstrate_VB Spi-B_NN mRNA_JJ in_VBG the_DT medulla_CD of_VBG the_DT thymus_JJ ,_VBG the_VBG white_VBG pulp_VBG of_VBG the_VBG spleen_VBG ,_VBG and_VBG the_VBG germinal_VBG centers_VBG of_VBG lymph_VBG nodes_VBG ._VBG
All-trans_IN retinoic_JJ acid_CC RA_NN is_VBZ an_IN important_JJ morphogen_VBN in_VBG vertebrate_VBG development_VBG ,_VBG a_VBG normal_VBG constituent_VBG in_VBG human_VBG adult_VBG blood_VBG and_VBG is_VBG also_VBG involved_VBG in_VBG the_VBG control_VBG of_VBG cell_VBG growth_VBG and_VBG differentiation_VBG in_VBG acute_VBG promyelocytic_VBG leukemia_VBG ._VBG
Oct2_VBG transactivation_VBG from_VBG a_VBG remote_VBG enhancer_VBG position_VBG requires_VBG a_VBG B-cell-restricted_VBG activity_VBG ._VBG
Activation_IN of_VBG human_VBG monocytic_VBG cells_VBG by_VBG Treponema_VBG pallidum_VBG and_VBG Borrelia_VBG burgdorferi_VBG lipoproteins_VBG and_VBG synthetic_VBG lipopeptides_VBG proceeds_VBG via_VBG a_VBG pathway_VBG distinct_VBG from_VBG that_VBG of_VBG lipopolysaccharide_VBG but_VBG involves_VBG the_VBG transcriptional_VBG activator_VBG NF-kappa_VBG B_VBG ._VBG
A_DT similar_JJ result_JJ was_NNS obtained_VBN with_CC the_DT mature_VBP monocytic_JJ leukemia_NN cell_NNS line_NN THP-1_NN ._.
Cotransfection_IN of_VBG a_VBG YB-1_JJ expression_NN plasmid_VBD increases_VBZ HTLV-I_NN basal_NN transcription_NN approximately_RB 14-fold_VBN in_VBG Jurkat_FW T_NN lymphocytes_NNS ._.
The_VBG current_VBG study_VBG examined_VBG the_VBG effects_VBG of_VBG oxidative_VBG stress_VBG on_VBG transcriptional_VBG activities_VBG mediated_VBG by_VBG AP-1_VBG and_VBG the_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG NF-AT_VBG ._VBG
A_DT novel_RB T_NN cell-specific_NN negative_JJ regulatory_JJ element_JJ NRE_NN composed_VBD of_VBG two_CD protein-binding_VBG sites_VBG were_VBG mapped_VBG in_VBG the_VBG flanking_VBG region_VBG of_VBG the_VBG IL-4_VBG gene_VBG :_VBG -311CTCCCTTCT-303_VBG NRE-I_VBG and_VBG -288CTTTTTGCTT-TGC-300_VBG NRE-II_VBG ._VBG
Furthermore_PRP ,_VBG JunD_VBG is_VBG shown_VBG to_VBG activate_VBG transcription_VBG of_VBG genes_VBG linked_VBG to_VBG both_VBG cAMP_VBG and_VBG phorbol_VBG ester_VBG response_VBG elements_VBG in_VBG a_VBG protein_VBG kinase_VBG A-dependent_VBG fashion_VBG ,_VBG further_VBG blurring_VBG the_VBG distinction_VBG between_VBG these_VBG response_VBG elements_VBG ._VBG
GCs_VBG induce_VBG apoptosis_VBG in_VBG neoplastic_VBG lymphoid_VBG cells_VBG ;_VBG and_VBG ,_VBG defective_VBG apoptosis_VBG is_VBG implicated_VBG in_VBG the_VBG genesis_VBG of_VBG chronic_VBG lymphocytic_VBG leukemia_VBG CLL_VBG ._VBG
At_RB the_DT level_CD of_VBG the_VBG genomic_VBG TNF_VBG gene_VBG ,_VBG a_VBG DNase_VBG I_VBG hypersensitive_VBG site_VBG is_VBG detected_VBG within_VBG the_VBG TNF_VBG promoter_VBG between_VBG -200_VBG to_VBG -100_VBG bp_VBG relative_VBG to_VBG the_VBG transcription_VBG initiation_VBG site_VBG ._VBG
Increased_VBG expression_VBG of_VBG the_VBG oncogene_VBG in_VBG breast_VBG cancer_VBG correlates_VBG with_VBG decreased_VBG estrogen_VBG receptor_VBG concentration_VBG and_VBG seems_VBG to_VBG be_VBG an_VBG important_VBG prognostic_VBG factor_VBG ._VBG
Exposing_VBG HUVECs_VBG to_VBG induces_VBG an_VBG increase_VBG in_VBG nuclear_VBG factor_VBG kappaB_VBG NF-kappaB_VBG in_VBG HUVEC_VBG nuclei_VBG within_VBG 4_VBG hours_VBG ._VBG
Within_DT this_DT region_RB ,_VBG we_VBG define_VBG a_VBG minimal_VBG promoter_VBG -62_VBG to_VBG that_VBG displays_VBG erythroid-specific_VBG activity_VBG and_VBG contains_VBG two_VBG DNA_VBG binding_VBG sites_VBG ._VBG
This_VBG indicates_VBG an_VBG increase_VBG in_VBG either_VBG episomal_VBG DNA_VBG or_VBG concatameric_VBG linear_VBG DNA_VBG ._VBG
In_NN T_NN cells_VBZ ,_VBG HIV_NNS transcription_NN is_IN poorly_RB detected_JJ in_VBG vivo_NN ._.
No_TO correlation_NN was_IN observed_VBN between_IN c-myc_DT mRNA_NN and_CC B_NN lymphocyte_JJ monoclonicity_NN or_CC lymphoma_NNS ._.
Electrophoretically_VBG purified_VBG p50_VBG alone_VBG can_VBG form_VBG a_VBG protein-DNA_VBG complex_VBG ,_VBG but_VBG in_VBG the_VBG mixture_VBG ,_VBG p50_VBG associates_VBG preferentially_VBG with_VBG p65_VBG to_VBG form_VBG the_VBG NF-GM2_VBG complex_VBG ._VBG
NF-kB_VBG is_VBG a_VBG eukaryotic_VBG transcription_VBG regulatory_VBG factor_VBG ._VBG
Thus_NNS ,_VBG the_VBG estrogen_VBG receptor-related_VBG protein_VBG is_VBG HSP27_VBG ,_VBG and_VBG the_VBG three_VBG major_VBG 29-kDa_VBG proteins_VBG phosphorylated_VBG in_VBG thrombin-activated_VBG platelets_VBG are_VBG forms_VBG of_VBG HSP27_VBG ._VBG
The_VBG BZLF1_VBG protein_VBG of_VBG Epstein-Barr_VBG virus_VBG EBV_VBG is_VBG a_VBG key_VBG immediate-early_VBG protein_VBG which_VBG has_VBG been_VBG shown_VBG to_VBG disrupt_VBG virus_VBG latency_VBG in_VBG EBV-infected_VBG B_VBG cells_VBG ._VBG
In_VBG addition_VBG to_VBG these_VBG novel_VBG E2F_VBG complexes_VBG ,_VBG three_VBG distinct_VBG forms_VBG of_VBG unbound_VBG free_VBG E2F_VBG were_VBG resolved_VBG in_VBG gel_VBG shift_VBG experiments_VBG ._VBG
Pb-induced_VBG activation_VBG of_VBG NF-kappa_VBG B_VBG is_VBG blocked_VBG by_VBG antibodies_VBG for_VBG p65_VBG and_VBG p50_VBG subunits_VBG but_VBG not_VBG cRel_VBG ,_VBG indicating_VBG that_VBG the_VBG p65:p50_VBG heterodimer_VBG NF-kappa_VBG B_VBG is_VBG involved_VBG ._VBG
Basal_DT total_JJ white_NN blood_VBD cell_NN and_NN granulocyte_NN counts_NNS did_JJ not_RB appreciably_RB differ_IN between_IN transgenic_NN and_CC control_NN mice_NN ._.
The_DT implications_NN ,_VBG in_VBG particular_RB ,_VBG in_VBG relation_VBP to_VBG future_VBG prognosis_VBG of_VBG the_VBG patient_VBG ,_VBG remain_VBG obscure_VBG ._VBG
GR_DT was_VBD determined_VBD by_VBG whole_NN cell_NN assay_RB with_IN 3H-Dex_NN ._.
In_VBG contrast_VBG ,_VBG the_VBG C26_VBG element_VBG itself_VBG was_VBG profoundly_VBG activated_VBG upon_VBG stimulation_VBG with_VBG 12-O-tetradecanoylphorbol-13-acetate_VBG ._VBG
Furthermore_PRP ,_VBG an_IN antiserum_NN against_IN KBF1_NN identical_NN to_VBG 50_VBG kDa_DT NF-kappa_NN B_CD protein_NN reacted_NN with_IN the_DT p50_JJ of_VBG NF-GM2_NNS ,_VBG indicating_VBP that_VBG the_VBG NF-GM2_VBG polypeptide_VBG can_VBG not_VBG be_VBG immunologically_VBG differentiated_VBG from_VBG the_VBG 50_VBG kDa_VBG subunit_VBG of_VBG NF-kappa_VBG B_VBG ._VBG
The_DT difference_VB in_VBG signals_VBG transduced_VBG through_VBG sIgM_VBG and_VBG sIgD_VBG in_VBG B104_VBG cells_VBG is_VBG discussed_VBG ._VBG
A_DT novel_RB SP-1_NN site_JJ in_VBG the_VBG human_VBG interleukin-1_VBG beta_VBG promoter_VBG confers_VBG preferential_VBG transcriptional_VBG activity_VBG in_VBG keratinocytes_VBG ._VBG
This_VBG common_VBG pathway_VBG may_VBG involve_VBG reactive_VBG oxygen_VBG intermediates_VBG ROI_VBG as_VBG messenger_VBG molecules_VBG ._VBG
FK506_NNS and_CC cyclosporin_IN A_VBG block_VBG translocation_VBG of_VBG the_VBG cytoplasmic_VBG component_VBG without_VBG affecting_VBG synthesis_VBG of_VBG the_VBG nuclear_VBG subunit_VBG ._VBG
The_VBG molecular_VBG basis_VBG for_VBG restricted_VBG cytokine_VBG expression_VBG by_VBG T_VBG helper_VBG 1_VBG Th1_VBG and_VBG T_VBG helper_VBG 2_VBG Th2_VBG cells_VBG is_VBG unclear_VBG ._VBG
The_DT B_RB cell_NN NFAT_NN complex_NNS ,_VBG however_JJ ,_VBG was_VBG not_VBG functional_VBG ,_VBG since_VBG it_VBG failed_VBG to_VBG activate_VBG transcription_VBG from_VBG an_VBG NFAT-driven_VBG chloramphenicol_VBG acetyltransferase_VBG CAT_VBG construct_VBG ._VBG
HIV-1_NN can_JJ also_RB establish_VB a_VBG latent_VBG or_VBG persistent_VBG infection_VBG in_VBG some_VBG T_VBG cell_VBG lines_VBG that_VBG show_VBG minimal_VBG constitutive_VBG virus_VBG expression_VBG ._VBG
Data_VBG obtained_VBG from_VBG studies_VBG in_VBG laboratories_VBG demonstrate_VBG that_VBG the_VBG proteasome_VBG plays_VBG an_VBG important_VBG role_VBG in_VBG the_VBG inflammatory_VBG cascade_VBG by_VBG regulating_VBG the_VBG activation_VBG of_VBG NF-kappa_VBG B_VBG ._VBG
However_DT ,_VBG when_JJ HL60R_NN cells_NNS were_RB transduced_VBN with_VBD a_VBG functional_JJ copy_JJ of_VBG the_VBG RAR_VBG alpha_VBG gene_VBG ,_VBG RA_VBG induced_VBG a_VBG 10-fold_VBG increase_VBG in_VBG E3_VBG mRNA_VBG levels_VBG ._VBG
In_VBG six_VBG cases_VBG we_VBG determined_VBG MR_VBG ,_VBG plasma_VBG aldosterone_VBG ,_VBG and_VBG SPD_VBG in_VBG patients_VBG with_VBG preeclampsia_VBG before_VBG and_VBG 3_VBG months_VBG after_VBG delivery_VBG ._VBG
In_VBG contrast_VBG ,_VBG GATA-2_VBG is_VBG strongly_VBG expressed_VBG in_VBG both_VBG most_VBG primitive_VBG and_VBG committed_VBG progenitors_VBG cells_VBG ,_VBG whereas_VBG GATA-3_VBG is_VBG mostly_VBG detected_VBG in_VBG most_VBG primitive_VBG ones_VBG ._VBG
Transcription_IN of_VBG the_PRP hypersensitive_JJ site_NN HS2_NN enhancer_JJ in_VBG erythroid_NN cells_NNS ._.
Inhibition_IN of_VBG protein_NN phosphatases_NN by_VBG okadaic_VBG acid_VBG induces_VBG AP1_VBG in_VBG human_VBG T_VBG cells_VBG ._VBG
Activated_VBD T-lymphocytes_NNS are_VBP found_JJ early_JJ in_VBG atherosclerosis_VBG lesions_VBG ,_VBG but_VBG little_VBG is_VBG known_VBG about_VBG role_VBG ._VBG
In_VBG this_VBG work_VBG ,_VBG we_VBG report_VBG that_VBG these_VBG anergic_VBG T_VBG cells_VBG are_VBG defective_VBG in_VBG ability_VBG to_VBG up-regulate_VBG protein_VBG binding_VBG and_VBG transactivation_VBG at_VBG two_VBG critical_VBG IL-2_VBG DNA_VBG enhancer_VBG elements_VBG :_VBG NF-AT_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG ;_VBG a_VBG sequence_VBG that_VBG binds_VBG a_VBG heterotrimeric_VBG NFATp_VBG ,_VBG Fos_VBG ,_VBG and_VBG Jun_VBG protein_VBG complex_VBG and_VBG Activator_VBG Protein-1_VBG AP-1_VBG that_VBG binds_VBG Fos_VBG and_VBG Jun_VBG heterodimers_VBG ._VBG
Lymphocytes_RB activated_VBN with_IN the_JJ OKT3_NN antibody_JJ to_VBG the_DT T-cell_JJ antigen_JJ receptor_NN expressed_VBD fewer_IN binding_VBG sites_VBG as_VBG compared_VBG to_VBG lymphocytes_VBG that_VBG were_VBG activated_VBG by_VBG the_VBG polyclonal_VBG activator_VBG phytohemagglutinin_VBG PHA_VBG ._VBG
Using_JJ a_VBG structure-function_NN mutagenesis_NN approach_RB ,_VBG two_VBG tyrosine_VBG residues_VBG Tyr427_VBG and_VBG Tyr477_VBG in_VBG the_VBG intracellular_VBG domain_VBG of_VBG the_VBG murine_VBG IL-10_VBG receptor_VBG were_VBG found_VBG to_VBG be_VBG redundantly_VBG required_VBG for_VBG receptor_VBG function_VBG and_VBG for_VBG activation_VBG of_VBG Stat3_VBG but_VBG not_VBG for_VBG Stat1_VBG or_VBG Stat5_VBG ._VBG
Threonine_JJ 78_VBG lies_VBG within_VBG the_VBG D-box_VBG of_VBG the_VBG v-erb_VBG A_VBG protein_VBG ,_VBG a_VBG region_VBG thought_VBG to_VBG mediate_VBG receptor-receptor_VBG dimerizations_VBG ,_VBG and_VBG is_VBG not_VBG in_VBG physical_VBG proximity_VBG to_VBG the_VBG serine_VBG at_VBG position_VBG 61_VBG ._VBG
Surprisingly_IN ,_VBG multimers_VBZ of_VBG kappa_DT 1_VBG -_VBG kappa_VBG 3_VBG can_VBG confer_VBG PMA_VBG inducibility_VBG on_VBG a_VBG heterologous_VBG promoter_VBG in_VBG a_VBG B_VBG Raji_VBG ,_VBG but_VBG not_VBG a_VBG T_VBG HUT78_VBG cell_VBG line_VBG ._VBG
Here_EX we_PRP report_VBD that_VBG LTB4_VBG induces_VBG synthesis_VBG of_VBG interleukin_VBG IL_VBG -6_VBG by_VBG human_VBG blood_VBG monocytes_VBG through_VBG transcriptional_VBG activation_VBG of_VBG the_VBG IL-6_VBG gene_VBG ._VBG
The_DT extent_VBP to_VBG which_WDT peptides_NN containing_VBG chemically_JJ and_CC post-translationally_RB modified_VBN amino_IN acid_JJ side_NN chains_VBZ are_VBP recognized_VBD by_VBG primed_VBD CTL_NN has_VBD not_RB been_VB clearly_NN defined_VBN ._.
The_DT data_JJ also_RB indicate_JJ that_VBG CD2_NN receptor_IN activation_NN and_IN phytohemagglutinin_NN plus_VBZ phorbol_NN 12-myristate_NN 13-acetate_NN stimulation_NN augment_JJ T_NN cell_NN IL3_JJ gene_NN expression_IN through_DT the_DT same_JJ cis-_JJ and_CC trans-activating_VBG signals_NNS ._.
A_DT comparison_NNS of_VBG in_VBG situ_VBG hybridization_VBG to_VBG EBV_VBG DNA_VBG and_VBG viral_VBG capsid_VBG antigen_VBG staining_VBG with_VBG BZ1_VBG reactivity_VBG suggested_VBG that_VBG BZLF1_VBG expression_VBG precedes_VBG rampant_VBG virus_VBG replication_VBG ._VBG
Protein_VBG kinase_VBG C_VBG activation_VBG and_VBG protooncogene_VBG expression_VBG in_VBG of_VBG human_VBG U-937_VBG leukemia_VBG cells_VBG ._VBG
Comparison_IN of_VBG the_DT sequences_JJ of_VBG all_NN elements_NNS recognized_JJ by_VBG TCF-1_VBG defines_VBG a_VBG consensus_VBG motif_VBG C_VBG A_VBG A_VBG G_VBG ._VBG
ABSTRACT_NNS TRUNCATED_NN AT_CD 250_VBG WORDS_NN
The_DT binding_VBG affinity_NN was_VBD not_DT different_JJ between_IN patients_NN and_CC controls_NNS ._.
Eosinophils_VBG play_VBG an_VBG important_VBG role_VBG in_VBG the_VBG effector_VBG phase_VBG of_VBG allergic_VBG inflammation_VBG ._VBG
The_DT numbers_VBZ of_VBG leucocytic_JJ ER_NN were_VBP significantly_RB increased_VBN after_NN treatment_NN ._.
Using_JJ a_VBG human_IN TSH_NN receptor_CC TSH-R_NN cDNA_NN probe_JJ ,_VBG we_VBG investigated_VBG TSH-R_VBG transcript_VBG levels_VBG in_VBG 13_VBG human_VBG thyroid_VBG fragments_VBG by_VBG Northern_VBG blot_VBG analysis_VBG ;_VBG 7_VBG Graves_VBG disease_VBG ,_VBG 2_VBG Hashimoto_VBG disease_VBG ,_VBG 3_VBG endemic_VBG goiter_VBG ,_VBG and_VBG 1_VBG healthy_VBG thyroid_VBG gland_VBG were_VBG studied_VBG ._VBG
Expression_VBG was_VBG confirmed_VBG in_VBG the_VBG bone_VBG marrow_VBG with_VBG a_VBG reverse_VBG transcription_VBG PCR_VBG assay_VBG ._VBG
Antiphosphotyrosine_VBG immunoblots_VBG of_VBG whole_VBG cell_VBG lysates_VBG prepared_VBG from_VBG neutrophils_VBG show_VBG that_VBG the_VBG G-CSF_VBG rapidly_VBG induces_VBG prominent_VBG tyrosine_VBG phosphorylation_VBG of_VBG a_VBG protein_VBG of_VBG a_VBG relative_VBG molecular_VBG mass_VBG of_VBG 80_VBG kDa_VBG ._VBG
Most_CD of_VBG the_VBG AP-1_VBG activity_VBG could_VBG be_VBG eliminated_VBG when_VBG the_VBG anti-AIM_VBG mAb_VBG was_VBG added_VBG to_VBG the_VBG culture_VBG medium_VBG in_VBG the_VBG presence_VBG of_VBG cycloheximide_VBG ,_VBG suggesting_VBG that_VBG de_VBG novo_VBG protein_VBG synthesis_VBG is_VBG crucial_VBG for_VBG the_VBG induction_VBG of_VBG AP-1-binding_VBG activity_VBG ._VBG
In_VBG vitro_VBG effects_VBG of_VBG aldosterone_VBG on_VBG the_VBG intracellular_VBG concentrations_VBG of_VBG sodium_VBG ,_VBG potassium_VBG and_VBG calcium_VBG ,_VBG cell_VBG volume_VBG and_VBG the_VBG sodium-proton-antiport_VBG have_VBG been_VBG described_VBG in_VBG intact_VBG human_VBG mononuclear_VBG leukocytes_VBG HML_VBG ._VBG
These_NN findings_NNS suggest_JJ that_VBG the_VBG combination_VBG of_VBG p49_VBG 100_VBG and_VBG p65_VBG NF-kappa_VBG B_VBG can_VBG act_VBG in_VBG concert_VBG with_VBG the_VBG tat-I_VBG gene_VBG product_VBG to_VBG stimulate_VBG the_VBG synthesis_VBG of_VBG HIV_VBG RNA_VBG ._VBG
IL4_VBG and_VBG IL13_VBG receptors_VBG share_VBG the_VBG gamma_VBG c_VBG chain_VBG and_VBG activate_VBG STAT6_VBG ,_VBG STAT3_VBG and_VBG STAT5_VBG proteins_VBG in_VBG normal_VBG human_VBG B_VBG cells_VBG ._VBG
Primary_VBG lymphocyte_VBG cultures_VBG showed_VBG partial_VBG independence_VBG from_VBG exogenous_VBG growth_VBG stimuli_VBG and_VBG increased_VBG resistance_VBG to_VBG low-serum_VBG apoptosis_VBG ._VBG
Retinoic_VBG acid_VBG activates_VBG interferon_VBG regulatory_VBG factor-1_VBG gene_VBG expression_VBG in_VBG myeloid_VBG cells_VBG ._VBG
BACKGROUND_NN ._.
We_NN have_VBP tested_JJ a_VBG variety_JJ of_VBG Oct2_VBG isoforms_VBG generated_VBG by_VBG alternative_VBG splicing_VBG for_VBG the_VBG capability_VBG to_VBG activate_VBG an_VBG octamer_VBG enhancer_VBG in_VBG nonlymphoid_VBG cells_VBG and_VBG a_VBG B-cell_VBG line_VBG ._VBG
Furthermore_PRP ,_VBG the_VBG physical_VBG interaction_VBG of_VBG Tax_VBG with_VBG p100_VBG leads_VBG to_VBG the_VBG inhibition_VBG of_VBG Tax-induced_VBG activation_VBG of_VBG the_VBG HTLV-I_VBG and_VBG human_VBG immunodeficiency_VBG virus_VBG type_VBG 1_VBG long_VBG terminal_VBG repeats_VBG ,_VBG reflecting_VBG p100-mediated_VBG cytoplasmic_VBG sequestration_VBG of_VBG the_VBG normally_VBG nuclearly_VBG expressed_VBG Tax_VBG protein_VBG ._VBG
The_VBG inhibitor_VBG also_VBG dramatically_VBG inhibited_VBG monocyte_VBG chemotactic_VBG activity_VBG of_VBG and_VBG MCP-1_VBG production_VBG by_VBG the_VBG cells_VBG ._VBG
Spi-B_CD and_CC PU.1_NN are_JJ hematopoietic-specific_JJ transcription_NN factors_VBZ that_VBG constitute_NN a_VBG subfamily_JJ of_VBG the_VBG Ets_VBG family_VBG of_VBG DNA-binding_VBG proteins_VBG ._VBG
We_NN have_VBP investigated_VBN whether_RB a_VBG palmitate_VBG conjugate_VBG of_VBG a_VBG human_VBG monoclonal_VBG antibody_VBG specific_VBG for_VBG thyroglobulin_VBG TG_VBG could_VBG function_VBG as_VBG a_VBG surrogate_VBG TG_VBG receptor_VBG on_VBG blood_VBG mononuclear_VBG cells_VBG separated_VBG into_VBG fractions_VBG enriched_VBG for_VBG T_VBG cells_VBG or_VBG depleted_VBG of_VBG T_VBG cells_VBG non-T_VBG cells_VBG ._VBG
Phorbol_DT esters_NNS are_VBP required_VBD to_VBG induce_VBG cell-surface_VBG expression_VBG as_VBG well_VBG as_VBG for_VBG triggering_VBG the_VBG proliferation_VBG of_VBG T_VBG cells_VBG in_VBG conjunction_VBG with_VBG anti-AIM_VBG mAb_VBG ._VBG
The_DT affinity_NNS of_VBG the_VBG BAT_VBG box_VBG binding_VBG proteins_VBG for_VBG the_VBG BAT_VBG box_VBG was_VBG approximately_VBG 25-fold_VBG less_VBG than_VBG for_VBG the_VBG octamer_VBG sequence_VBG and_VBG the_VBG BAT_VBG box_VBG binding_VBG proteins_VBG dissociated_VBG from_VBG the_VBG BAT_VBG box_VBG 10-fold_VBG more_VBG rapidly_VBG than_VBG from_VBG the_VBG octamer_VBG sequence_VBG ._VBG
Although_JJ NFAT_NN has_NNS been_VBN recently_RB shown_IN to_VBG be_VBG inducible_VBG in_VBG several_VBG non-T_VBG immune_VBG cells_VBG ,_VBG the_VBG NFAT_VBG gene_VBG family_VBG members_VBG characterized_VBG to_VBG date_VBG have_VBG been_VBG isolated_VBG only_VBG from_VBG T_VBG cells_VBG ._VBG
Induction_IN of_VBG vascular_VBG cell_VBG adhesion_VBG molecule-1_VBG by_VBG low-density_VBG lipoprotein_VBG ._VBG
Thus_NNS ,_VBG signaling_JJ in_VBG NK3.3_JJ cells_NNS is_NNS not_RB always_VB identical_JJ with_JJ that_VBG in_VBG primary_RB NK_NN cells_NNS ._.
was_VBG found_VBG to_VBG be_VBG hyposialylated_VBG ,_VBG bearing_VBG predominantly_VBG O-linked_VBG monosaccharide_VBG glycans_VBG ,_VBG whereas_VBG bore_VBG complex_VBG sialylated_VBG tetra-_VBG and_VBG hexasaccharide_VBG chains_VBG ._VBG
The_DT experiments_NN in_VBG this_VBG report_VBG show_VBG that_VBG cysteine_VBG or_VBG N-acetylcysteine_VBG NP_VBG raise_VBG the_VBG intracellular_VBG glutathione_VBG GSH_VBG level_VBG and_VBG inhibit_VBG HIV-1_VBG replication_VBG in_VBG persistently_VBG infected_VBG Molt-4_VBG and_VBG U937_VBG cells_VBG ._VBG
3_VBG ._VBG Initial_VBG and_VBG post-dexamethasone_VBG in_VBG vitro_VBG fibroblast_VBG binding_VBG to_VBG glucocorticoid_VBG was_VBG not_VBG different_VBG between_VBG major_VBG depressive_VBG disorder_VBG and_VBG non-depressed_VBG control_VBG subjects_VBG ._VBG
Using_DT electrophoretic_JJ mobility_NN shift_NN assays_NN ,_VBG we_VBG find_VBG that_VBG TPCK_VBG virtually_VBG abolishes_VBG to_VBG less_VBG than_VBG 1_VBG the_VBG levels_VBG of_VBG NF-LRB-kappa-RRB-B_VBG but_VBG not_VBG Oct-1_VBG found_VBG in_VBG nuclear_VBG and_VBG whole_VBG cell_VBG extracts_VBG of_VBG activated_VBG T_VBG cells_VBG ._VBG
In_NN this_DT report_RB ,_VBG we_VBG demonstrate_VBG that_VBG the_VBG corresponding_VBG mutations_VBG in_VBG murine_VBG calcineurin_VBG render_VBG the_VBG T_VBG cell_VBG receptor_VBG signal_VBG transduction_VBG cascade_VBG CsA_VBG resistant_VBG in_VBG human_VBG Jurkat_VBG T_VBG cells_VBG ._VBG
NF-ATn_VBG is_VBG a_VBG ubiquitous_VBG protein_VBG ,_VBG can_VBG be_VBG synthesized_VBG in_VBG response_VBG to_VBG PMA_VBG ,_VBG and_VBG has_VBG many_VBG similarities_VBG to_VBG AP-1_VBG ._VBG
The_DT functional_JJ domains_VBZ of_VBG HS-40_NN were_NN also_RB mapped_VBD ._.
Measurement_DT of_VBG GR_NN mRNA_NNS turnover_JJR in_VBG 6TG1.1_VBG cells_VBG treated_VBG with_VBG actinomycin-D_VBG revealed_VBG a_VBG half-life_VBG of_VBG 2.5_VBG h_VBG ,_VBG which_VBG was_VBG unaffected_VBG by_VBG dexamethasone_VBG treatment_VBG ._VBG
It_VBG is_VBG very_VBG likely_VBG that_VBG these_VBG domains_VBG bind_VBG megakaryocyte-specific_VBG nuclear_VBG proteins_VBG acting_VBG as_VBG positive_VBG transcription_VBG factors_VBG ._VBG
The_DT proband_JJ had_JJ no_TO detectable_VB DPD_NN activity_NN ._.
The_VBG proto-oncoprotein_VBG c-Rel_VBG is_VBG a_VBG member_VBG of_VBG the_VBG nuclear_VBG factor_VBG kappa_VBG B_VBG transcription_VBG factor_VBG family_VBG ,_VBG which_VBG includes_VBG the_VBG p50_VBG and_VBG p65_VBG subunits_VBG of_VBG nuclear_VBG factor_VBG kappa_VBG B_VBG ._VBG
In_VBG addition_VBG ,_VBG the_VBG product_VBG of_VBG the_VBG proto-oncogene_VBG c-rel_VBG can_VBG bind_VBG to_VBG similar_VBG DNA_VBG motifs_VBG by_VBG itself_VBG or_VBG as_VBG a_VBG heterodimer_VBG with_VBG p50_VBG or_VBG p65_VBG ._VBG
This_VBG is_VBG the_VBG first_VBG documented_VBG case_VBG of_VBG female_VBG twins_VBG discordant_VBG for_VBG Fabry_VBG disease_VBG ._VBG
Treatment_DT of_VBG chronically_VBG HIV-infected_VBG PBMC_VBG with_VBG anti-CD2_VBG mAb_VBG has_VBG been_VBG shown_VBG to_VBG induce_VBG the_VBG expression_VBG of_VBG infectious_VBG virus_VBG from_VBG these_VBG cultures_VBG ._VBG
Such_JJ transcription_NN factors_NNS play_VBP a_VBG key_VBG role_VBG in_VBG the_VBG development_VBG of_VBG the_VBG mature_VBG T-cell_VBG phenotype_VBG by_VBG functioning_VBG as_VBG master_VBG regulators_VBG of_VBG T-cell_VBG differentiation_VBG ._VBG
Characterization_IN of_VBG the_DT human_NN myeloid_NN cell_JJ nuclear_JJ differentiation_NN antigen_JJ gene_NN promoter_NN ._.
Increased_VBG natural_VBG killer_VBG cell_VBG activity_VBG correlates_VBG with_VBG low_VBG or_VBG negative_VBG expression_VBG of_VBG the_VBG oncogene_VBG in_VBG patients_VBG with_VBG breast_VBG cancer_VBG ._VBG
SRC-related_VBD proto-oncogenes_NNS and_VBP transcription_NN factors_VBZ in_VBG primary_JJ human_IN T_NN cells_VBZ :_VBG modulation_IN by_VBG cyclosporin_IN A_VBG and_IN FK506_NN ._.
However_DT ,_VBG specific_JJ function_JJ in_VBG these_DT processes_VBZ has_VBZ not_RB been_VB clearly_NN defined_VBN ._.
The_DT involvement_VBP of_VBG p21-LRB-ras-RRB-_CD in_VBG the_VBG regulation_VBG of_VBG calcium-dependent_VBG signals_VBG has_VBG been_VBG suggested_VBG through_VBG analysis_VBG of_VBG role_VBG in_VBG the_VBG activation_VBG of_VBG NF-AT_VBG ._VBG
The_VBG Thy-1_VBG gene_VBG promoter_VBG resembles_VBG a_VBG housekeeping_VBG promoter_VBG in_VBG that_VBG it_VBG is_VBG located_VBG within_VBG a_VBG methylation-free_VBG island_VBG ,_VBG lacks_VBG a_VBG canonical_VBG TATA_VBG box_VBG ,_VBG and_VBG displays_VBG heterogeneity_VBG in_VBG the_VBG termini_VBG of_VBG the_VBG mRNA_VBG ._VBG
Here_DT we_PRP demonstrate_VBD that_VBG hexamethylene_CD bisacetamide_NN HMBA_NN induced_JJ K562_NN cells_VBZ to_VBG differentiate_VB along_NN a_VBG third_VBN pathway_NN ._.
We_VBG have_VBG investigated_VBG the_VBG constitutive_VBG and_VBG inducible_VBG transcriptional_VBG activity_VBG mediated_VBG by_VBG five_VBG kappa_VBG B-related_VBG sequence_VBG elements_VBG in_VBG two_VBG different_VBG cell_VBG types_VBG ._VBG
However_DT ,_VBG X_NN failed_JJ to_VBG react_VBG with_VBG a_VBG variety_VBG of_VBG antibodies_VBG against_VBG Rb_VBG or_VBG p107_VBG ,_VBG implicating_VBG the_VBG involvement_VBG of_VBG an_VBG E1A-binding_VBG protein_VBG other_VBG than_VBG Rb_VBG or_VBG p107_VBG ._VBG
Nuclear_JJ factor_IN kappa_NN B_IN NF-kappa_NN B_CD ;_VBG heterodimer_RB of_VBG p50_VBG and_VBG p65_VBG proteins_VBG have_VBG been_VBG suggested_VBG to_VBG play_VBG an_VBG important_VBG role_VBG in_VBG gene_VBG transcription_VBG of_VBG inflammatory_VBG mediators_VBG when_VBG monocytes_VBG are_VBG stimulated_VBG with_VBG lipopolysaccharide_VBG ._VBG
The_VBG latter_VBG defect_VBG may_VBG provide_VBG an_VBG explanation_VBG for_VBG many_VBG of_VBG the_VBG XP_VBG and_VBG CS_VBG symptoms_VBG that_VBG are_VBG difficult_VBG to_VBG rationalize_VBG based_VBG solely_VBG on_VBG an_VBG NER_VBG defect_VBG ._VBG
Much_JJ attention_NN has_NNS recently_RB focused_JJ on_VBG the_VBG observation_VBG that_VBG UV_VBG light_VBG can_VBG activate_VBG the_VBG long_VBG terminal_VBG repeat_VBG LTR_VBG of_VBG the_VBG human_VBG immunodeficiency_VBG virus_VBG HIV_VBG ._VBG
These_NN results_NNS indicate_VB that_VBG E3_NN is_NNS a_VBG hematopoietic-specific_JJ gene_JJ that_VBG is_VBZ an_RB immediate_JJ target_IN for_VBG the_DT activated_JJ RAR_NN alpha_NN during_VBG myelopoiesis_NN ._.
Structure-function_VBG studies_VBG of_VBG the_VBG GATA-1_VBG protein_VBG could_VBG be_VBG greatly_VBG simplified_VBG and_VBG a_VBG larger_VBG number_VBG of_VBG mutants_VBG studied_VBG ._VBG
T_VBG cell_VBG proliferation_VBG was_VBG induced_VBG by_VBG three_VBG peptides_VBG ,_VBG P1_VBG ,_VBG P4_VBG ,_VBG and_VBG P7_VBG ,_VBG in_VBG 71-100_VBG of_VBG the_VBG donors_VBG tested_VBG before_VBG and_VBG after_VBG vaccination_VBG using_VBG DC_VBG as_VBG APC_VBG ._VBG
We_PRP further_VBP demonstrate_VBP the_DT impact_CD of_VBG platelet-activating_NN factor_NN binding_JJ to_VBG B_VBG cells_VBG by_VBG measuring_VBG platelet-activating_VBG factor_VBG induced_VBG arachidonic_VBG acid_VBG release_VBG and_VBG 5-hydroxyeicosatetraenoic_VBG acid_VBG production_VBG ._VBG
The_DT half-life_NNS of_VBG c-jun_VBG mRNA_VBG was_VBG similar_VBG 45-50_VBG min_VBG in_VBG both_VBG untreated_VBG and_VBG okadaic_VBG acid-induced_VBG cells_VBG ._VBG
In_VBG contrast_VBG ,_VBG there_VBG was_VBG no_VBG regulation_VBG by_VBG glucocorticoids_VBG of_VBG either_VBG the_VBG CD8_VBG or_VBG CD4_VBG antigens_VBG in_VBG the_VBG leukemic_VBG clone_VBG CEM_VBG C1_VBG ._VBG
Rhom-2_VBG mRNA_VBG is_VBG expressed_VBG in_VBG early_VBG mouse_VBG development_VBG in_VBG central_VBG nervous_VBG system_VBG ,_VBG lung_VBG ,_VBG kidney_VBG ,_VBG liver_VBG ,_VBG and_VBG spleen_VBG but_VBG only_VBG very_VBG low_VBG levels_VBG occur_VBG in_VBG thymus_VBG ._VBG
In_NN 1991_VBG ,_VBG we_VBG demonstrated_VBG ,_VBG using_VBG electrophoretic_VBG mobility_VBG shift_VBG assays_VBG ,_VBG that_VBG 3_VBG different_VBG factors_VBG termed_VBG B1_VBG ,_VBG B2_VBG and_VBG B3_VBG with_VBG affinity_VBG for_VBG the_VBG KB-enhancer_VBG target_VBG sequence_VBG were_VBG specifically_VBG detected_VBG in_VBG nuclear_VBG extracts_VBG from_VBG HIV1-infected_VBG monocytes_VBG and_VBG macrophages_VBG ._VBG
In_VBG this_VBG study_VBG ,_VBG we_VBG demonstrate_VBG that_VBG HTLV-I_VBG Tax_VBG can_VBG physically_VBG associate_VBG with_VBG p100_VBG ,_VBG the_VBG product_VBG of_VBG the_VBG Rel-related_VBG NF-kappa_VBG B2_VBG gene_VBG ,_VBG both_VBG in_VBG transfected_VBG cells_VBG and_VBG in_VBG HTLV-I-infected_VBG leukemic_VBG T-cell_VBG lines_VBG ._VBG
Estrogen_IN receptor_NN positive_VBP :_VBG MCF-7_VBG and_VBG negative_VBG ER-_VBG :_VBG MDA-MB-231_VBG human_VBG breast_VBG cancer_VBG cell_VBG lines_VBG were_VBG utilized_VBG to_VBG evaluate_VBG the_VBG effects_VBG of_VBG tamoxifen_VBG TAM_VBG and_VBG estradiol_VBG E2_VBG on_VBG modulation_VBG of_VBG breast_VBG cancer_VBG target_VBG susceptibility_VBG to_VBG lysis_VBG by_VBG lymphokine-activated_VBG killer_VBG LAK_VBG cells_VBG ._VBG
Thus_NNS ,_VBG autoreactive_JJ T-cells_NN identify_RB a_VBG novel_VBG antigen_VBG ,_VBG p38_VBG jun-B_VBG ,_VBG in_VBG IDDM_VBG and_VBG appear_VBG to_VBG indicate_VBG subjects_VBG at_VBG risk_VBG for_VBG the_VBG development_VBG of_VBG clinical_VBG disease_VBG ._VBG
Results_DT of_VBG preliminary_VBG studies_VBG ,_VBG many_VBG of_VBG which_VBG were_VBG conducted_VBG by_VBG Dr._VBG Dezube_VBG ,_VBG suggest_VBG that_VBG use_VBG of_VBG this_VBG agent_VBG in_VBG combination_VBG with_VBG antiretroviral_VBG compounds_VBG may_VBG prove_VBG useful_VBG in_VBG the_VBG treatment_VBG of_VBG patients_VBG with_VBG HIV-1_VBG infection_VBG
However_DT ,_VBG activation_DT of_VBG the_DT T_JJ cell_NN lines_VBZ leading_VBG to_VBG enhanced_VBG HIV-1_VBG replication_VBG can_VBG be_VBG induced_VBG by_VBG antigens_VBG ,_VBG mitogens_VBG ,_VBG and_VBG cytokines_VBG tumor_VBG necrosis_VBG factor_VBG alpha_VBG TNF-alpha_VBG ,_VBG interleukin_VBG 1_VBG ,_VBG and_VBG interleukin-2_VBG ._VBG
Cell_JJ activation_NN resulted_JJ in_VBG a_VBG delayed_VBG induction_VBG of_VBG STAT_VBG DNA-binding_VBG activity_VBG ,_VBG which_VBG was_VBG sustained_VBG for_VBG several_VBG days_VBG ,_VBG was_VBG composed_VBG predominantly_VBG of_VBG Stat1_VBG and_VBG Stat3_VBG ,_VBG and_VBG was_VBG blocked_VBG by_VBG cycloheximide_VBG and_VBG actinomycin_VBG D_VBG ._VBG
Glucocorticoid-mediated_VBG inhibition_VBG of_VBG RANTES_VBG expression_VBG in_VBG human_VBG T_VBG lymphocytes_VBG ._VBG
Jurkat_PRP cells_NNS were_RB transfected_VBN with_IN plasmids_JJ containing_VBG either_VBG the_VBG intact_VBG IL-2_VBG promoter_VBG or_VBG AP-1_VBG ,_VBG NF-AT_VBG ,_VBG and_VBG NF-kB_VBG motifs_VBG ._VBG
The_DT presence_NNS of_VBG an_VBG AP-1_VBG protein_VBG in_VBG the_VBG NF-AT_VBG protein_VBG complex_VBG may_VBG regulate_VBG NF-AT-binding_VBG activity_VBG through_VBG protein-protein_VBG interaction_VBG ._VBG
Estrogens_NN and_CC anti-estrogens_NNS enhance_NN the_DT number_CD of_VBG immunoglobulin_JJ Ig_NN -secreting_VBG cells_VBG in_VBG pokeweed_VBG mitogen_VBG PWM_VBG -stimulated_VBG lymphocyte_VBG cultures_VBG ._VBG
First_PRP ,_VBG Tax_VBG was_VBG found_VBG to_VBG interact_VBG with_VBG the_VBG 35-kDa_VBG alpha_VBG subunit_VBG of_VBG TFIIA_VBG in_VBG the_VBG yeast_VBG two-hybrid_VBG interaction_VBG system_VBG ._VBG
The_DT results_NN are_VBP discussed_VBD in_VBG the_DT context_VBP of_VBG a_VBG model_JJ relating_VBG the_DT two_JJ nuclear_JJ NF-AT_NN complexes_JJ to_VBG NF-ATp_NN ._.
Here_EX we_PRP report_VBD that_VBG tepoxalin_VBG selectively_VBG inhibits_VBG intercellular_VBG adhesion_VBG molecule-1_VBG ICAM-1_VBG ,_VBG CD54_VBG dependent_VBG adhesion_VBG of_VBG polymorphonuclear_VBG cells_VBG to_VBG IL-1_VBG activated_VBG human_VBG umbilical_VBG vein_VBG endothelial_VBG cells_VBG ._VBG
Therefore_RB oxygen_IN therapy_DT is_VBZ helpful_RB in_VBG raising_VBG the_VBG activity_VBG of_VBG glucocorticoid_VBG receptors_VBG and_VBG controlling_VBG the_VBG development_VBG of_VBG the_VBG disease_VBG ._VBG
Acquired_VBD immunodeficiency_NN syndrome_VBP AIDS_NN results_NN from_VBG infection_VBG with_VBG a_VBG human_VBG immunodeficiency_VBG virus_VBG HIV_VBG ._VBG
In_VBG this_VBG study_VBG we_VBG analyzed_VBG the_VBG T_VBG cell_VBG receptor_VBG TcR_VBG delta_VBG transcripts_VBG expressed_VBG by_VBG cells_VBG and_VBG we_VBG investigated_VBG whether_VBG these_VBG cells_VBG expressed_VBG the_VBG hGATA-3_VBG T_VBG cell_VBG transcription_VBG factor_VBG and_VBG the_VBG recombination-activating_VBG gene_VBG RAG_VBG -1_VBG ._VBG
The_VBG first_VBG objective_VBG of_VBG this_VBG study_VBG was_VBG to_VBG determine_VBG whether_VBG human_VBG DC_VBG mediate_VBG in_VBG vitro_VBG sensitization_VBG of_VBG naive_VBG T_VBG cells_VBG to_VBG epitopes_VBG of_VBG the_VBG immediate_VBG early_VBG 62_VBG IE62_VBG protein_VBG of_VBG varicella_VBG zoster_VBG virus_VBG VZV_VBG ._VBG
Here_DT we_PRP show_VBD that_VBG phorbol_VBG ester_VBG treatment_VBG also_VBG abolishes_VBG induction_VBG of_VBG chloramphenicol_VBG acetyltransferase_VBG activity_VBG in_VBG Ar-5_VBG cells_VBG transfected_VBG with_VBG a_VBG plasmid_VBG containing_VBG the_VBG IL-2_VBG promoter_VBG linked_VBG to_VBG this_VBG reporter_VBG gene_VBG ._VBG
IL-12_VBG is_VBG a_VBG powerful_VBG skewer_VBG of_VBG T_VBG cell_VBG responses_VBG toward_VBG the_VBG Th1_VBG phenotype_VBG by_VBG inducing_VBG IFN-gamma_VBG production_VBG in_VBG naive_VBG Th_VBG cells_VBG ._VBG
Using_JJ this_DT assay_RB ,_VBG we_VBG have_VBG detected_VBG NF_VBG kappa_VBG B_VBG in_VBG extracts_VBG of_VBG nuclei_VBG from_VBG normal_VBG human_VBG monocytes_VBG ._VBG
These_DT data_JJ support_NN the_DT view_JJ of_VBG an_VBG impaired_VBG ligand-induced_VBG plasticity_VBG of_VBG glucocorticoid_VBG receptor_VBG regulation_VBG rather_VBG than_VBG the_VBG hypothesis_VBG of_VBG decreased_VBG glucocorticoid_VBG receptor_VBG numbers_VBG during_VBG depression_VBG ._VBG
The_DT emergence_NNS of_VBG nuclear_DT binding_NN proteins_NN was_VBD investigated_JJ using_VBG interleukin-2_VBG sequence_VBG specific_VBG oligonucleotide_VBG probes_VBG in_VBG the_VBG electrophoretic_VBG mobility_VBG shift_VBG assay_VBG ._VBG
We_VBG demonstrated_VBG that_VBG CMV_VBG infection_VBG increased_VBG both_VBG IL-6_VBG protein_VBG and_VBG mRNA_VBG in_VBG peripheral_VBG blood_VBG mononuclear_VBG cells_VBG ._VBG
Naive_VBG T_VBG lymphocytes_VBG are_VBG more_VBG sensitive_VBG to_VBG oxidative_VBG stress-induced_VBG signals_VBG than_VBG memory_VBG cells_VBG ._VBG
Selective_VBG effects_VBG of_VBG DNA_VBG damaging_VBG agents_VBG on_VBG HIV_VBG long_VBG terminal_VBG repeat_VBG activation_VBG and_VBG virus_VBG replication_VBG in_VBG vitro_VBG ._VBG
We_VBG have_VBG now_VBG examined_VBG expression_VBG of_VBG the_VBG mouse_VBG E2A_VBG gene_VBG at_VBG the_VBG protein_VBG level_VBG using_VBG polyclonal_VBG antisera_VBG directed_VBG against_VBG distinct_VBG portions_VBG of_VBG the_VBG E2A_VBG protein_VBG to_VBG probe_VBG blots_VBG of_VBG cellular_VBG extracts_VBG ._VBG
In_VBG contrast_VBG ,_VBG TGF-beta_VBG had_VBG only_VBG minimal_VBG effects_VBG on_VBG two_VBG other_VBG B_VBG cell_VBG membrane_VBG proteins_VBG ,_VBG HLA-DR_VBG and_VBG CD20_VBG ._VBG
Concomitant_VBG stimulation_VBG by_VBG VitD3_VBG inhibited_VBG the_VBG RA-stimulated_VBG formation_VBG of_VBG RAR_VBG heterodimers_VBG ,_VBG favoring_VBG binding_VBG to_VBG the_VBG RARE_VBG ._VBG
Since_PRP recent_JJ studies_NNS have_VBP shown_RB that_VBG lipopolysaccharide-induced_VBN tyrosine_JJ kinase_JJ activation_NN is_NNS not_RB required_VB for_VBG NFkappaB_NNS nuclear_JJ translocation_JJ ,_VBG we_VBG sought_VBG to_VBG determine_VBG whether_VBG NFkappaB_VBG translocated_VBG in_VBG the_VBG absence_VBG of_VBG tyrosine_VBG kinase_VBG activity_VBG was_VBG active_VBG in_VBG stimulating_VBG transcription_VBG ._VBG
Although_VBG both_VBG viruses_VBG establish_VBG latency_VBG in_VBG quiescent_VBG human-peripheral-blood_VBG T_VBG cells_VBG ,_VBG the_VBG asymptomatic_VBG phase_VBG of_VBG HIV-2_VBG infection_VBG may_VBG be_VBG more_VBG prolonged_VBG than_VBG that_VBG of_VBG HIV-1_VBG ._VBG
These_VBG results_VBG show_VBG that_VBG ,_VBG physiologically_VBG ,_VBG high_VBG levels_VBG of_VBG nuclear_VBG of_VBG p50_VBG ,_VBG p52_VBG and_VBG RelB_VBG are_VBG restricted_VBG to_VBG accessory_VBG cells_VBG of_VBG the_VBG immune_VBG system_VBG ,_VBG which_VBG include_VBG FDC_VBG in_VBG GC_VBG ,_VBG and_VBG DC_VBG and_VBG macrophages_VBG in_VBG the_VBG T_VBG cell_VBG zone_VBG ,_VBG that_VBG specialized_VBG scavenger_VBG macrophages_VBG from_VBG GC_VBG do_VBG not_VBG have_VBG detectable_VBG levels_VBG of_VBG p52_VBG and_VBG RelB_VBG ,_VBG whereas_VBG macrophages_VBG from_VBG the_VBG T_VBG cell_VBG area_VBG ,_VBG known_VBG to_VBG present_VBG the_VBG antigen_VBG to_VBG T_VBG cells_VBG ,_VBG do_VBG have_VBG both_VBG nuclear_VBG p52_VBG and_VBG RelB_VBG ,_VBG and_VBG that_VBG in_VBG the_VBG T_VBG cell_VBG zone_VBG ,_VBG p52_VBG and_VBG RelB_VBG are_VBG located_VBG in_VBG nuclei_VBG of_VBG both_VBG ,_VBG or_VBG both_VBG ,_VBG cells_VBG APC_VBG ,_VBG whereas_VBG p50_VBG is_VBG restricted_VBG to_VBG CD1a-_VBG and_VBG CD68-_VBG APC_VBG ._VBG
Functional_IN interaction_NN between_VBN the_DT two_CD zinc_CD finger_NN domains_NN of_VBG the_DT v-erb_CD A_VBG oncoprotein_NN ._.
Susceptibility_RB of_VBG these_VBG transformed_VBG cell_VBG lines_VBG to_VBG NK_VBG cells_VBG was_VBG determined_VBG by_VBG cytolytic_VBG assays_VBG ._VBG
This_NN is_VBZ most_JJ likely_RB due_VB to_VBG the_DT presence_CD of_VBG the_DT lymphoid-specific_NN OTF-2_JJ factor_NN ._.
v-erbA_VBG overexpression_VBG is_VBG required_VBG to_VBG extinguish_VBG c-erbA_VBG function_VBG in_VBG erythroid_VBG cell_VBG differentiation_VBG and_VBG regulation_VBG of_VBG the_VBG erbA_VBG target_VBG gene_VBG CAII_VBG ._VBG
Sterol_VBG dependent_VBG LDL-receptor_VBG gene_VBG transcription_VBG in_VBG lymphocytes_VBG from_VBG normal_VBG and_VBG CML_VBG patients_VBG ._VBG
Purified_VBG NF-kB_VBG is_VBG also_VBG able_VBG to_VBG bind_VBG to_VBG the_VBG TCEd_VBG ,_VBG but_VBG TCF-1_VBG binds_VBG stronger_VBG than_VBG NF-kB_VBG to_VBG TCEd_VBG DNA_VBG ._VBG
Cytomegalovirus_NN modulates_VBZ interleukin-6_NN gene_CD expression_NN ._.
The_DT results_NN of_VBG the_VBG present_VBG study_VBG demonstrate_VBG that_VBG dysfunction_VBG of_VBG these_VBG genes_VBG also_VBG occurs_VBG during_VBG recurrence_VBG of_VBG glial_VBG tumors_VBG that_VBG were_VBG highly_VBG malignant_VBG at_VBG first_VBG presentation_VBG ._VBG
2_CD ._. These_FW two_CD types_CD of_VBG estrogen_VBN binding_NN sites_NNS existed_JJ in_VBG human_JJ peripheral_NN blood_VBD monocytes_NNS ._.
The_DT GCR_NN binding_VBG affinity_VBG for_VBG budesonide_VBG was_VBG significantly_VBG higher_VBG in_VBG both_VBG groups_VBG i.e._VBG ,_VBG lower_VBG dissociation_VBG constant_VBG than_VBG that_VBG obtained_VBG for_VBG dexamethasone_VBG ._VBG
Further_JJ deletional_NN and_CC alanine_DT mutagenesis_NN analyses_CC and_CC comparison_VBN with_IN TRAF_NN binding_VBG sequences_VBG in_VBG CD40_VBG ,_VBG in_VBG CD30_VBG ,_VBG and_VBG in_VBG the_VBG LMP1_VBG of_VBG other_VBG lymphycryptoviruses_VBG provide_VBG the_VBG first_VBG evidence_VBG that_VBG is_VBG a_VBG core_VBG TRAF_VBG binding_VBG motif_VBG ._VBG
The_VBG hepatitis_VBG B_VBG virus_VBG genome_VBG encodes_VBG a_VBG transcriptional_VBG transactivator_VBG protein_VBG designated_VBG HBxAg_VBG ._VBG
Differences_DT in_VBG pre-_VBG and_VBG postoperative_VBG values_VBG of_VBG cancer_VBG patients_VBG were_VBG seen_VBG in_VBG plasma_VBG RIA_VBG values_VBG :_VBG PGE2_VBG and_VBG 6-k-PGF1_VBG alpha_VBG were_VBG significantly_VBG higher_VBG preoperatively_VBG when_VBG compared_VBG with_VBG postoperatively_VBG ,_VBG however_VBG ,_VBG such_VBG differences_VBG were_VBG seen_VBG in_VBG the_VBG control_VBG groups_VBG as_VBG well_VBG ._VBG
The_DT purified_VBD NF-GM2_NN activated_JJ in_VBG vitro_VBG transcription_VBG from_VBG the_VBG kappa_VBG B_VBG enhancer_VBG ,_VBG while_VBG it_VBG failed_VBG to_VBG stimulate_VBG transcription_VBG from_VBG the_VBG GM-CSF_VBG promoter_VBG harboring_VBG the_VBG GM2_VBG sequence_VBG ._VBG
NF-E1_CD is_VBZ encoded_VBD by_VBG the_VBG same_VBG gene_VBG as_VBG the_VBG YY-1_VBG protein_VBG ,_VBG which_VBG binds_VBG to_VBG the_VBG adeno-associated_VBG virus_VBG P5_VBG promoter_VBG ._VBG
Circadian_VBG rhythm_VBG in_VBG glucocorticoid_VBG receptor_VBG GR_VBG was_VBG studied_VBG in_VBG the_VBG rat_VBG liver_VBG and_VBG human_VBG peripheral_VBG leukocytes_VBG ._VBG
Starting_VBG with_VBG a_VBG replication-incompetent_VBG molecular_VBG clone_VBG of_VBG human_VBG immunodeficiency_VBG virus_VBG type_VBG 1_VBG ,_VBG lacking_VBG all_VBG the_VBG NF-kappa_VBG B_VBG and_VBG Sp1_VBG binding_VBG sites_VBG present_VBG in_VBG the_VBG native_VBG long_VBG terminal_VBG repeat_VBG LTR_VBG ,_VBG proviruses_VBG containing_VBG reconstructed_VBG LTRs_VBG with_VBG individual_VBG or_VBG combinations_VBG of_VBG NF-kappa_VBG B_VBG and_VBG Sp1_VBG elements_VBG were_VBG generated_VBG and_VBG evaluated_VBG for_VBG capacity_VBG to_VBG produce_VBG virus_VBG progeny_VBG following_VBG transfection-cocultivation_VBG ._VBG
In_DT preincubated_JJ cells_JJ ,_VBG the_VBG cycloheximide_VBG response_VBG is_VBG decreased_VBG ,_VBG especially_VBG in_VBG the_VBG case_VBG of_VBG FOSB_VBG ._VBG
Native_VBG PTF_VBG beta_VBG ,_VBG in_VBG either_VBG protein_VBG fractions_VBG or_VBG a_VBG PTF-Oct-1-DNA_VBG complex_VBG ,_VBG can_VBG be_VBG recognized_VBG by_VBG polyclonal_VBG antibodies_VBG raised_VBG against_VBG recombinant_VBG PTF_VBG beta_VBG ._VBG
For_VBG all_VBG other_VBG arginine_VBG mutations_VBG ,_VBG no_VBG differences_VBG in_VBG affinity_VBG were_VBG detectable_VBG ._VBG
If_VBG GATA-1-_VBG -red_VBG cells_VBG were_VBG available_VBG ,_VBG the_VBG analyses_VBG would_VBG involve_VBG the_VBG actual_VBG transcription_VBG of_VBG or_VBG chromatin_VBG structure_VBG surrounding_VBG the_VBG globin_VBG genes_VBG ._VBG
These_NN results_NNS indicate_VB that_VBG activation_VBN of_VBG c-fos_VBG is_VBG involved_VBG in_VBG IL_VBG 6-induced_VBG differentiation_VBG of_VBG SKW_VBG 6.4_VBG cells_VBG into_VBG IgM-secreting_VBG cells_VBG ._VBG
Here_EX we_PRP report_VBD that_VBG both_DT IL-4_NN and_CC IL-13_JJ share_NN signaling_VBG events_VBG in_VBG human_VBG colon_VBG carcinoma_VBG cell_VBG lines_VBG HT-29_VBG and_VBG WiDr_VBG ._VBG
First_PRP ,_VBG it_VBG gives_VBG no_VBG information_VBG on_VBG memory_VBG to_VBG lytic_VBG cycle_VBG antigens_VBG ;_VBG second_VBG ,_VBG it_VBG preferentially_VBG amplifies_VBG the_VBG dominant_VBG components_VBG of_VBG latent_VBG antigen-specific_VBG memory_VBG at_VBG the_VBG expense_VBG of_VBG key_VBG subdominant_VBG reactivities_VBG ._VBG
Transfection_IN of_VBG an_NN AP-2_NN expression_NN construct_CC into_VBG T-lymphocytes_VBG activated_VBG gene_VBG expression_VBG from_VBG the_VBG HTLV-I_VBG LTR_VBG ._VBG
The_DT kinetics_CD of_VBG expression_NNS of_VBG the_VBG two_VBG genes_VBG were_VBG also_VBG slightly_VBG different_VBG ,_VBG with_VBG c-fos_VBG mRNA_VBG reaching_VBG a_VBG peak_VBG at_VBG 15_VBG min_VBG after_VBG stimulation_VBG and_VBG c-jun_VBG at_VBG 30_VBG min_VBG ._VBG
c-myc_IN protooncogene_NN is_VBZ implicated_VBD in_VBG the_VBG pathogenesis_VBG of_VBG B_VBG cell_VBG lymphoid_VBG malignancies_VBG and_VBG high_VBG levels_VBG of_VBG c-myc_VBG mRNA_VBG expression_VBG are_VBG observed_VBG in_VBG activated_VBG blood_VBG mononuclear_VBG cells_VBG ._VBG
Lymphocyte_JJ glucocorticoid_NN receptor_NN number_JJR in_VBG posttraumatic_JJ stress_NN disorder_NN ._.
Differential_VBG autoregulation_VBG of_VBG glucocorticoid_VBG receptor_VBG expression_VBG in_VBG human_VBG T-_VBG and_VBG B-cell_VBG lines_VBG ._VBG
However_DT ,_VBG inhibition_DT of_VBG HIV-1_VBG replication_VBG appears_VBG not_VBG to_VBG be_VBG directly_VBG correlated_VBG with_VBG GSH_VBG levels_VBG ._VBG
In_NN 19_VBG patients_VBG with_VBG a_VBG malignant_VBG breast_VBG tumor_VBG ,_VBG tumor_VBG tissue_VBG and_VBG blood_VBG were_VBG taken_VBG to_VBG determine_VBG the_VBG eicosanoid_VBG profile_VBG and_VBG platelet_VBG aggregation_VBG ._VBG
G0S24_VBG is_VBG a_VBG member_VBG of_VBG a_VBG set_VBG of_VBG genes_VBG putative_VBG switch_VBG regulatory_VBG genes_VBG that_VBG are_VBG expressed_VBG transiently_VBG within_VBG 1-2_VBG hr_VBG of_VBG the_VBG addition_VBG of_VBG lectin_VBG or_VBG cycloheximide_VBG to_VBG human_VBG blood_VBG mononuclear_VBG cells_VBG ._VBG
We_VBG report_VBG on_VBG the_VBG CTL_VBG recognition_VBG of_VBG a_VBG MHC_VBG class_VBG I-restricted_VBG peptide_VBG containing_VBG a_VBG cyclized_VBG asparagine_VBG succinimide_VBG residue_VBG ._VBG
Since_VBG induction_VBG of_VBG the_VBG IL-2_VBG receptor_VBG alpha_VBG subunit_VBG is_VBG a_VBG hallmark_VBG of_VBG lymphocyte_VBG activation_VBG ,_VBG we_VBG suggest_VBG that_VBG p21ras_VBG naturally_VBG triggers_VBG B_VBG cell_VBG activation_VBG ._VBG
Regulation_IN of_VBG glucocorticoid_VBG receptor_VBG GR_VBG expression_VBG by_VBG cognate_VBG ligand_VBG was_VBG examined_VBG in_VBG the_VBG glucocorticoid-sensitive_VBG human_VBG leukemic_VBG T-cell_VBG line_VBG 6TG1.1_VBG and_VBG in_VBG the_VBG human_VBG B-cell_VBG line_VBG IM-9_VBG ._VBG
Induced_VBD myeloid_JJ differentiation_IN of_VBG K562_VBG cells_VBG with_VBG downregulation_VBG of_VBG erythroid_VBG and_VBG megakaryocytic_VBG transcription_VBG factors_VBG :_VBG a_VBG novel_VBG experimental_VBG model_VBG for_VBG hemopoietic_VBG lineage_VBG restriction_VBG ._VBG
corresponding_DT plasma_NN cortisol_NN levels_VBZ were_RB assessed_VBN ._.
Changes_DT in_VBG leucocytic_JJ estrogen_IN receptor_NN levels_VBZ in_VBG patients_NNS with_IN gynecomastia_NN
Egr-1_DT mRNA_NN expression_NN induced_JJ by_VBG sIgM-_NNS and_CC sIgD-crosslinking_VBG was_VBD inhibited_JJ by_VBG H7_FW ,_VBG erbstatin_JJ and_CC genistein_RB ,_VBG but_CC not_JJ by_VBG HA1004_NN ._.
Low-density_IN lipoprotein_NN LDL_NN is_NNS a_VBG well-established_VBG risk_VBG factor_VBG for_VBG atherosclerosis_VBG ._VBG
Activation_IN of_VBG T_VBG cells_VBG by_VBG antigen_VBG ,_VBG lectin_VBG ,_VBG or_VBG a_VBG combination_VBG of_VBG phorbol-12-myristate_VBG acetate_VBG PMA_VBG and_VBG calcium_VBG ionophore_VBG A23187_VBG leads_VBG to_VBG the_VBG induction_VBG of_VBG genes_VBG for_VBG a_VBG set_VBG of_VBG lymphokines_VBG ,_VBG including_VBG granulocyte-macrophage_VBG colony-stimulating_VBG factor_VBG GM-CSF_VBG ._VBG
We_DT have_VBP found_JJ that_VBG the_VBG basic_VBG domains_VBG of_VBG all_VBG the_VBG myogenic_VBG factors_VBG remain_VBG unaltered_VBG in_VBG rhabdomyosarcomas_VBG ._VBG
The_DT mechanism_NNS by_VBG which_WDT NF-ATc_JJ enters_VBZ the_DT nucleus_NNS is_VBZ unknown_RB ,_VBG and_VBG although_VBG it_VBG appears_VBG to_VBG require_VBG calcineurin_VBG ,_VBG NF-ATc_VBG has_VBG not_VBG yet_VBG been_VBG shown_VBG to_VBG be_VBG an_VBG in_VBG vivo_VBG substrate_VBG of_VBG calcineurin_VBG ._VBG
A_VBG 2-4-fold_VBG increase_VBG in_VBG IFN-beta_VBG promoter_VBG transcription_VBG was_VBG observed_VBG in_VBG Sendai_VBG virus_VBG induced_VBG extracts_VBG ,_VBG and_VBG deletion_VBG of_VBG PRDI_VBG and_VBG PRDII_VBG elements_VBG decreased_VBG this_VBG induced_VBG level_VBG of_VBG transcription_VBG ._VBG
Deletion_IN of_VBG all_RB the_DT Sp_NN 1-binding_VBG sites_VBG from_VBG the_VBG enhancer_VBG reduces_VBG transcription_VBG by_VBG 80-90_VBG in_VBG HeLa_VBG ,_VBG as_VBG well_VBG as_VBG in_VBG BJA-B_VBG cells_VBG ,_VBG whereas_VBG the_VBG removal_VBG of_VBG the_VBG octamer-binding_VBG site_VBG reduces_VBG transcription_VBG to_VBG levels_VBG below_VBG detection_VBG in_VBG both_VBG cell_VBG types_VBG ._VBG
Basophils_DT express_NNS GATA-2_NN and_CC GATA-3_JJ ._.
To_CD further_JJ characterize_JJ the_NN protein-DNA_NN interactions_VBZ mediating_VBG IFN-beta_VBG induction_VBG ,_VBG positive_VBG regulatory_VBG domain_VBG PRD_VBG II_VBG binding_VBG proteins_VBG were_VBG purified_VBG from_VBG phorbol_VBG ester_VBG induced_VBG Jurkat_VBG T-cells_VBG and_VBG from_VBG IFN_VBG primed_VBG ,_VBG acid_VBG treated_VBG HeLa_VBG S3_VBG cells_VBG ._VBG
We_VBG show_VBG that_VBG the_VBG ability_VBG to_VBG detect_VBG NF-ATp_VBG in_VBG a_VBG gel_VBG shift_VBG assay_VBG ,_VBG which_VBG is_VBG essential_VBG for_VBG purification_VBG and_VBG biochemical_VBG studies_VBG of_VBG this_VBG protein_VBG ,_VBG is_VBG strikingly_VBG dependent_VBG on_VBG the_VBG precise_VBG sequence_VBG of_VBG the_VBG NF-AT_VBG oligonucleotide_VBG used_VBG as_VBG the_VBG labeled_VBG probe_VBG ._VBG
We_PRP ,_VBG therefore_DT ,_VBG examined_JJ glucocorticoid_NN receptor_NN characteristics_VBZ on_VBG mononuclear_JJ leukocytes_NN by_VBG measuring_JJ -LCB-3H-RCB-dexamethasone_NN binding_VBG and_VBG the_VBG effect_VBG of_VBG dexamethasone_VBG on_VBG -LCB-3H-RCB-thymidine_VBG incorporation_VBG ,_VBG which_VBG is_VBG one_VBG of_VBG the_VBG effects_VBG of_VBG glucocorticoid_VBG receptor_VBG activation_VBG ._VBG
The_VBG resultant_VBG primer_VBG products_VBG are_VBG analysed_VBG by_VBG denaturing_VBG polyacrylamide_VBG gel_VBG electrophoresis_VBG and_VBG autoradiography_VBG ._VBG
We_DT previously_RB reported_VBP the_DT purification_CD of_VBG human_VBG PTF_VBG ,_VBG a_VBG complex_VBG of_VBG four_VBG subunits_VBG ,_VBG and_VBG the_VBG molecular_VBG cloning_VBG and_VBG characterization_VBG of_VBG PTF_VBG gamma_VBG and_VBG delta_VBG subunits_VBG ._VBG
One_DT of_VBG the_DT major_JJ objectives_NN in_VBG the_DT study_NNS of_VBG thrombogenesis_VBG is_VBG to_VBG determine_VBG the_VBG mechanisms_VBG by_VBG which_VBG a_VBG hematopoietic_VBG progenitor_VBG is_VBG activated_VBG and_VBG committed_VBG to_VBG the_VBG megakaryocytic_VBG lineage_VBG ._VBG
The_VBG anaphylatoxin_VBG C3a_VBG has_VBG been_VBG reported_VBG to_VBG have_VBG immunomodulatory_VBG effects_VBG on_VBG a_VBG number_VBG of_VBG different_VBG cell_VBG types_VBG ._VBG
One_PRP HIV-1_NN variant_IN was_VBD detected_VBN containing_VBG an_JJ additional_JJ binding_VBG site_VBG for_VBG the_VBG transcription_VBG factor_VBG Sp1_VBG ._VBG
The_DT microA_NN motif_CD was_VBD required_VBD for_VBG microB-dependent_DT enhancer_NN activity_IN ,_VBG which_VBG suggests_VBG that_VBG a_VBG minimal_VBG B_VBG cell-specific_VBG enhancer_VBG is_VBG composed_VBG of_VBG both_VBG the_VBG PU.1_VBG and_VBG Ets-1_VBG binding_VBG sites_VBG ._VBG
Characterization_IN of_VBG Grb2-binding_VBG proteins_VBG in_VBG human_VBG platelets_VBG activated_VBG by_VBG Fc_VBG gamma_VBG RIIA_VBG cross-linking_VBG ._VBG
RESULTS_NN ._.
Propylthiouracil_JJ 50_VBG did_VBG not_VBG affect_VBG the_VBG action_VBG of_VBG T3SO4_VBG ,_VBG suggesting_VBG that_VBG deiodination_VBG was_VBG not_VBG important_VBG for_VBG this_VBG activity_VBG of_VBG T3SO4_VBG ._VBG
CsA_CD and_CC FK506_NN associate_JJ with_IN intracellular_JJ binding_VBG proteins_NNS i.e._CD ,_VBG CsA_JJ with_IN cyclophilin_DT A_VBG and_VBG FK506_VBG with_VBG FKBP12_VBG to_VBG form_VBG complexes_VBG that_VBG suppress_VBG the_VBG immune_VBG system_VBG by_VBG preventing_VBG activation_VBG of_VBG T_VBG cells_VBG in_VBG response_VBG to_VBG antigen_VBG presentation_VBG ._VBG
The_DT response_VBP to_VBG antigen_NN proceeds_NN at_VBG the_DT T_NN helper_JJ cell_NN level_JJ through_IN two_TO independent_JJ forms_IN of_VBG cellular_VBG collaboration_VBG ,_VBG contact_VBG and_VBG lymphokine_VBG ._VBG
The_VBG increased_VBG levels_VBG of_VBG these_VBG proteins_VBG correlated_VBG with_VBG increases_VBG in_VBG the_VBG amounts_VBG of_VBG mRNAs_VBG during_VBG LPS_VBG activation_VBG of_VBG THP-1_VBG cells_VBG ._VBG
The_VBG amplified_VBG product_VBG showed_VBG an_VBG identical_VBG nucleotide_VBG sequence_VBG to_VBG the_VBG DNA-binding_VBG domain_VBG of_VBG the_VBG human_VBG intestinal_VBG receptor_VBG ._VBG
Therefore_VBG the_VBG rel-related_VBG 65-kD_VBG protein_VBG may_VBG represent_VBG the_VBG p65_VBG subunit_VBG of_VBG the_VBG active_VBG NF-kappa_VBG B_VBG transcription_VBG factor_VBG complex_VBG ._VBG
The_VBG KBF1_VBG factor_VBG ,_VBG which_VBG binds_VBG to_VBG the_VBG enhancer_VBG A_VBG located_VBG in_VBG the_VBG promoter_VBG of_VBG the_VBG mouse_VBG MHC_VBG class_VBG I_VBG gene_VBG H-2Kb_VBG ,_VBG is_VBG indistinguishable_VBG from_VBG the_VBG p50_VBG DNA_VBG binding_VBG subunit_VBG of_VBG the_VBG transcription_VBG factor_VBG NF-kappa_VBG B_VBG ,_VBG which_VBG regulates_VBG a_VBG series_VBG of_VBG genes_VBG involved_VBG in_VBG immune_VBG and_VBG inflammatory_VBG responses_VBG ._VBG
The_DT tumors_NN showed_VBD high_JJ radiosensitivity_NN ._.
To_VBG address_VBG possible_VBG mechanisms_VBG that_VBG could_VBG explain_VBG this_VBG selective_VBG activity_VBG of_VBG c-ErbB_VBG ,_VBG we_VBG analyzed_VBG the_VBG ability_VBG of_VBG these_VBG receptors_VBG to_VBG activate_VBG the_VBG different_VBG members_VBG of_VBG the_VBG Stat_VBG transcription_VBG factor_VBG family_VBG ._VBG
The_DT effect_JJ of_VBG toremifene_VBG therapy_VBG on_VBG serum_VBG immunoglobulin_VBG levels_VBG in_VBG breast_VBG cancer_VBG ._VBG
Despite_VBG the_VBG widespread_VBG use_VBG of_VBG glucocorticoids_VBG in_VBG the_VBG treatment_VBG of_VBG diseases_VBG characterized_VBG by_VBG inflammation_VBG ,_VBG the_VBG molecular_VBG mechanism_VBG s_VBG by_VBG which_VBG these_VBG hormones_VBG exert_VBG this_VBG beneficial_VBG effect_VBG in_VBG patients_VBG with_VBG asthma_VBG remains_VBG to_VBG be_VBG elucidated_VBG ._VBG
Acetylsalicylic_VBG acid_VBG and_VBG sodium_VBG salicylate_VBG inhibit_VBG LPS-induced_VBG NF-kappa_VBG nuclear_VBG translocation_VBG ,_VBG and_VBG synthesis_VBG of_VBG tissue_VBG factor_VBG TF_VBG and_VBG tumor_VBG necrosis_VBG factor_VBG alfa_VBG TNF-alpha_VBG in_VBG human_VBG monocytes_VBG ._VBG
Thus_NNS ,_VBG there_VBG was_VBG a_VBG statistically_VBG significant_VBG correlation_VBG of_VBG cytolytic_VBG effector_VBG cell_VBG function_VBG with_VBG expression_VBG of_VBG the_VBG tumor_VBG P_VBG 0.003_VBG ,_VBG and_VBG overexpression_VBG correlated_VBG with_VBG a_VBG negative_VBG estrogen_VBG receptor_VBG status_VBG P_VBG 0.005_VBG ._VBG
Tissue-specific_VBG expression_VBG of_VBG the_VBG platelet_VBG GPIIb_VBG gene_VBG ._VBG
Furthermore_PRP ,_VBG the_VBG significance_VBG of_VBG the_VBG present_VBG study_VBG is_VBG that_VBG the_VBG T_VBG cells_VBG ,_VBG not_VBG the_VBG antigen-presenting_VBG cells_VBG ,_VBG are_VBG likely_VBG to_VBG be_VBG the_VBG limiting_VBG element_VBG in_VBG the_VBG T_VBG cell_VBG proliferative_VBG response_VBG to_VBG TG_VBG and_VBG other_VBG thyroid_VBG autoantigens_VBG ._VBG
GM2_VBG defines_VBG a_VBG binding_VBG site_VBG for_VBG protein_VBG s_VBG binding_VBG is_VBG inducible_VBG by_VBG PMA_VBG ._VBG
Consistent_PRP with_IN these_DT results_NN ,_VBG quantitative_JJ DNase_JJ footprinting_VBG of_VBG the_JJ TNF-alpha_NN promoter_NN using_VBG increasing_VBG amounts_VBG of_VBG recombinant_VBG NFATp_VBG demonstrated_VBG that_VBG the_VBG -76_VBG site_VBG binds_VBG to_VBG NFATp_VBG with_VBG a_VBG higher_VBG affinity_VBG than_VBG the_VBG kappa_VBG 3_VBG site_VBG ._VBG
To_VBG confirm_VBG the_VBG physiological_VBG relevance_VBG of_VBG these_VBG findings_VBG ,_VBG we_VBG carried_VBG out_VBG in_VBG vivo_VBG footprinting_VBG experiments_VBG which_VBG showed_VBG that_VBG stimulation_VBG of_VBG IL-2R_VBG alpha_VBG expression_VBG correlated_VBG with_VBG occupancy_VBG of_VBG the_VBG GASd_VBG element_VBG ._VBG
ORF1_VBG consists_VBG of_VBG 240_VBG bp_VBG that_VBG would_VBG encode_VBG 80_VBG amino_VBG acids_VBG ,_VBG while_VBG the_VBG major_VBG ORF2_VBG consists_VBG of_VBG 648_VBG bp_VBG capable_VBG of_VBG coding_VBG for_VBG 216_VBG amino_VBG acids_VBG ._VBG
Two_DT different_JJ strains_RB of_VBG HHV-6_NNS ,_VBG GS_CD and_CC Z29_RB ,_VBG transactivated_VBN the_DT HIV_NNS promoter_NN ._.
In_VBG S107_VBG cells_VBG stably_VBG transfected_VBG with_VBG relB_VBG genes_VBG ,_VBG stimulation_VBG of_VBG nuclear_VBG RelB_VBG translocation_VBG by_VBG CD40_VBG was_VBG observed_VBG ._VBG
These_VBG studies_VBG ,_VBG the_VBG first_VBG to_VBG demonstrate_VBG induction_VBG of_VBG LT_VBG promoter_VBG activity_VBG over_VBG basal_VBG levels_VBG ,_VBG indicate_VBG that_VBG HTLV-I_VBG tax_VBG causes_VBG low-level_VBG activation_VBG of_VBG both_VBG endogenous_VBG LT_VBG and_VBG the_VBG LT_VBG promoter_VBG ,_VBG at_VBG least_VBG in_VBG part_VBG through_VBG activation_VBG of_VBG NF-kappa_VBG B_VBG ._VBG
Transcription_NN factor_JJ NF-kappa_NN B_JJ is_VBZ generally_RB localized_VBD to_VBG the_DT cytoplasm_VBN by_VBG inhibitor_VBP I_NN kappa_CD B_NN ._.
The_DT fact_VBP that_VBG BCL-6_VBG rearrangements_VBG identify_VBG biologically_VBG and_VBG clinically_VBG distinct_VBG subsets_VBG of_VBG DLCL_VBG suggests_VBG that_VBG these_VBG lesions_VBG may_VBG be_VBG useful_VBG as_VBG markers_VBG in_VBG selection_VBG of_VBG differential_VBG therapeutic_VBG strategies_VBG based_VBG on_VBG different_VBG risk_VBG groups_VBG ._VBG
Neither_DT IL-10_NN nor_RB IL-4_NN inhibited_VBP LPS-induced_JJ NF-kappa_NNS B_NN binding_VBG activity_NN ._.
The_DT study_RB of_VBG human_VBG disorders_VBG known_VBG as_VBG premature_VBG aging_VBG syndromes_VBG may_VBG provide_VBG insight_VBG into_VBG the_VBG mechanisms_VBG of_VBG cellular_VBG senescence_VBG ._VBG
T_VBG cell_VBG blasts_VBG treated_VBG with_VBG PMA_VBG are_VBG now_VBG responsive_VBG to_VBG IFN-gamma_VBG ._VBG
The_VBG current_VBG work_VBG describes_VBG the_VBG regulation_VBG of_VBG TNF_VBG in_VBG human_VBG myelomonocytic_VBG cell_VBG lines_VBG after_VBG PMA_VBG stimulation_VBG ._VBG
This_VBG probe_VBG was_VBG used_VBG to_VBG identify_VBG a_VBG rel-related_VBG complementary_VBG DNA_VBG that_VBG hybridized_VBG to_VBG a_VBG 2.6-kilobase_VBG messenger_VBG RNA_VBG present_VBG in_VBG human_VBG T_VBG and_VBG B_VBG lymphocytes_VBG ._VBG
Analysis_NNS of_VBG the_DT ligand-binding_VBG domain_VBG of_VBG human_VBG retinoic_VBG acid_VBG receptor_VBG alpha_VBG by_VBG site-directed_VBG mutagenesis_VBG ._VBG
The_DT presence_NNS of_VBG mRNA_NNS for_VBG these_VBG proteins_VBG in_VBG eosinophils_VBG and_VBG basophils_VBG suggests_VBG that_VBG gene_VBG transcription_VBG in_VBG these_VBG lineages_VBG may_VBG be_VBG regulated_VBG by_VBG GATA-binding_VBG proteins_VBG ._VBG
Furthermore_PRP ,_VBG 68_VBG triple-labellings_VBZ with_IN mAbs_NNS were_VBD performed_RB on_VBG the_VBG cells_VBG of_VBG each_VBG volunteer_VBG to_VBG possibly_VBG generate_VBG further_VBG hypotheses_VBG ._VBG
To_VBG determine_VBG the_VBG role_VBG of_VBG AP-2_VBG in_VBG the_VBG regulation_VBG of_VBG the_VBG HTLV-I_VBG LTR_VBG gene_VBG expression_VBG ,_VBG we_VBG used_VBG an_VBG AP-2_VBG cDNA_VBG in_VBG DNA_VBG binding_VBG and_VBG transient_VBG expression_VBG assays_VBG ._VBG
We_VBG therefore_VBG determined_VBG whether_VBG corticosteroids_VBG suppress_VBG inflammation_VBG by_VBG inhibiting_VBG endothelial_VBG expression_VBG of_VBG adhesion_VBG molecules_VBG for_VBG neutrophils_VBG polymorphonuclear_VBG leukocytes_VBG ._VBG
Transcription_VBG factor_VBG AP-2_VBG activates_VBG gene_VBG expression_VBG of_VBG HTLV-I_VBG ._VBG
Currently_VBG available_VBG data_VBG indicate_VBG that_VBG erythroid_VBG and_VBG megakaryocytic_VBG differentiation_VBG pathways_VBG are_VBG closely_VBG related_VBG to_VBG each_VBG other_VBG ,_VBG and_VBG there_VBG may_VBG exist_VBG progenitor_VBG cells_VBG common_VBG to_VBG those_VBG two_VBG lineages_VBG may_VBG exist_VBG ._VBG
The_VBG present_VBG studies_VBG have_VBG examined_VBG the_VBG effects_VBG of_VBG M-CSF_VBG on_VBG potential_VBG signaling_VBG pathways_VBG involving_VBG expression_VBG of_VBG the_VBG jun_VBG and_VBG fos_VBG early_VBG response_VBG genes_VBG ._VBG
Inhibition_IN of_VBG HIV-1_VBG replication_VBG and_VBG NF-kappa_VBG B_VBG activity_VBG by_VBG cysteine_VBG and_VBG cysteine_VBG derivatives_VBG ._VBG
Further_VBG evidence_VBG that_VBG the_VBG action_VBG of_VBG dexamethasone_VBG was_VBG mediated_VBG through_VBG ligation_VBG of_VBG corticosteroid_VBG receptors_VBG human_VBG glucocorticoid_VBG receptors_VBG hGRs_VBG was_VBG provided_VBG by_VBG experiments_VBG utilizing_VBG the_VBG steroid_VBG antagonist_VBG RU-486_VBG ._VBG
The_VBG c-Jun_VBG delta-domain_VBG inhibits_VBG neuroendocrine_VBG promoter_VBG activity_VBG in_VBG a_VBG DNA_VBG sequence-_VBG and_VBG pituitary-specific_VBG manner_VBG ._VBG
One_DT of_VBG these_VBG activities_VBG was_VBG found_VBG to_VBG be_VBG a_VBG novel_VBG ,_VBG less_VBG abundant_VBG ,_VBG Rb-E2F_VBG complex_VBG ._VBG
Granulocyte-macrophage_VBG colony-stimulating_VBG factor_VBG GM-CSF_VBG induces_VBG immediate_VBG effects_VBG in_VBG monocytes_VBG by_VBG activation_VBG of_VBG the_VBG Janus_VBG kinase_VBG JAK2_VBG and_VBG STAT_VBG transcription_VBG factor_VBG STAT5_VBG pathway_VBG ._VBG
This_DT yields_NN a_VBG fusion_VBG transcript_VBG ,_VBG ,_VBG a_VBG transcription_VBG factor_VBG with_VBG reported_VBG dominant_VBG negative_VBG functions_VBG in_VBG the_VBG absence_VBG of_VBG hormone_VBG ._VBG
Polymyxin_DT B_NN abrogated_JJ only_RB the_DT response_VBP to_VBG LPS_NN ._.
It_DT has_VBZ been_VBN thought_RB that_VBG the_VBG virally_VBG induced_VBG inhibition_VBG of_VBG IFN-MCP_VBG is_VBG secondary_VBG to_VBG the_VBG shutdown_VBG of_VBG cellular_VBG macromolecular_VBG synthesis_VBG that_VBG accompanies_VBG cytopathic_VBG virus_VBG infections_VBG ._VBG
Phorbol_JJ activation_NN was_NNS positively_RB modulated_JJ by_VBG influx_NN while_JJ TNF_NN alpha_DT activation_NN was_IN not_RB ._.
In_NN this_DT report_RB ,_VBG we_VBG demonstrate_VBG that_VBG the_VBG supernatant_VBG from_VBG activated_VBG T-lymphocytes_VBG is_VBG able_VBG to_VBG induce_VBG the_VBG transcription_VBG of_VBG a_VBG potent_VBG cytokine_VBG ,_VBG TGF-beta_VBG 2_VBG in_VBG glial_VBG cells_VBG ._VBG
In_VBG comparison_VBG to_VBG K562_VBG ,_VBG nucleated_VBG erythroblasts_VBG from_VBG adult_VBG human_VBG bone_VBG marrow_VBG exhibited_VBG a_VBG similar_VBG but_VBG nonidentical_VBG pattern_VBG of_VBG nuclear_VBG factor_VBG binding_VBG in_VBG vivo_VBG at_VBG the_VBG HS-40_VBG region_VBG ._VBG
Thus_NNS ,_VBG tyrosine_VBG phosphorylation_VBG is_VBG an_VBG important_VBG and_VBG perhaps_VBG mandatory_VBG proximal_VBG step_VBG in_VBG the_VBG activation_VBG of_VBG the_VBG protein_VBG kinase_VBG C_VBG signaling_VBG cascade_VBG in_VBG human_VBG B-lymphocyte_VBG precursors_VBG ._VBG
Spi-B_VBG expression_VBG is_VBG very_VBG abundant_VBG in_VBG B_VBG cells_VBG and_VBG both_VBG Spi-B_VBG mRNA_VBG and_VBG protein_VBG are_VBG detected_VBG in_VBG some_VBG T_VBG cells_VBG ._VBG
The_DT multimerized_VBD recognition_NN motif_IN of_VBG TCF-1_NN constituted_JJ a_VBG T_NN cell-specific_NN enhancer_NN ._.
expression_VBG remained_VBG very_VBG low_VBG in_VBG nuclei_VBG of_VBG HIV1-infected_VBG macrophages_VBG ._VBG
However_DT ,_VBG most_JJS attention_NN has_NN been_VBN focused_VBD on_VBG lipopolysaccharide_VB LPS_NN ._.
Using_IN deletion_NN mutants_VBZ ,_VBG the_VBG downstream_VBG parathyroid_VBG hormone-related_VBG protein_VBG PTHrP_VBG promoter_VBG is_VBG shown_VBG to_VBG be_VBG responsive_VBG to_VBG both_VBG HTLV-I_VBG and_VBG HTLV-II_VBG Tax_VBG as_VBG well_VBG as_VBG the_VBG proto-oncogene_VBG ._VBG
In_IN directing_VBG the_VBG synthesis_VBG of_VBG RNA_VBG through_VBG the_VBG intervening_VBG DNA_VBG and_VBG the_VBG gene_VBG by_VBG a_VBG tracking_VBG and_VBG transcription_VBG mechanism_VBG ,_VBG the_VBG HS2_VBG enhancer_VBG may_VBG i_VBG open_VBG up_VBG the_VBG chromatin_VBG structure_VBG of_VBG a_VBG gene_VBG domain_VBG and_VBG ii_VBG deliver_VBG enhancer_VBG binding_VBG proteins_VBG to_VBG the_VBG promoter_VBG sequence_VBG where_VBG they_VBG may_VBG stimulate_VBG the_VBG transcription_VBG of_VBG the_VBG gene_VBG at_VBG the_VBG cap_VBG site_VBG ._VBG
TCR_VBG signaling_VBG was_VBG triggered_VBG by_VBG treating_VBG Jurkat_VBG T_VBG cells_VBG with_VBG PHA_VBG or_VBG anti-CD3_VBG Abs_VBG ,_VBG and_VBG NF-kappaB_VBG activation_VBG was_VBG monitored_VBG by_VBG electrophoretic_VBG mobility_VBG shift_VBG assays_VBG by_VBG kappaB-dependent_VBG reporter_VBG assays_VBG ._VBG
Other_DT cellular_JJ parameters_VBZ ,_VBG such_DT as_VBG glycosidase_VBG activities_VBG ,_VBG cytokine_VBG release_VBG ,_VBG and_VBG filament_VBG expression_VBG ,_VBG returned_VBG to_VBG levels_VBG similar_VBG to_VBG that_VBG observed_VBG in_VBG uninduced_VBG cells_VBG ._VBG
These_NN results_NNS indicate_VB that_VBG defective_VBG recruitment_VBG of_VBG NF-kappa_VBG B_VBG may_VBG underlie_VBG Nef_VBG negative_VBG transcriptional_VBG effects_VBG on_VBG the_VBG HIV-1_VBG and_VBG interleukin_VBG 2_VBG promoters_VBG ._VBG
The_VBG reaction_VBG is_VBG enhanced_VBG by_VBG incubation_VBG of_VBG the_VBG tumor_VBG cells_VBG for_VBG 30_VBG min_VBG at_VBG 37_VBG degrees_VBG C_VBG prior_VBG to_VBG fixation_VBG ._VBG
In_VBG addition_VBG ,_VBG this_VBG proliferative_VBG parameter_VBG maintained_VBG prognostic_VBG significance_VBG when_VBG the_VBG patients_VBG were_VBG stratified_VBG according_VBG to_VBG lymph_VBG node_VBG involvement_VBG ,_VBG menopausal_VBG status_VBG ,_VBG and_VBG nuclear_VBG estrogen_VBG receptor_VBG content_VBG ._VBG
Alteration_IN of_VBG structural_JJ order_IN of_VBG human_VBG erythrocyte_VBG ghost_VBG membrane_VBG by_VBG glucocorticoids_VBG and_VBG the_VBG influence_VBG of_VBG the_VBG glucocorticoid_VBG receptor_VBG antagonist_VBG RU_VBG 486_VBG ._VBG
Nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG NF-AT_VBG is_VBG a_VBG transcriptional_VBG activator_VBG involved_VBG in_VBG the_VBG induction_VBG of_VBG IL-2_VBG gene_VBG expression_VBG ._VBG
Activated_VBG viral_VBG gene_VBG expression_VBG associated_VBG with_VBG phenotypic_VBG conversion_VBG of_VBG group_VBG I_VBG cell_VBG lines_VBG in_VBG to_VBG group_VBG II_VBG or_VBG III_VBG restores_VBG the_VBG Egr-1_VBG gene_VBG expression_VBG ._VBG
We_DT also_RB show_VB that_VBG platelet-activating_VBG factor_VBG from_VBG 10-LRB--12-RRB-_VBG to_VBG 10-LRB--6-RRB-_VBG M_VBG induced_VBG rapid_VBG and_VBG significant_VBG elevation_VBG in_VBG intracellular_VBG calcium_VBG levels_VBG ,_VBG whereas_VBG lyso-platelet-activating_VBG factor_VBG was_VBG again_VBG ineffective_VBG ._VBG
The_VBG HTLV-I_VBG LTR_VBG contains_VBG three_VBG conserved_VBG regulatory_VBG elements_VBG known_VBG as_VBG 21_VBG base_VBG pair_VBG repeats_VBG which_VBG are_VBG required_VBG for_VBG stimulation_VBG of_VBG gene_VBG expression_VBG by_VBG the_VBG transactivator_VBG protein_VBG tax_VBG ._VBG
The_DT BAT_NNS box_NN and_CC Oct-2_NN were_NN also_RB implicated_JJ in_VBG the_VBG induction_VBG of_VBG CD20_VBG in_VBG the_VBG pre-B_VBG cell_VBG line_VBG ,_VBG PB-697_VBG ,_VBG via_VBG phorbol_VBG esters_VBG ._VBG
The_DT nature_NNS of_VBG the_VBG nuclear_VBG factors_VBG involved_VBG in_VBG regulation_VBG of_VBG these_VBG cytokine_VBG genes_VBG is_VBG still_VBG unknown_VBG ._VBG
Chlorinated_VBD dibenzo-p-dioxins_NNS and_CC dibenzofurans_CD and_CC the_JJ human_JJ immune_JJ system_NN ._.
The_VBG human_VBG T-cell_VBG leukemia_VBG virus_VBG type_VBG 1_VBG posttranscriptional_VBG trans-activator_VBG Rex_VBG contains_VBG a_VBG nuclear_VBG export_VBG signal_VBG ._VBG
We_NN have_VBP examined_JJ the_DT effects_VBZ of_VBG RA_NNS on_VBG normal_VBG hematopoiesis_VBG by_VBG using_VBG early_VBG hematopoietic_VBG progenitor_VBG cells_VBG HPC_VBG stringently_VBG purified_VBG from_VBG adult_VBG peripheral_VBG blood_VBG ._VBG
ROI_NN appear_NN to_VBG serve_NN as_VBG messengers_VBZ mediating_VBG directly_VBG or_VBG indirectly_VBG the_VBG release_VBG of_VBG the_VBG inhibitory_VBG subunit_VBG I_VBG kappa_VBG B_VBG from_VBG NF-kappa_VBG B_VBG ._VBG
We_NN have_VBP studied_RB the_DT impact_CD of_VBG gangliosides_CD on_VBG the_VBG expression_VBG of_VBG TNF_VBG in_VBG blood_VBG monocytes_VBG and_VBG in_VBG the_VBG monocytic_VBG cell_VBG line_VBG Mono_VBG Mac_VBG 6_VBG ._VBG
Rather_JJ ,_VBG tyrosine_VBG phosphorylation_VBG was_VBG shown_VBG to_VBG be_VBG directly_VBG involved_VBG in_VBG mediating_VBG CD40-dependent_VBG signals_VBG ._VBG
In_VBG addition_VBG ,_VBG p65_VBG gave_VBG per_VBG se_VBG ,_VBG with_VBG low_VBG affinity_VBG ,_VBG a_VBG protein-DNA_VBG complex_VBG that_VBG migrated_VBG more_VBG slowly_VBG than_VBG native_VBG NF-GM2_VBG complex_VBG ._VBG
After_VBG T_VBG cell_VBG activation_VBG ,_VBG the_VBG phosphorylation_VBG of_VBG Rb_VBG results_VBG in_VBG the_VBG release_VBG of_VBG Elf-1_VBG ,_VBG which_VBG is_VBG correlated_VBG temporally_VBG with_VBG the_VBG activation_VBG of_VBG Elf-1-mediated_VBG transcription_VBG ._VBG
The_DT numbers_VBZ and_CC binding_VBG affinities_VBG of_VBG these_VBG receptors_VBG could_VBG not_VBG account_VBG for_VBG the_VBG observed_VBG difference_VBG in_VBG the_VBG susceptibility_VBG of_VBG these_VBG cells_VBG to_VBG functional_VBG inhibition_VBG by_VBG dexamethasone_VBG in_VBG vitro_VBG ._VBG
During_VBG embryogenesis_VBG ,_VBG the_VBG BSAP_VBG gene_VBG is_VBG transiently_VBG expressed_VBG in_VBG the_VBG mesencephalon_VBG and_VBG spinal_VBG cord_VBG with_VBG a_VBG spatial_VBG and_VBG temporal_VBG expression_VBG pattern_VBG that_VBG is_VBG distinct_VBG from_VBG that_VBG of_VBG other_VBG Pax_VBG genes_VBG in_VBG the_VBG developing_VBG central_VBG nervous_VBG system_VBG CNS_VBG ._VBG
Recombinant_VBG NFAT1_VBG NFATp_VBG is_VBG regulated_VBG by_VBG calcineurin_VBG in_VBG T_VBG cells_VBG and_VBG mediates_VBG transcription_VBG of_VBG several_VBG cytokine_VBG genes_VBG ._VBG
The_VBG transcription_VBG factor_VBG HIV-TF1_VBG ,_VBG which_VBG binds_VBG to_VBG a_VBG region_VBG about_VBG 60_VBG bp_VBG upstream_VBG from_VBG the_VBG enhancer_VBG of_VBG the_VBG human_VBG immunodeficiency_VBG virus-1_VBG HIV-1_VBG ,_VBG was_VBG purified_VBG from_VBG human_VBG B_VBG cells_VBG ._VBG
In_VBG addition_VBG ,_VBG we_VBG observed_VBG cell_VBG type-specific_VBG permissiveness_VBG to_VBG replication_VBG of_VBG some_VBG mutant_VBG viruses_VBG ._VBG
In_NN human_JJ monocytes_VBZ ,_VBG the_DT inhibitors_VBZ of_VBG these_VBG phosphatases_VBG ,_VBG okadaic_VBG acid_VBG and_VBG calyculin_VBG A_VBG ,_VBG were_VBG found_VBG to_VBG increase_VBG the_VBG mRNA_VBG accumulation_VBG and_VBG cytokine_VBG production_VBG of_VBG interleukin-1_VBG beta_VBG and_VBG interleukin-1_VBG alpha_VBG ._VBG
Transcription_IN of_VBG the_VBG human_VBG immunodeficiency_VBG virus_VBG type-1_VBG HIV-1_VBG genome_VBG is_VBG regulated_VBG in_VBG part_VBG by_VBG cellular_VBG factors_VBG and_VBG is_VBG stimulated_VBG by_VBG activation_VBG of_VBG latently_VBG infected_VBG T_VBG cells_VBG ._VBG
Tumor_VBG samples_VBG ,_VBG obtained_VBG from_VBG 129_VBG patients_VBG who_VBG underwent_VBG surgery_VBG between_VBG January_VBG 1987_VBG and_VBG December_VBG 1988_VBG ,_VBG were_VBG processed_VBG for_VBG staining_VBG by_VBG an_VBG immunohistochemical_VBG procedure_VBG avidin-biotin_VBG complex_VBG ._VBG
Induction_IN by_VBG hemin_VBG increases_VBG ,_VBG while_VBG induction_VBG with_VBG 12-O-tetradecanoylphorbol-13-acetate_VBG TPA_VBG represses_VBG ,_VBG erythroid-specific_VBG gene_VBG expression_VBG in_VBG the_VBG human_VBG cell_VBG line_VBG K562_VBG ._VBG
Nasal_VBG NK-_VBG and_VBG T-cell_VBG lymphomas_VBG share_VBG the_VBG same_VBG type_VBG of_VBG Epstein-Barr_VBG virus_VBG latency_VBG as_VBG nasopharyngeal_VBG carcinoma_VBG and_VBG Hodgkin_VBG disease_VBG ._VBG
Since_PRP C3a_NN has_NN been_VBN shown_NN to_VBG induce_DT PGE2_NN production_IN by_VBG monocytes_NN ,_VBG and_VBG PGE2_VBG has_VBG been_VBG shown_VBG to_VBG influence_VBG cytokine_VBG production_VBG ,_VBG we_VBG investigated_VBG the_VBG potential_VBG role_VBG of_VBG PGE2_VBG in_VBG C3a-mediated_VBG enhancement_VBG of_VBG LPS-_VBG and_VBG IL-1beta-induced_VBG IL-6_VBG production_VBG ._VBG
Furthermore_VBG both_VBG childrens_VBG T_VBG cells_VBG were_VBG unable_VBG to_VBG produce_VBG the_VBG cytokines_VBG IL-2_VBG ,_VBG interferon-gamma_VBG IFN-gamma_VBG ,_VBG IL-4_VBG and_VBG tumor_VBG necrosis_VBG factor-alpha_VBG TNF-alpha_VBG ._VBG
Prostaglandin_IN E2_NN induction_CD of_VBG binding_VBG activity_VBG to_VBG CRE_VBG and_VBG AP-2_VBG elements_VBG in_VBG human_VBG T_VBG lymphocytes_VBG ._VBG
Targeted_VBG degradation_VBG of_VBG c-Fos_VBG ,_VBG but_VBG not_VBG v-Fos_VBG ,_VBG by_VBG a_VBG phosphorylation-dependent_VBG signal_VBG on_VBG c-Jun_VBG ._VBG
These_NN studies_NNS suggest_VBD that_VBG interaction_CD of_VBG CD2_VBG with_VBG natural_VBG ligand_VBG ,_VBG LFA-3_VBG ,_VBG may_VBG play_VBG a_VBG role_VBG in_VBG regulation_VBG of_VBG HIV_VBG expression_VBG ._VBG
In_VBG all_VBG subjects_VBG ,_VBG in_VBG addition_VBG ,_VBG lymphocyte_VBG subsets_VBG were_VBG determined_VBG as_VBG an_VBG index_VBG of_VBG corticosteroid_VBG action_VBG ._VBG
Primer_NN extension_NN and_CC nuclease_DT S1_NN protection_NN analysis_NN revealed_VBN two_TO major_VB transcription_NN initiation_IN sites_NN ._.
The_VBG data_VBG obtained_VBG demonstrate_VBG that_VBG phorbol_VBG ionophore_VBG A23187_VBG combination_VBG induced_VBG a_VBG clearly_VBG higher_VBG nuclear_VBG translocation_VBG of_VBG NF-kappa_VBG B_VBG in_VBG neonatal_VBG than_VBG adult_VBG T_VBG cells_VBG ._VBG
The_VBG restricted_VBG pattern_VBG of_VBG SCL_VBG protein_VBG synthesis_VBG is_VBG consistent_VBG with_VBG the_VBG restricted_VBG expression_VBG of_VBG SCL_VBG mRNA_VBG documented_VBG previously_VBG ._VBG
The_DT pAT_NNS 133_VBG gene_NN is_IN immediately_RB induced_JJ ,_VBG with_VBG FOS-like_VBG kinetics_VBG ,_VBG in_VBG human_VBG T_VBG cells_VBG and_VBG in_VBG fibroblasts_VBG ._VBG
BZLF_NNS 1_VBG ,_VBG transiently_VBG expressed_VBG in_VBG R7-57_VBG reporter_VBG cells_VBG ,_VBG was_VBG the_VBG only_VBG EBV_VBG trans-activator_VBG found_VBG ,_VBG sufficient_VBG in_VBG inducing_VBG the_VBG viral_VBG lytic_VBG cycle_VBG ._VBG
Taken_VBG together_VBG ,_VBG the_VBG findings_VBG of_VBG the_VBG present_VBG study_VBG are_VBG consistent_VBG with_VBG a_VBG role_VBG for_VBG NF-kappaB_VBG in_VBG the_VBG development_VBG of_VBG tolerance_VBG with_VBG respect_VBG to_VBG PMN_VBG adhesion_VBG ,_VBG perhaps_VBG by_VBG transcriptional_VBG regulation_VBG of_VBG GTP-cyclohydrolase_VBG ._VBG
Oligonucleotide_VBG primers_VBG based_VBG on_VBG the_VBG murine_VBG sequence_VBG were_VBG used_VBG to_VBG construct_VBG a_VBG quantitative_VBG reverse_VBG transcription-PCR_VBG assay_VBG for_VBG gene_VBG expression_VBG ._VBG
Exposure_PRP of_VBG certain_IN cell_NN types_NN to_VBG bacterial_DT lipopolysaccharide_NN LPS_NN leads_NN to_VBG activation_VB of_VBG nuclear_VBG factor_VBG kappa_VBG B_VBG NF-kappa_VBG B_VBG ,_VBG an_VBG inducible_VBG transcription_VBG factor_VBG ._VBG
The_DT NK-kappa_NN B_CD transcription_NN factor_NN complex_VBD is_VBZ sequestered_VBD in_VBG the_DT cytoplasm_VBN by_VBG the_DT inhibitory_NN protein_NN I_FW kappa_NN B-alpha_JJ MAD-3_NN ._.
TRAF3_VBG is_VBG a_VBG negative_VBG modulator_VBG of_VBG LMP1-LRB-1-231-RRB--mediated_VBG NF-kappaB_VBG activation_VBG ._VBG
Sodium_IN dodecyl_NN sulfate-polyacrylamide_NN gel_JJ electrophoresis_NN showed_VBN significant_JJ aldosterone_NN binding_VBG at_VBG a_VBG molecular_VBG weight_VBG of_VBG approximately_VBG 50000_VBG Dalton_VBG which_VBG was_VBG absent_VBG with_VBG 1_VBG microM_VBG cold_VBG aldosterone_VBG ,_VBG but_VBG not_VBG cortisol_VBG in_VBG the_VBG binding_VBG media_VBG ._VBG
We_DT show_VBP here_NN that_VBG in_VBG circulating_VBG monocytes_VBG ,_VBG NF-Y_VBG binding_VBG activity_VBG is_VBG not_VBG detected_VBG on_VBG the_VBG CCAAT_VBG motif_VBG present_VBG in_VBG the_VBG promoters_VBG of_VBG genes_VBG such_VBG as_VBG major_VBG histocompatibility_VBG complex_VBG MHC_VBG class_VBG II_VBG ,_VBG gp91-phox_VBG ,_VBG mig_VBG ,_VBG and_VBG fibronectin_VBG ,_VBG whereas_VBG during_VBG macrophage_VBG differentiation_VBG ,_VBG a_VBG progressive_VBG increase_VBG in_VBG NF-Y_VBG binding_VBG activity_VBG is_VBG observed_VBG on_VBG these_VBG promoters_VBG ._VBG
TSC2_VBG is_VBG a_VBG gene_VBG on_VBG chromosome_VBG 16p13.3_VBG associated_VBG with_VBG the_VBG autosomal_VBG dominant_VBG neurocutaneous_VBG disorder_VBG ,_VBG tuberous_VBG sclerosis_VBG complex_VBG TSC_VBG ._VBG
In_VBG this_VBG study_VBG ,_VBG we_VBG have_VBG attempted_VBG to_VBG determine_VBG whether_VBG c-fos_VBG expression_VBG is_VBG induced_VBG by_VBG radiotherapy_VBG in_VBG human_VBG squamous_VBG cell_VBG carcinomas_VBG of_VBG the_VBG head_VBG and_VBG neck_VBG and_VBG to_VBG establish_VBG a_VBG possible_VBG correlation_VBG between_VBG c-fos_VBG expression_VBG and_VBG the_VBG therapeutic_VBG effects_VBG of_VBG radiation_VBG therapy_VBG ._VBG
Both_VBG TCDD_VBG and_VBG estradiol_VBG induce_VBG extrathymic_VBG T-cell_VBG differentiation_VBG in_VBG the_VBG liver_VBG ._VBG
In_VBG this_VBG work_VBG ,_VBG we_VBG show_VBG that_VBG human_VBG peripheral_VBG blood_VBG T_VBG cells_VBG that_VBG are_VBG stimulated_VBG through_VBG the_VBG TCR_VBG and_VBG expanded_VBG with_VBG IL-2_VBG are_VBG unresponsive_VBG to_VBG IFN-gamma_VBG ,_VBG as_VBG determined_VBG by_VBG a_VBG lack_VBG of_VBG activation_VBG of_VBG jak_VBG kinases_VBG and_VBG the_VBG transcription_VBG factor_VBG ,_VBG STAT1-LRB-alpha-RRB-_VBG ,_VBG a_VBG signal_VBG transducer_VBG and_VBG activator_VBG of_VBG transcription_VBG ._VBG
Despite_VBG this_VBG lower_VBG affinity_VBG ,_VBG a_VBG trimer_VBG of_VBG the_VBG BAT_VBG box_VBG sequence_VBG was_VBG as_VBG efficiently_VBG transactivated_VBG by_VBG an_VBG Oct-2_VBG expression_VBG vector_VBG as_VBG was_VBG a_VBG trimer_VBG of_VBG the_VBG octamer_VBG sequence_VBG in_VBG HeLa_VBG cells_VBG ._VBG
These_VBG associations_VBG were_VBG found_VBG to_VBG be_VBG statistically_VBG significant_VBG ._VBG
We_DT previously_RB reported_VBP that_VBG human_VBG umbilical_VBG vein_VBG EC_VBG provide_VBG costimulatory_VBG signals_VBG to_VBG PHA-stimulated_VBG PBL_VBG via_VBG CD2:lymphocyte_VBG function-associated_VBG Ag-3_VBG and_VBG an_VBG unidentified_VBG ligand_VBG pair_VBG ,_VBG resulting_VBG in_VBG a_VBG three-_VBG to_VBG eight-fold_VBG enhancement_VBG of_VBG IL-2_VBG production_VBG ._VBG
These_VBG findings_VBG are_VBG consistent_VBG with_VBG a_VBG model_VBG for_VBG Rex-mediated_VBG trans-activation_VBG in_VBG which_VBG Rex-viral_VBG mRNA_VBG complexes_VBG are_VBG targeted_VBG for_VBG nuclear_VBG export_VBG by_VBG the_VBG direct_VBG action_VBG of_VBG the_VBG activation_VBG domain_VBG ._VBG
The_DT mean_DT concentrations_NNS necessary_RB to_VBG cause_DT 50_VBG inhibition_CD of_VBG lymphocyte_DT proliferation_NN IC50s_VBZ for_VBG the_JJ steroid-sensitive_JJ group_NN ranged_VBD from_VBG 2_VBG x_VBG 10-LRB--10-RRB-_VBG for_VBG budesonide_VBG to_VBG 7_VBG x_VBG 10-LRB--8-RRB-_VBG for_VBG hydrocortisone_VBG ,_VBG whereas_VBG the_VBG mean_VBG IC50s_VBG for_VBG the_VBG steroid-resistant_VBG group_VBG ranged_VBG from_VBG approximately_VBG 2_VBG x_VBG 10-LRB--8-RRB-_VBG for_VBG budesonide_VBG to_VBG greater_VBG than_VBG 10-LRB--6-RRB-_VBG for_VBG hydrocortisone_VBG ._VBG
These_VBG findings_VBG may_VBG help_VBG in_VBG understanding_VBG the_VBG pathogenesis_VBG of_VBG the_VBG immunodeficiency_VBG that_VBG occurs_VBG with_VBG mutations_VBG of_VBG JAK3_VBG and_VBG may_VBG suggest_VBG a_VBG mechanism_VBG for_VBG the_VBG pleiotropic_VBG effects_VBG of_VBG IL-4_VBG ._VBG
results_VBG indicate_VBG that_VBG the_VBG AP-1_VBG site_VBG at_VBG -150_VBG bp_VBG represents_VBG a_VBG major_VBG ,_VBG if_VBG not_VBG the_VBG only_VBG ,_VBG site_VBG of_VBG PKC_VBG responsiveness_VBG in_VBG the_VBG IL-2_VBG promoter_VBG ._VBG
Role_CD of_VBG AP-1-_CD and_CC octamer-binding_VBG proteins_VBG in_VBG control_VBG of_VBG IL3_VBG gene_VBG expression_VBG ._VBG
Glutathione-S-transferase_VBG GST_VBG -Grb2_VBG fusion_VBG proteins_VBG have_VBG been_VBG used_VBG to_VBG identify_VBG the_VBG potential_VBG role_VBG of_VBG Grb2-binding_VBG proteins_VBG in_VBG platelet_VBG activation_VBG by_VBG the_VBG platelet_VBG low-affinity_VBG IgG_VBG receptor_VBG ,_VBG Fc_VBG gamma_VBG RIIA_VBG ._VBG
We_VBG conclude_VBG that_VBG a_VBG different_VBG set_VBG of_VBG proteins_VBG recognize_VBG IL-2_VBG and_VBG IL-4_VBG genes_VBG ._VBG
Since_DT T_NN cells_NNS normally_JJ express_VBP Bcl-2_NN and_IN Bcl-xL_NN following_VBG activation_VBG ,_VBG inability_VBG to_VBG block_VBG Fas-mediated_VBG apoptosis_VBG may_VBG allow_VBG for_VBG the_VBG elimination_VBG of_VBG self-reactive_VBG cells_VBG and_VBG the_VBG appropriate_VBG regulation_VBG of_VBG immune_VBG responses_VBG ._VBG
Association_IN of_VBG the_VBG newly_VBG synthesized_VBG I_VBG kappa_VBG B_VBG alpha_VBG with_VBG p65_VBG restores_VBG intracellular_VBG inhibition_VBG of_VBG NF-kappa_VBG B_VBG DNA_VBG binding_VBG activity_VBG and_VBG prolongs_VBG the_VBG survival_VBG of_VBG this_VBG labile_VBG inhibitor_VBG ._VBG
Calcium_VBG dependent_VBG activation_VBG of_VBG the_VBG NF-AT_VBG transcription_VBG factor_VBG by_VBG p59fyn_VBG ._VBG
Here_VBG we_VBG demonstrate_VBG complete_VBG correlation_VBG between_VBG the_VBG expression_VBG pattern_VBG of_VBG the_VBG CD19_VBG gene_VBG and_VBG the_VBG B-cell-specific_VBG transcription_VBG factor_VBG BSAP_VBG in_VBG a_VBG large_VBG panel_VBG of_VBG B-lymphoid_VBG cell_VBG lines_VBG ._VBG
TSH-R_IN expression_NN levels_IN were_VBD variable_NN ,_VBG but_CC displayed_JJ a_VBG close_VBG correlation_VBG to_VBG the_VBG expression_VBG of_VBG thyroid_VBG peroxidase_VBG r_VBG 0.703_VBG ;_VBG P_VBG 0.05_VBG ,_VBG thyroglobulin_VBG r_VBG 0.817_VBG ;_VBG P_VBG 0.01_VBG ,_VBG and_VBG the_VBG nuclear_VBG oncogene_VBG c-fos_VBG r_VBG 0.935_VBG ;_VBG P_VBG 0.001_VBG ,_VBG but_VBG not_VBG c-myc_VBG ._VBG
The_DT interaction_NNS of_VBG the_VBG Oct2_VBG transcription_VBG factor_VBG with_VBG the_VBG cognate_VBG octamer_VBG motif_VBG ATGCAAAT_VBG is_VBG a_VBG critical_VBG determinant_VBG of_VBG the_VBG lymphoid-specific_VBG expression_VBG of_VBG immunoglobulin_VBG genes_VBG ._VBG
A_DT protein_JJ of_VBG the_VBG AP-1_VBG family_VBG is_VBG a_VBG component_VBG of_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG ._VBG
This_IN observation_NN supports_IN a_VBG model_JJ ,_VBG in_VBG which_IN promoter_NN selectivity_NN reflects_IN the_DT selectively_JJ increased_VBN antiproliferative_JJ effect_VBP of_VBG VD_JJ analogues_NNS ._.
In_IN this_NNS study_NN we_PRP investigated_VBP the_DT mechanisms_NN whereby_IN anti-CD2_NN antibodies_NNS stimulate_VBP viral_IN production_NN ._.
The_DT data_JJ are_VBP discussed_VBD with_IN regard_VBP to_VBG potential_VBG clinical_VBG relevance_VBG for_VBG gastroenterology_VBG ._VBG
The_DT forms_NNS produced_JJ in_VBG B_VBG lymphocytes_VBG have_VBG a_VBG predominantly_VBG activating_VBG effect_VBG on_VBG gene_VBG expression_VBG whereas_VBG those_VBG produced_VBG in_VBG neuronal_VBG cells_VBG have_VBG a_VBG predominantly_VBG inhibitory_VBG effect_VBG and_VBG can_VBG repress_VBG the_VBG expression_VBG of_VBG both_VBG the_VBG herpes_VBG simplex_VBG virus_VBG immediate-early_VBG genes_VBG and_VBG the_VBG cellular_VBG tyrosine_VBG hydroxylase_VBG gene_VBG ._VBG
Retinoic_PRP acid_NN RA_NN and_NN 1,25_CD alpha-dihydroxycholecalciferol_JJ VitD3_NN are_JJ potent_JJ regulators_VBZ of_VBG hematopoletic_DT differentiation_NN ._.
The_VBG glutamine-rich_VBG activation_VBG domain_VBG present_VBG in_VBG the_VBG amino-terminal_VBG portion_VBG of_VBG Oct2_VBG and_VBG the_VBG POU_VBG domain_VBG contribute_VBG only_VBG marginally_VBG to_VBG the_VBG transactivation_VBG function_VBG from_VBG a_VBG distal_VBG position_VBG ._VBG
1,25-dihydroxy_VBG vitamin_VBG D3_VBG and_VBG 12-O-tetradecanoyl_VBG phorbol-13-acetate_VBG TPA_VBG interact_VBG synergistically_VBG to_VBG induce_VBG monocytic_VBG differentiation_VBG of_VBG U937_VBG histiocytic_VBG lymphoma_VBG cells_VBG ._VBG
A_VBG serum_VBG response_VBG element_VBG and_VBG a_VBG binding_VBG site_VBG for_VBG NF-Y_VBG mediate_VBG the_VBG serum_VBG response_VBG of_VBG the_VBG human_VBG thrombospondin_VBG 1_VBG gene_VBG ._VBG
Enhanced_DT NF-kappa_NN B_NN binding_VBG activity_VBG is_VBG followed_VBG by_VBG functional_VBG activation_VBG in_VBG that_VBG inducibility_VBG of_VBG the_VBG IL-2_VBG receptor_VBG alpha_VBG chain_VBG is_VBG mediated_VBG by_VBG enhanced_VBG NF-kappa_VBG B_VBG binding_VBG and_VBG that_VBG a_VBG heterologous_VBG promoter_VBG containing_VBG the_VBG NF-kappa_VBG B_VBG consensus_VBG sequence_VBG -291_VBG to_VBG -245_VBG of_VBG the_VBG IL-2_VBG receptor_VBG alpha_VBG chain_VBG gene_VBG is_VBG activated_VBG ._VBG
Both_VBG inhibitors_VBG inhibited_VBG monocyte_VBG chemotactic_VBG activity_VBG in_VBG the_VBG culture_VBG supernatant_VBG of_VBG P-LPS-treated_VBG cells_VBG ._VBG
TPA_JJ induction_NN inhibits_NNS the_DT binding_JJ of_VBG the_VBG lineage_VBG limited_VBG transcription_VBG factor_VBG NF-E2_VBG to_VBG this_VBG transcriptional_VBG control_VBG element_VBG ._VBG
lymphocytes_VBZ ,_VBG at_VBG both_VBG polyclonal_VBG and_VBG clonal_VBG level_VBG ,_VBG recognized_VBG peptide_VBG in_VBG an_VBG HLA-DR--restricted_VBG fashion_VBG on_VBG presentation_VBG by_VBG autologous_VBG antigen-presenting_VBG cell_VBG APC_VBG or_VBG by_VBG APC_VBG expressing_VBG the_VBG HLA-DR11_VBG restricting_VBG molecule_VBG ._VBG
The_DT sequence_NN between_IN -1.7_DT and_CC -0.2_CD kb_NN linked_JJ to_VBG a_VBG heterologous_JJ thymidine_DT kinase_NN promoter_NN failed_JJ to_VBG respond_VBN to_VBG PRL_VBG stimulation_VBG ,_VBG suggesting_VBG that_VBG the_VBG activity_VBG of_VBG upstream_VBG PRL_VBG response_VBG elements_VBG may_VBG require_VBG an_VBG interaction_VBG with_VBG promoter-proximal_VBG elements_VBG ._VBG
In_VBG this_VBG study_VBG ,_VBG we_VBG characterize_VBG an_VBG essential_VBG upstream_VBG IL-2_VBG response_VBG element_VBG that_VBG contains_VBG both_VBG consensus_VBG and_VBG non-consensus_VBG GAS_VBG motifs_VBG ,_VBG two_VBG putative_VBG Ets_VBG binding_VBG sites_VBG EBS_VBG ,_VBG one_VBG of_VBG which_VBG overlaps_VBG the_VBG consensus_VBG GAS_VBG motif_VBG ,_VBG and_VBG a_VBG GATA_VBG motif_VBG ,_VBG which_VBG overlaps_VBG the_VBG non-consensus_VBG GAS_VBG motif_VBG ._VBG
PU.1_CD is_VBZ expressed_VBD at_VBG high_VBG levels_VBG in_VBG B_VBG cells_VBG ,_VBG mast_VBG cells_VBG ,_VBG megakaryocytes_VBG ,_VBG macrophages_VBG ,_VBG neutrophils_VBG ,_VBG and_VBG immature_VBG erythroid_VBG cells_VBG and_VBG at_VBG lower_VBG levels_VBG in_VBG mature_VBG erythrocytes_VBG ._VBG
In_JJ previous_JJ studies_RB ,_VBG we_PRP identified_VBP calcineurin_NN mutations_NN that_VBG block_VBG binding_VBG by_VBG the_VBG cyclophilin_VBG or_VBG complexes_VBG and_VBG thereby_VBG render_VBG yeast_VBG cells_VBG resistant_VBG to_VBG the_VBG antifungal_VBG effects_VBG of_VBG CsA_VBG or_VBG FK506_VBG ._VBG
Afternoon_DT ACTH_NN and_CC cortisol_JJ concentrations_NN did_VBD not_RB differ_JJ significantly_RB between_VBN the_DT three_CD groups_NN ._.
A_DT novel_NN primer_NN extension_NN method_JJ to_VBG detect_IN the_DT number_CD of_VBG CAG_NN repeats_NN in_VBG the_DT androgen_VBN receptor_NN gene_NNS in_VBG families_NNS with_IN X-linked_NN spinal_JJ and_CC bulbar_IN muscular_JJ atrophy_NN ._.
Although_VBG the_VBG CRE_VBG site_VBG is_VBG necessary_VBG ,_VBG optimal_VBG induction_VBG of_VBG bcl-2_VBG expression_VBG requires_VBG participation_VBG of_VBG the_VBG upstream_VBG regulatory_VBG element_VBG ,_VBG suggesting_VBG that_VBG phosphorylation_VBG of_VBG CREB_VBG alters_VBG interaction_VBG with_VBG the_VBG upstream_VBG regulatory_VBG element_VBG ._VBG
Recombinant_VBG NFAT1_VBG can_VBG mediate_VBG transcription_VBG of_VBG the_VBG interleukin-2_VBG ,_VBG interleukin-4_VBG ,_VBG tumor_VBG necrosis_VBG factor_VBG alpha_VBG ,_VBG and_VBG granulocyte-macrophage_VBG colony-stimulating_VBG factor_VBG promoters_VBG in_VBG T_VBG cells_VBG ,_VBG suggesting_VBG that_VBG NFAT1_VBG contributes_VBG to_VBG the_VBG CsA-sensitive_VBG transcription_VBG of_VBG these_VBG genes_VBG during_VBG the_VBG immune_VBG response_VBG ._VBG
The_VBG first_VBG results_VBG of_VBG continuous_VBG blood_VBG pressure_VBG measurements_VBG with_VBG a_VBG noninvasive_VBG ,_VBG real-time_VBG blood_VBG pressure_VBG monitor_VBG Finapres_VBG are_VBG presented_VBG ._VBG
In_VBG chloramphenicol_VBG acetyltransferase_VBG assays_VBG ,_VBG utilizing_VBG the_VBG transient_VBG transfection_VBG of_VBG a_VBG chloramphenicol_VBG acetyltransferase_VBG reporter_VBG plasmid_VBG containing_VBG the_VBG IL-6_VBG gene_VBG promoter_VBG ,_VBG IL-4_VBG ,_VBG but_VBG not_VBG IL-10_VBG ,_VBG suppressed_VBG the_VBG transcriptional_VBG activity_VBG of_VBG the_VBG IL-6_VBG gene_VBG promoter_VBG stimulated_VBG by_VBG PMA_VBG and_VBG LPS_VBG ._VBG
When_VBG expressed_VBG in_VBG Jurkat_VBG T_VBG cells_VBG ,_VBG recombinant_VBG NFAT1_VBG is_VBG regulated_VBG ,_VBG as_VBG expected_VBG ,_VBG by_VBG the_VBG calmodulin-dependent_VBG phosphatase_VBG calcineurin_VBG ,_VBG and_VBG function_VBG is_VBG inhibited_VBG by_VBG the_VBG immunosuppressive_VBG agent_VBG cyclosporin_VBG A_VBG CsA_VBG ._VBG
The_VBG partial_VBG cDNA_VBG encodes_VBG a_VBG protein_VBG which_VBG is_VBG homologous_VBG to_VBG the_VBG C-terminal_VBG 196_VBG amino_VBG acids_VBG of_VBG the_VBG 36-kDa_VBG transcription_VBG factor_VBG ,_VBG YB-1_VBG ._VBG
We_NN have_VBP observed_JJ that_VBG the_VBG R24_VBG mAb_VBG stimulates_VBG T_VBG cell_VBG proliferation_VBG ,_VBG cytotoxicity_VBG ,_VBG and_VBG surface_VBG marker_VBG expression_VBG of_VBG IL-2R_VBG alpha-chain_VBG ,_VBG IL-2R_VBG beta-chain_VBG ,_VBG HLA-DR_VBG ,_VBG CD11a_VBG ,_VBG and_VBG CD11c_VBG ._VBG
In_VBG the_VBG present_VBG study_VBG ,_VBG analysis_VBG of_VBG the_VBG interleukin-2_VBG IL-2_VBG gene_VBG activation_VBG shows_VBG that_VBG naive_VBG human_VBG helper_VBG T_VBG cells_VBG cord_VBG blood_VBG T_VBG cells_VBG ,_VBG adult_VBG T_VBG cells_VBG regulate_VBG IL-2_VBG transcription_VBG by_VBG a_VBG mechanism_VBG involving_VBG both_VBG a_VBG silencer_VBG and_VBG an_VBG activator_VBG acting_VBG on_VBG the_VBG purine-rich_VBG IL-2_VBG promoter_VBG elements_VBG NF-AT_VBG binding_VBG sites_VBG ._VBG
PBL_NN constitutively_NN express_VBZ c-jun_NN transcripts_RB ,_VBG and_VBG the_VBG level_VBG of_VBG c-jun_VBG mRNA_VBG is_VBG not_VBG altered_VBG by_VBG PHA_VBG activation_VBG in_VBG the_VBG absence_VBG or_VBG presence_VBG of_VBG EC_VBG ._VBG
The_DT combined_VBN data_NN lend_CC additional_JJ support_VBP to_VBG the_DT proposal_VBP that_VBG spirochetal_VBG lipoproteins_VBG and_VBG LPS_VBG initiate_VBG monocyte_VBG activation_VBG via_VBG different_VBG cell_VBG surface_VBG events_VBG but_VBG that_VBG the_VBG signaling_VBG pathways_VBG ultimately_VBG converge_VBG to_VBG produce_VBG qualitatively_VBG similar_VBG cellular_VBG responses_VBG ._VBG
Control_DT peptides_NNS corresponding_JJ to_VBG the_VB normal_JJ pml_NN and_NN RAR_NN alpha_IN proteins_NNS were_VBP not_RB recognized_VBN ._.
Thus_NNS ,_VBG HTLV-I_VBG Tax_VBG ,_VBG HTLV-II_VBG Tax_VBG ,_VBG and_VBG c-jun_VBG transactivate_VBG PTHrP_VBG and_VBG may_VBG contribute_VBG to_VBG the_VBG pathogenesis_VBG of_VBG hypercalcemia_VBG in_VBG adult_VBG T-cell_VBG leukemia_VBG ._VBG
Moreover_DT ,_VBG platelet-activating_NN factor_NN was_VBD capable_DT of_VBG inducing_VBG transcription_VBG of_VBG the_VBG nuclear_VBG proto-oncogenes_VBG c-fos_VBG and_VBG c-jun_VBG ._VBG
The_VBG cDNA_VBG clone_VBG encodes_VBG a_VBG new_VBG isoform_VBG ,_VBG NFATc.beta_VBG ,_VBG of_VBG the_VBG NFAT_VBG gene_VBG family_VBG member_VBG NFATc_VBG designated_VBG here_VBG NFATc.alpha_VBG ._VBG
Additionally_IN ,_VBG Nef_NN expressing_VBG cells_VBG were_VBG transiently_VBG transfected_VBG with_VBG a_VBG plasmid_VBG in_VBG which_VBG HIV-1_VBG AP-1_VBG DNA_VBG recognition_VBG sequences_VBG were_VBG cloned_VBG downstream_VBG of_VBG the_VBG chloramphenicol_VBG acetyltransferase_VBG CAT_VBG gene_VBG ._VBG
We_VBG now_VBG report_VBG that_VBG EC_VBG costimulation_VBG causes_VBG increased_VBG levels_VBG of_VBG IL-2_VBG mRNA_VBG as_VBG a_VBG result_VBG of_VBG increased_VBG IL-2_VBG transcription_VBG in_VBG PBL_VBG ._VBG
We_VBG have_VBG isolated_VBG cDNA_VBG clones_VBG of_VBG myeloid_VBG differentiation_VBG primary_VBG response_VBG MyD_VBG genes_VBG ,_VBG activated_VBG in_VBG the_VBG absence_VBG of_VBG de_VBG novo_VBG protein_VBG synthesis_VBG following_VBG induction_VBG for_VBG differentiation_VBG along_VBG either_VBG the_VBG macrophage_VBG or_VBG granulocyte_VBG lineage_VBG in_VBG human_VBG myeloblastic_VBG leukemia_VBG HL-60_VBG cells_VBG ._VBG
Characterization_IN of_VBG HB24_VBG expression_VBG in_VBG lymphoid_VBG and_VBG select_VBG developing_VBG tissues_VBG was_VBG performed_VBG by_VBG in_VBG situ_VBG hybridization_VBG ._VBG
These_NN observations_NNS establish_JJ the_DT importance_CD of_VBG different_JJ signal_JJ transducing_VBG pathways_NNS leading_VBG to_VBG CD40_VBG activation_VBG of_VBG B_VBG lymphocytes_VBG ._VBG
Cortisone-resistant_IN bronchial_JJ asthma_NN
Moreover_DT ,_VBG cAMP_JJ activators_NNS did_IN not_RB activate_VBP NF-kappa_NN B_CD in_VBG Jurkat_JJ cells_NNS ._.
Positive_VBG and_VBG negative_VBG regulation_VBG of_VBG immunoglobulin_VBG gene_VBG expression_VBG by_VBG a_VBG novel_VBG B-cell-specific_VBG enhancer_VBG element_VBG ._VBG
Charybdotoxin-sensitive_RB ,_VBG membrane_VBG potential_VBG changes_VBG are_VBG not_VBG involved_VBG in_VBG human_VBG T_VBG or_VBG B_VBG cell_VBG activation_VBG and_VBG proliferation_VBG ._VBG
The_VBG A_VBG site_VBG in_VBG the_VBG 21_VBG bp_VBG repeat_VBG has_VBG strong_VBG homology_VBG with_VBG previously_VBG described_VBG binding_VBG sites_VBG for_VBG the_VBG transcription_VBG factor_VBG AP-2_VBG ._VBG
There_DT was_VBD no_RB detectable_VB binding_VBG of_VBG in_VBG vitro_VBG translated_VBG heterodimer_VBG AP-1_VBG to_VBG the_VBG NF-AT_VBG sequence_VBG ,_VBG and_VBG the_VBG NF-AT_VBG sequence_VBG was_VBG unable_VBG to_VBG inhibit_VBG the_VBG binding_VBG of_VBG to_VBG the_VBG AP-1_VBG sequence_VBG ._VBG
Nuclear_VBG association_VBG of_VBG a_VBG T-cell_VBG transcription_VBG factor_VBG blocked_VBG by_VBG FK-506_VBG and_VBG cyclosporin_VBG A_VBG see_VBG comments_VBG
Studies_DT of_VBG cell_JJ lines_NNS representing_VBG endocrine_VBG ,_VBG fibroblast_VBG ,_VBG and_VBG lymphoid_VBG lineages_VBG using_VBG polyclonal_VBG antisera_VBG to_VBG detect_VBG E2A_VBG proteins_VBG have_VBG suggested_VBG that_VBG significant_VBG E2A_VBG protein_VBG expression_VBG is_VBG restricted_VBG to_VBG B-lymphocytes_VBG ._VBG
Both_VBG drugs_VBG dose-dependently_VBG inhibited_VBG LPS-induced_VBG TF_VBG and_VBG TNF-alpha_VBG synthesis_VBG at_VBG the_VBG mRNA_VBG and_VBG the_VBG protein_VBG level_VBG ,_VBG and_VBG reduced_VBG PGE2_VBG production_VBG ._VBG
Using_VBG amino_TO acid_NN sequence_IN information_NN derived_NN from_VBG the_VBG DNA_VBG affinity-purified_VBG protein_VBG ,_VBG we_VBG have_VBG now_VBG isolated_VBG cDNA_VBG clones_VBG encoding_VBG TCF-1_VBG alpha_VBG ._VBG
Nonhuman_VBG primates_VBG are_VBG naturally_VBG infected_VBG with_VBG a_VBG B-lymphotropic_VBG herpesvirus_VBG closely_VBG related_VBG to_VBG Epstein-Barr_VBG virus_VBG EBV_VBG ._VBG
Association_DT with_IN the_DT precursors_NN is_VBZ sufficient_VBN for_VBG cytoplasmic_VBG retention_VBG of_VBG either_VBG p65_VBG or_VBG c-Rel_VBG ,_VBG both_VBG of_VBG which_VBG are_VBG otherwise_VBG nuclear_VBG ._VBG
Furthermore_PRP ,_VBG P-LPS-induced_VBG expression_VBG of_VBG the_VBG MCP-1_VBG gene_VBG in_VBG the_VBG cells_VBG also_VBG was_VBG blocked_VBG by_VBG inhibitors_VBG of_VBG two_VBG transcription_VBG factors_VBG ,_VBG i.e._VBG ,_VBG curcumin_VBG ,_VBG an_VBG inhibitor_VBG of_VBG AP-1_VBG ,_VBG and_VBG pyrolidine_VBG dithiocarbamate_VBG ,_VBG an_VBG inhibitor_VBG of_VBG NF-kappaB_VBG ._VBG
We_JJ report_NN here_NN that_VBG interleukin_VBZ 2_VBG IL-2_NN acts_NN on_VBG human_VBG blood_VBG monocytes_VBG by_VBG enhancing_VBG binding_VBG activity_VBG of_VBG the_VBG transcription_VBG factor_VBG NF-kappa_VBG B_VBG to_VBG consensus_VBG sequence_VBG in_VBG the_VBG regulatory_VBG enhancer_VBG region_VBG of_VBG the_VBG IL-2_VBG receptor_VBG alpha_VBG chain_VBG p55_VBG ._VBG
Moreover_DT ,_VBG Elf-1_VBG is_VBG the_VBG only_VBG factor_VBG present_VBG in_VBG activated_VBG T-cell_VBG nuclear_VBG extracts_VBG that_VBG binds_VBG to_VBG these_VBG sites_VBG in_VBG electrophoretic_VBG mobility_VBG shift_VBG assays_VBG ._VBG
We_JJ report_NN two_CD patients_VBZ with_IN transient_NN pseudohypoaldosteronism_NN due_CD to_VBG obstructive_VB renal_JJ disease_NN ._.
To_VBG study_VBG the_VBG transcription_VBG factor_VBG requirement_VBG in_VBG B-cells_VBG ,_VBG different_VBG U2_VBG enhancer_VBG constructions_VBG were_VBG transfected_VBG into_VBG the_VBG lymphoid_VBG cell_VBG line_VBG ,_VBG BJA-B_VBG ._VBG
The_DT number_DT of_VBG GR_NNS in_VBG MNL_NNS from_VBG these_VBG patients_VBG was_VBG significantly_VBG decreased_VBG one_VBG month_VBG after_VBG the_VBG initiation_VBG of_VBG prednisolone_VBG therapy_VBG ._VBG
These_VBG differences_VBG in_VBG expression_VBG of_VBG FOS_VBG and_VBG FOSB_VBG suggest_VBG different_VBG roles_VBG and_VBG regulation_VBG ._VBG
This_VBG factor_VBG is_VBG composed_VBG of_VBG a_VBG DNA-binding_VBG protein_VBG ISGF3_VBG gamma_VBG ,_VBG which_VBG normally_VBG is_VBG present_VBG in_VBG the_VBG cytoplasm_VBG ,_VBG and_VBG other_VBG IFN-alpha-activated_VBG proteins_VBG which_VBG preexist_VBG as_VBG latent_VBG cytoplasmic_VBG precursors_VBG ISGF3_VBG alpha_VBG ._VBG
In_NN human_JJ leukocytes_VBZ ,_VBG the_VBG peak_VBG value_VBG of_VBG GR_VBG was_VBG found_VBG to_VBG parallel_VBG that_VBG of_VBG plasma_VBG cortisol_VBG with_VBG high_VBG and_VBG low_VBG values_VBG detected_VBG at_VBG 04:00-08:00_VBG h_VBG and_VBG 23:00-24:00_VBG h_VBG ,_VBG respectively_VBG ._VBG
By_VBG Northern_VBG blot_VBG analysis_VBG ,_VBG DM_VBG caused_VBG a_VBG comparable_VBG decrease_VBG in_VBG IL-2R_VBG alpha_VBG and_VBG in_VBG IL-2R_VBG beta_VBG mRNA_VBG levels_VBG to_VBG membrane_VBG receptor_VBG expression_VBG in_VBG mitogen-stimulated_VBG T_VBG cells_VBG ._VBG
These_JJ inhibitory_JJ effects_VBZ of_VBG c-Rel_NN correlate_JJ with_IN DNA-binding_VBG activity_VBG but_VBG not_VBG with_VBG ability_VBG to_VBG heterodimerize_VBG with_VBG p50_VBG ,_VBG suggesting_VBG that_VBG c-Rel_VBG inhibition_VBG involves_VBG competition_VBG with_VBG for_VBG occupancy_VBG of_VBG the_VBG kappa_VBG B_VBG enhancer_VBG element_VBG ._VBG
Northern_VBG blot_VBG analysis_VBG revealed_VBG in_VBG these_VBG cells_VBG ,_VBG an_VBG increase_VBG in_VBG the_VBG transcription_VBG of_VBG these_VBG two_VBG proto-oncogenes_VBG ,_VBG and_VBG this_VBG increase_VBG was_VBG amplified_VBG after_VBG treatment_VBG with_VBG phorbol_VBG myristate_VBG acetate_VBG ._VBG
The_VBG results_VBG demonstrate_VBG that_VBG physiologic_VBG concentrations_VBG of_VBG all_VBG three_VBG of_VBG these_VBG agents_VBG inhibit_VBG the_VBG anti-CD3_VBG mAb-induced_VBG proliferation_VBG of_VBG T_VBG cells_VBG ._VBG
Studies_VBG were_VBG also_VBG performed_VBG with_VBG an_VBG revertant_VBG line_VBG that_VBG has_VBG regained_VBG partial_VBG sensitivity_VBG to_VBG vincristine_VBG ._VBG
The_VBG BCL6_VBG gene_VBG encodes_VBG a_VBG 95-kDa_VBG protein_VBG containing_VBG six_VBG C-terminal_VBG zinc-finger_VBG motifs_VBG and_VBG an_VBG N-terminal_VBG POZ_VBG domain_VBG ,_VBG suggesting_VBG that_VBG it_VBG may_VBG function_VBG as_VBG a_VBG transcription_VBG factor_VBG ._VBG
Using_DT these_DT drugs_JJ as_VBG probes_RB ,_VBG chemists_VBZ and_CC biologists_VBZ have_JJ uncovered_VBN several_NN intracellular_JJ signalling_VBG molecules_NNS bridging_JJ the_DT generation_JJ of_VBG second-messenger_VBG ions_VBG and_VBG the_VBG transcriptional_VBG activation_VBG of_VBG IL-2_VBG ,_VBG among_VBG which_VBG are_VBG calmodulin_VBG ,_VBG calcineurin_VBG and_VBG the_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG NF-AT_VBG ._VBG
In_VBG this_VBG paper_VBG we_VBG have_VBG investigated_VBG the_VBG role_VBG of_VBG Egr-1_VBG in_VBG B_VBG cell_VBG growth_VBG regulation_VBG by_VBG examining_VBG the_VBG gene_VBG expression_VBG in_VBG a_VBG panel_VBG of_VBG B_VBG cell_VBG lines_VBG ,_VBG including_VBG both_VBG EBV_VBG genome_VBG negative_VBG and_VBG EBV_VBG carrying_VBG cell_VBG lines_VBG ._VBG
Loss_DT of_VBG heterozygosity_RB in_VBG PB_VBG granulocytes_VBG would_VBG be_VBG masked_VBG by_VBG the_VBG presence_VBG of_VBG significant_VBG numbers_VBG of_VBG normal_VBG granulocytes_VBG not_VBG derived_VBG from_VBG the_VBG malignant_VBG clone_VBG ._VBG
To_VBG further_VBG reduce_VBG the_VBG size_VBG of_VBG the_VBG common_VBG deleted_VBG region_VBG we_VBG have_VBG searched_VBG for_VBG small_VBG deletions_VBG or_VBG mitotic_VBG recombination_VBG events_VBG ,_VBG neither_VBG of_VBG which_VBG would_VBG be_VBG detected_VBG by_VBG conventional_VBG cytogenetics_VBG ._VBG
In_VBG summary_VBG ,_VBG the_VBG expression_VBG of_VBG E1A_VBG gene_VBG products_VBG inhibited_VBG IFN-MCP_VBG independently_VBG of_VBG virus_VBG infection_VBG ._VBG
Eicosanoids_IN in_VBG breast_IN cancer_NN patients_NNS before_VBD and_CC after_NN mastectomy_NN ._.
Interleukin-10_VBG IL-10_VBG ,_VBG like_VBG IL-4_VBG ,_VBG is_VBG known_VBG to_VBG inhibit_VBG cytokine_VBG expression_VBG in_VBG activated_VBG human_VBG monocytes_VBG ._VBG
The_VBG results_VBG demonstrate_VBG that_VBG the_VBG simultaneous_VBG activation_VBG of_VBG PKC_VBG and_VBG elevation_VBG of_VBG cAMP_VBG leads_VBG to_VBG an_VBG enhanced_VBG AP-1_VBG transcriptional_VBG activity_VBG in_VBG a_VBG T-leukemia_VBG cell_VBG line_VBG ,_VBG suggesting_VBG that_VBG the_VBG previously_VBG observed_VBG interaction_VBG between_VBG the_VBG parallel_VBG signal_VBG transduction_VBG pathways_VBG may_VBG have_VBG functional_VBG consequences_VBG at_VBG the_VBG level_VBG of_VBG gene_VBG transcription_VBG ._VBG
We_VBG investigated_VBG the_VBG upstream_VBG regulatory_VBG elements_VBG of_VBG the_VBG human_VBG IL-4_VBG promoter_VBG ._VBG
Improvement_PRP in_VBG urinary_VBG protein_VBG excretion_VBG and_VBG in_VBG disease_VBG activity_VBG ,_VBG which_VBG was_VBG scored_VBG according_VBG to_VBG the_VBG SLE_VBG Disease_VBG Activity_VBG Index_VBG system_VBG of_VBG the_VBG University_VBG of_VBG Toronto_VBG ,_VBG closely_VBG related_VBG to_VBG the_VBG glucocorticoid_VBG receptor_VBG concentrations_VBG in_VBG MNL_VBG isolated_VBG from_VBG the_VBG corresponding_VBG patients_VBG ._VBG
Retinoic_VBG acid_VBG treatment_VBG of_VBG irradiated_VBG mice_VBG enhanced_VBG granulocyte_VBG recovery_VBG ._VBG
When_VBG cells_VBG were_VBG treated_VBG with_VBG IL-4_VBG for_VBG 5_VBG hours_VBG before_VBG LPS_VBG activation_VBG ,_VBG both_VBG the_VBG c-fos_VBG and_VBG the_VBG c-jun_VBG mRNA_VBG expression_VBG was_VBG decreased_VBG ._VBG
Two_VBG stable_VBG B_VBG cell_VBG lines_VBG were_VBG established_VBG :_VBG R59Z_VBG activator_VBG cells_VBG were_VBG used_VBG to_VBG induce_VBG lytic_VBG EBV_VBG expression_VBG in_VBG a_VBG constitutive_VBG manner_VBG by_VBG the_VBG production_VBG of_VBG the_VBG BZLF_VBG 1_VBG trans-activator_VBG Zta_VBG ._VBG
Cloning_DT of_VBG a_VBG human_VBG homeobox_VBG gene_VBG that_VBG resembles_VBG a_VBG diverged_VBG Drosophila_VBG homeobox_VBG gene_VBG and_VBG is_VBG expressed_VBG in_VBG activated_VBG lymphocytes_VBG ._VBG
This_VBG inhibition_VBG of_VBG calcium-activated_VBG IE_VBG gene_VBG induction_VBG was_VBG reversed_VBG by_VBG treatment_VBG with_VBG cyclosporin_VBG A_VBG ,_VBG suggesting_VBG the_VBG involvement_VBG of_VBG calcineurin_VBG in_VBG this_VBG regulation_VBG ._VBG
Analysis_NNS of_VBG the_VBG p50_VBG and_VBG p65_VBG subunits_VBG of_VBG the_VBG NF-kappa_VBG B_VBG transcription_VBG factor_VBG complex_VBG has_VBG revealed_VBG that_VBG both_VBG proteins_VBG can_VBG interact_VBG with_VBG related_VBG DNA_VBG sequences_VBG through_VBG either_VBG homo-_VBG or_VBG heterodimer_VBG formation_VBG ._VBG
The_DT former_VBP two_CD substances_NNS interact_JJ with_IN T_DT cells_NNS via_RB the_DT glucocorticoid_JJ and_CC beta-adrenergic_NN receptors_NNS respectively_RB ._.
Further_VBG examination_VBG of_VBG this_VBG system_VBG has_VBG shown_VBG that_VBG the_VBG inhibition_VBG of_VBG HSV-1_VBG replication_VBG by_VBG the_VBG antiviral_VBG drug_VBG acyclovir_VBG does_VBG not_VBG inhibit_VBG HSV-1-mediated_VBG induction_VBG of_VBG HIV-1_VBG provirus_VBG ._VBG
The_VBG p65_VBG subunit_VBG of_VBG NF-kappa_VBG B_VBG regulates_VBG I_VBG kappa_VBG B_VBG by_VBG two_VBG distinct_VBG mechanisms_VBG ._VBG
Studies_DT of_VBG pluripotent_JJ islet_IN cultures_NNS ._.
Here_EX we_PRP describe_NN an_DT alternative_JJ approach_RB ,_VBG based_JJ on_VBG in_VBG vitro_JJ stimulation_NN with_IN epitope_NN peptide-loaded_VBN dendritic_NN cells_NNS DCs_VBZ ,_VBG which_VBG allows_VBG one_VBG to_VBG probe_VBG the_VBG CTL_VBG repertoire_VBG for_VBG any_VBG individual_VBG reactivity_VBG of_VBG choice_VBG ;_VBG this_VBG method_VBG proved_VBG significantly_VBG more_VBG efficient_VBG than_VBG stimulation_VBG with_VBG peptide_VBG alone_VBG ._VBG
We_VBG now_VBG report_VBG the_VBG identification_VBG of_VBG a_VBG cDNA_VBG clone_VBG 15B-7_VBG ,_VBG from_VBG a_VBG Jurkat_VBG expression_VBG library_VBG ,_VBG that_VBG binds_VBG specifically_VBG to_VBG the_VBG DRE_VBG 1_VBG regulatory_VBG sequence_VBG ._VBG
Murine_PRP and_CC human_NN TCF-1_NN displayed_VBN a_VBG 95.5_CD overall_NN amino_CD acid_JJ homology_NN ._.
These_VBG results_VBG demonstrate_VBG that_VBG Rb_VBG interacts_VBG specifically_VBG with_VBG a_VBG lineage-restricted_VBG Ets_VBG transcription_VBG factor_VBG ._VBG
Oct-2_VBG mRNA_VBG levels_VBG and_VBG both_VBG Oct-2_VBG and_VBG NF-kappa_VBG B_VBG proteins_VBG in_VBG nuclear_VBG extracts_VBG were_VBG not_VBG altered_VBG by_VBG treatment_VBG with_VBG TGF-beta_VBG ._VBG
All_DT cell_NN lines_NNS examined_JJ in_VBG this_NNS group_NN also_RB expressed_VBN 1,25-LRB-OH-RRB-2D3_JJ receptors_NNS ._.
In_NN patients_NNS infiltration_IN of_VBG c-fos-positive_VBG lymphocytes_VBG into_VBG tumor_VBG tissues_VBG were_VBG moderate_VBG or_VBG remarkable_VBG at_VBG 4_VBG Gy_VBG of_VBG radiotherapy_VBG ,_VBG the_VBG tumors_VBG responded_VBG significantly_VBG well_VBG to_VBG radiation_VBG therapy_VBG P_VBG 0.025_VBG ,_VBG chi2_VBG test_VBG ,_VBG and_VBG the_VBG patients_VBG took_VBG a_VBG significantly_VBG favorable_VBG clinical_VBG course_VBG P_VBG 0.05_VBG ,_VBG chi2_VBG test_VBG ._VBG
On_VBG the_VBG first_VBG day_VBG of_VBG the_VBG disease_VBG ,_VBG glucocorticoid_VBG receptor_VBG capacity_VBG was_VBG significantly_VBG decreased_VBG without_VBG alteration_VBG of_VBG the_VBG receptor-ligand_VBG affinity_VBG ,_VBG whereas_VBG on_VBG days_VBG 4_VBG and_VBG 12_VBG the_VBG number_VBG of_VBG receptor_VBG sites_VBG was_VBG normal_VBG again_VBG ._VBG
The_VBG PML_VBG gene_VBG is_VBG fused_VBG to_VBG the_VBG retinoic_VBG acid_VBG receptor_VBG alpha_VBG gene_VBG RAR_VBG alpha_VBG in_VBG the_VBG acute_VBG promyelocytic_VBG leukemia_VBG APL_VBG 15_VBG ;_VBG 17_VBG translocation_VBG ._VBG
A_DT 2-bp_DT mutation_NN within_NN the_DT CBF_NN site_NN resulted_JJ in_VBG a_VBG 2-3-fold_VBG decrease_VBG in_VBG the_VBG activities_VBG of_VBG both_VBG a_VBG 69-bp_VBG proximal_VBG promoter_VBG fragment_VBG and_VBG a_VBG 627-bp_VBG full-length_VBG promoter_VBG fragment_VBG ._VBG
Using_VBG purified_VBG recombinant_VBG p50_VBG ,_VBG p65_VBG ,_VBG and_VBG c-Rel_VBG proteins_VBG ,_VBG optimal_VBG DNA-binding_VBG motifs_VBG were_VBG selected_VBG from_VBG a_VBG pool_VBG of_VBG random_VBG oligonucleotides_VBG ._VBG
This_VBG absence_VBG of_VBG binding_VBG was_VBG localized_VBG to_VBG the_VBG NF-kappa_VBG B_VBG region_VBG of_VBG the_VBG HIV-1_VBG enhancer_VBG ;_VBG the_VBG 65-kDa_VBG plus_VBG 50-kDa_VBG NF-kappa_VBG B_VBG heterodimer_VBG was_VBG preferentially_VBG lost_VBG ._VBG
E3_VBG transcripts_VBG were_VBG RA-inducible_VBG in_VBG HL60_VBG cells_VBG ,_VBG but_VBG not_VBG in_VBG an_VBG RA-resistant_VBG subclone_VBG ,_VBG HL60R_VBG ,_VBG that_VBG harbors_VBG a_VBG mutated_VBG RAR_VBG alpha_VBG gene_VBG ._VBG
Nuclear_VBG factor_VBG kappa_VBG B_VBG activates_VBG proenkephalin_VBG transcription_VBG in_VBG T_VBG lymphocytes_VBG ._VBG
No_TO correlation_NN between_IN chromosome_JJ 1_VBG alterations_VBG and_VBG nuclear_VBG grade_VBG ,_VBG age_VBG ,_VBG size_VBG ,_VBG lymph-node_VBG involvement_VBG ,_VBG hormonal_VBG receptor_VBG presence_VBG ,_VBG proliferation_VBG activity_VBG or_VBG p53_VBG protein_VBG expression_VBG was_VBG detected_VBG ._VBG
In_VBG vitro_VBG translated_VBG hGR_VBG was_VBG indistinguishable_VBG from_VBG native_VBG hGR_VBG ,_VBG as_VBG determined_VBG by_VBG migration_VBG on_VBG sodium_VBG dodecyl_VBG sulfate-polyacrylamide_VBG gels_VBG ,_VBG sedimentation_VBG on_VBG sucrose_VBG density_VBG gradients_VBG ,_VBG and_VBG reactivity_VBG with_VBG antipeptide_VBG antibodies_VBG generated_VBG against_VBG hGR_VBG ._VBG
We_VBG investigated_VBG the_VBG pattern_VBG of_VBG tal-1_VBG expression_VBG in_VBG purified_VBG human_VBG hematopoietic_VBG cells_VBG by_VBG in_VBG situ_VBG hybridization_VBG and_VBG reverse_VBG transcriptase_VBG polymerase_VBG chain_VBG reaction_VBG analysis_VBG ._VBG
Abnormality_RB of_VBG Oct-1_NN DNA_NNS binding_VBG in_VBG T_VBG cells_VBG from_VBG Sjogren_VBG syndrome_VBG patients_VBG ._VBG
Mammal_VBG pyruvate_VBG kinases_VBG are_VBG encoded_VBG by_VBG two_VBG genes_VBG ._VBG
This_VBG phenomenon_VBG ,_VBG which_VBG is_VBG independent_VBG of_VBG tumour_VBG necrosis_VBG factor_VBG ,_VBG is_VBG associated_VBG with_VBG HIV_VBG replication_VBG ,_VBG and_VBG is_VBG thus_VBG likely_VBG to_VBG explain_VBG at_VBG least_VBG in_VBG part_VBG the_VBG perpetuation_VBG of_VBG HIV_VBG infection_VBG in_VBG monocytes_VBG ._VBG
As_VBG described_VBG by_VBG Jun_VBG Liu_VBG ,_VBG these_VBG drugs_VBG manifest_VBG effects_VBG in_VBG an_VBG unprecedented_VBG fashion_VBG ._VBG
Since_VBG APL_VBG cells_VBG do_VBG not_VBG express_VBG HLA_VBG class_VBG II_VBG molecules_VBG ,_VBG we_VBG tested_VBG in_VBG two_VBG donors_VBG D.E._VBG and_VBG C.H.R._VBG and_VBG in_VBG patients_VBG S.R._VBG and_VBG P.G._VBG whether_VBG the_VBG use_VBG of_VBG 9-mer_VBG peptides_VBG would_VBG generate_VBG a_VBG class_VBG I-restricted_VBG response_VBG ._VBG
The_DT anti-oxidative_JJ effect_VBP of_VBG BHA_VBG was_VBG accompanied_VBG by_VBG an_VBG increase_VBG in_VBG thiol_VBG ,_VBG but_VBG not_VBG glutathione_VBG ,_VBG content_VBG in_VBG stimulated_VBG and_VBG unstimulated_VBG T_VBG cell_VBG ,_VBG whereas_VBG TNF_VBG stimulation_VBG itself_VBG barely_VBG modified_VBG the_VBG cellular_VBG thiol_VBG level_VBG ._VBG
No_CD unifying_JJ hypothesis_NN has_VBZ yet_NN emerged_VBN explaining_JJ this_DT collection_CD of_VBG data_NNS ._.
One_JJ enigmatic_JJ aspect_DT of_VBG GATA_NN factor_IN expression_NN is_NNS that_VBG several_VBG GATA_VBG proteins_VBG ,_VBG which_VBG ostensibly_VBG share_VBG the_VBG same_VBG DNA-binding_VBG site_VBG specificity_VBG ,_VBG are_VBG coexpressed_VBG in_VBG erythroid_VBG cells_VBG ._VBG
Transient_VBG expression_VBG of_VBG NFATc.beta_VBG was_VBG capable_VBG of_VBG activating_VBG an_VBG interleukin-2_VBG NFAT-driven_VBG reporter_VBG gene_VBG in_VBG stimulated_VBG Jurkat_VBG cells_VBG in_VBG a_VBG CsA-sensitive_VBG manner_VBG ._VBG
We_VBG investigated_VBG the_VBG clinical_VBG significance_VBG of_VBG glucocorticoid_VBG receptor_VBG determination_VBG in_VBG 20_VBG patients_VBG with_VBG systemic_VBG lupus_VBG erythematosus_VBG SLE_VBG who_VBG afterwards_VBG developed_VBG nephrotic_VBG syndrome_VBG ._VBG
However_DT ,_VBG the_VBG transcription_VBG and_VBG synthesis_VBG of_VBG interleukin_VBG 2_VBG and_VBG other_VBG delayed_VBG early_VBG cytokines_VBG were_VBG markedly_VBG attenuated_VBG by_VBG BCL-2_VBG ._VBG
Different_JJ modes_NN ,_VBG like_DT chemical_JJ induction_RB ,_VBG lytic_NN superinfection_NN with_IN EBV_CD and_CC single_VBP gene_NN trans-activation_NN converted_IN the_DT recombinant_JJ ori_NNS Lyt_NN element_VBP in_VBG R7-57_FW reporter_NN cells_NNS ._.
Notably_IN ,_VBG we_PRP do_NN not_RB see_JJ particularly_RB strong_VBG transcription_VBG when_VBG the_VBG immunoglobulin_VBG kappa_VBG enhancer_VBG or_VBG the_VBG immunoglobulin_VBG heavy_VBG chain_VBG enhancer_VBG is_VBG used_VBG to_VBG activate_VBG a_VBG kappa_VBG gene_VBG promoter_VBG ._VBG
Potent_VBG gene_VBG regulatory_VBG and_VBG antiproliferative_VBG activities_VBG of_VBG 20-methyl_VBG analogues_VBG of_VBG 1,25_VBG dihydroxyvitamin_VBG D3_VBG ._VBG
Cyclosporin_DT A_VBG and_VBG FK506_VBG inhibit_VBG T-_VBG and_VBG B-cell_VBG activation_VBG and_VBG other_VBG processes_VBG essential_VBG to_VBG an_VBG effective_VBG immune_VBG response_VBG ._VBG
1,25-LRB-OH-RRB-2D3_CD is_VBZ therefore_RB one_JJ of_VBG the_VBG most_VBG potent_VBG regulators_VBG of_VBG HIV-1_VBG replication_VBG described_VBG to_VBG date_VBG ._VBG
Importantly_IN ,_VBG two_VBG previously_VBG characterized_VBG mutants_VBG with_VBG point_VBG mutations_VBG in_VBG Tax_VBG ,_VBG M32_VBG Y196A_VBG ,_VBG K197S_VBG and_VBG M41_VBG H287A_VBG ,_VBG P288S_VBG ,_VBG which_VBG were_VBG shown_VBG to_VBG be_VBG defective_VBG in_VBG Tax-activated_VBG transcription_VBG were_VBG unable_VBG to_VBG interact_VBG with_VBG TFIIA_VBG in_VBG this_VBG assay_VBG ._VBG
Addition_IN of_VBG KCl_NN resulted_JJ in_VBG less_JJ DNA_NN binding_VBG either_VBG due_VBG to_VBG blockage_VBG of_VBG DNA-receptor_VBG complex_VBG formation_VBG or_VBG disruption_VBG of_VBG the_VBG complexes_VBG ._VBG
Thus_NNS ,_VBG the_JJ 55_VBG kd_NN TNFR_NN plays_NN a_VBG decisive_VBG role_VBG in_VBG the_VBG host_VBG defense_VBG against_VBG microorganisms_VBG and_VBG pathogenic_VBG factors_VBG
Members_DT of_VBG this_DT group_JJ have_NN three_CD tetraproline_JJ repeats_NNS ._.
Ectopic_VBG expression_VBG of_VBG cloned_VBG Oct2_VBG cDNA_VBG was_VBG shown_VBG to_VBG be_VBG sufficient_VBG to_VBG reconstitute_VBG at_VBG least_VBG some_VBG aspects_VBG of_VBG this_VBG regulation_VBG in_VBG non-lymphoid_VBG cells_VBG ._VBG
We_VBG used_VBG phenolic_VBG ,_VBG lipid-soluble_VBG ,_VBG chain-breaking_VBG antioxidants_VBG butylated_VBG hydroxyanisole_VBG BHA_VBG ,_VBG nordihydroquairetic_VBG acid_VBG ,_VBG or_VBG alpha-tocopherol_VBG vitamin_VBG E_VBG to_VBG show_VBG that_VBG peroxyl_VBG radical_VBG scavenging_VBG in_VBG unstimulated_VBG and_VBG PMA-_VBG or_VBG TNF-stimulated_VBG cells_VBG blocks_VBG the_VBG functions_VBG depending_VBG on_VBG NF-kappa_VBG B_VBG activation_VBG ._VBG
It_IN also_RB bound_VBD to_VBG the_DT purine-rich_CD CD3R_NN element_CD from_VBG the_VBG human_VBG immunodeficiency_VBG virus_VBG type_VBG 2_VBG long_VBG terminal_VBG repeat_VBG ,_VBG which_VBG is_VBG required_VBG for_VBG inducible_VBG virus_VBG expression_VBG in_VBG response_VBG to_VBG signalling_VBG through_VBG the_VBG T-cell_VBG receptor_VBG ._VBG
We_VBG conclude_VBG that_VBG different_VBG domains_VBG of_VBG the_VBG pp56-LRB-lck-RRB-_VBG molecule_VBG contribute_VBG to_VBG regulate_VBG distinct_VBG biologic_VBG functions_VBG ._VBG
Furthermore_PRP ,_VBG GcR_VBG were_VBG unaltered_VBG after_VBG these_VBG patients_VBG received_VBG ketoconazole_VBG ,_VBG in_VBG spite_VBG of_VBG a_VBG marked_VBG reduction_VBG in_VBG morning_VBG plasma_VBG cortisol_VBG and_VBG urinary_VBG free_VBG cortisol_VBG ._VBG
The_DT binding_VBG protein_NN s_CD that_VBG recognize_VBG the_VBG P_VBG sequence_VBG of_VBG the_VBG IL-4_VBG gene_VBG were_VBG identified_VBG by_VBG DNA-mobility-shift_VBG assays_VBG ._VBG
In_VBG JM_VBG T_VBG cells_VBG ,_VBG tax_VBG induced_VBG LT-293_VBG activity_VBG by_VBG two-_VBG to_VBG four-fold_VBG ,_VBG though_VBG there_VBG was_VBG no_VBG induction_VBG of_VBG M1-CAT_VBG ._VBG
Once_VBG we_VBG identify_VBG the_VBG functional_VBG domains_VBG of_VBG the_VBG GATA-binding_VBG proteins_VBG ,_VBG we_VBG hope_VBG to_VBG learn_VBG what_VBG proteins_VBG GATA-1_VBG binds_VBG to_VBG in_VBG the_VBG basic_VBG transcription_VBG machinery_VBG or_VBG in_VBG chromatin_VBG ._VBG
REV_VBG LTRs_VBG work_VBG efficiently_VBG in_VBG human_VBG lymphoid_VBG cells_VBG ,_VBG and_VBG are_VBG viable_VBG alternatives_VBG to_VBG promoters_VBG commonly_VBG used_VBG for_VBG expression_VBG of_VBG cloned_VBG genes_VBG ._VBG
The_DT immunosuppressants_JJ ciclosporin_NN and_CC FK506_JJ block_IN the_DT signal-transduction_JJ pathway_NN emanating_VBG from_VBG the_VBG T-cell_VBG receptor_VBG ,_VBG thereby_VBG inhibiting_VBG the_VBG activation_VBG of_VBG helper_VBG T_VBG cells_VBG ._VBG
TSC2_NN messenger_IN RNA_NN was_VBZ widely_RB expressed_VBD in_VBG various_RB cell_NN types_NNS throughout_DT the_DT body_RB ,_VBG including_VBG epithelia_JJ ,_VBG lymphocytes_VBZ ,_VBG and_VBG cells_VBG with_VBG endocrine_VBG functions_VBG ,_VBG e.g._VBG ,_VBG adrenal_VBG cortex_VBG and_VBG anterior_VBG pituitary_VBG ._VBG
While_DT this_DT expectation_NN may_IN be_VB realized_VBD in_VBG some_VBG cases_VBG ,_VBG we_VBG have_VBG not_VBG found_VBG evidence_VBG for_VBG it_VBG ._VBG
We_JJ present_JJ evidence_JJ that_VBG induction_CD of_VBG neutrophil_VBG binding_VBG by_VBG LPS_VBG is_VBG actually_VBG suppressed_VBG by_VBG agents_VBG that_VBG elevated_VBG cAMP_VBG levels_VBG ._VBG
Interleukin-3_VBG expression_VBG by_VBG activated_VBG T_VBG cells_VBG involves_VBG an_VBG inducible_VBG ,_VBG T-cell-specific_VBG factor_VBG and_VBG an_VBG octamer_VBG binding_VBG protein_VBG ._VBG
Viruses_NN containing_VBG the_VBG human_VBG cytomegalovirus_VBG immediate-early_VBG enhancer_VBG exhibited_VBG infectious_VBG kinetics_VBG similar_VBG to_VBG that_VBG of_VBG wild-type_VBG HIV_VBG in_VBG activated_VBG human_VBG peripheral_VBG blood_VBG lymphocytes_VBG and_VBG AA2_VBG cells_VBG but_VBG replicated_VBG less_VBG efficiently_VBG in_VBG H9_VBG and_VBG CEM_VBG cells_VBG ._VBG
p52_RB and_CC RelB_JJ were_VBD detected_VBD in_VBG the_DT nuclei_NNS in_VBG both_JJ and_CC cells_JJ from_VBG the_VBG T_VBG cell_VBG area_VBG ,_VBG whereas_VBG p50_VBG was_VBG found_VBG only_VBG in_VBG CD68-_VBG and_VBG CD1a-_VBG cells_VBG ._VBG
Hydrochlorothiazide_VBG therapy_VBG resulted_VBG in_VBG life-threatening_VBG hypokalemia_VBG ._VBG
Nuclear_JJ factor_IN kappa_NN B_CD ,_VBG a_VBG mediator_JJ of_VBG lipopolysaccharide_DT effects_NNS ._.
Oct-2_VBG was_VBG found_VBG in_VBG and_VBG T_VBG cells_VBG prepared_VBG from_VBG human_VBG peripheral_VBG blood_VBG and_VBG in_VBG mouse_VBG lymph_VBG node_VBG T_VBG cells_VBG ._VBG
Therefore_PRP ,_VBG we_VBG conclude_VBG that_VBG IL-4_VBG and_VBG IL-10_VBG inhibit_VBG IL-6_VBG production_VBG by_VBG different_VBG mechanisms_VBG in_VBG human_VBG monocytic_VBG cell_VBG lines_VBG ._VBG
Northern_VBG blot_VBG analysis_VBG showed_VBG that_VBG C3a_VBG as_VBG well_VBG as_VBG C3a_VBG desArg_VBG enhanced_VBG LPS-induced_VBG mRNA_VBG levels_VBG for_VBG IL-6_VBG ._VBG
activators_IN are_VBP required_VBD for_VBG HIV-1_VBG replication_VBG and_VBG proviral_VBG induction_VBG in_VBG monocytic_VBG cell_VBG lines_VBG ._VBG
IL-2_DT transcription_NN seems_VBZ to_VBG be_VBG controlled_VBG solely_VBG by_VBG the_VBG transition_VBG from_VBG inactive_VBG to_VBG active_VBG functional_VBG state_VBG of_VBG a_VBG positive_VBG transcription_VBG factor_VBG binding_VBG to_VBG these_VBG promoter_VBG elements_VBG as_VBG well_VBG as_VBG cytoplasmic_VBG or_VBG nuclear_VBG location_VBG :_VBG in_VBG resting_VBG memory_VBG T_VBG cells_VBG the_VBG activator_VBG is_VBG located_VBG in_VBG the_VBG cytoplasm_VBG and_VBG is_VBG inactive_VBG ,_VBG whereas_VBG in_VBG stimulated_VBG cells_VBG it_VBG is_VBG functional_VBG in_VBG promoting_VBG transcription_VBG and_VBG now_VBG resides_VBG in_VBG the_VBG nucleus_VBG ._VBG
The_DT v-erb_RB A_VBG protein_NN has_NNS sustained_VBN two_CD amino_CD acid_NN alterations_VBZ within_IN DNA-binding_VBG domain_NN relative_VBP to_VBG that_VBG of_VBG c-erb_DT A_VBG ,_VBG one_JJ of_VBG which_IN ,_VBG at_VBG serine_CD 61_VBG ,_VBG is_VBG known_VBG to_VBG be_VBG important_VBG for_VBG v-erb_VBG A_VBG function_VBG in_VBG the_VBG neoplastic_VBG cell_VBG ._VBG
In_NN human_JJ monocytes_VBZ ,_VBG interleukin_VBG 1beta_VBG protein_VBG production_VBG and_VBG steady_VBG state_VBG mRNA_VBG levels_VBG are_VBG increased_VBG in_VBG response_VBG to_VBG lipopolysaccharide_VBG ,_VBG predominantly_VBG as_VBG a_VBG result_VBG of_VBG increased_VBG transcription_VBG of_VBG the_VBG interleukin_VBG 1beta_VBG gene_VBG ._VBG
Imbalanced_VBG expression_VBG of_VBG the_VBG glucocorticoid_VBG receptor_VBG isoforms_VBG in_VBG cultured_VBG lymphocytes_VBG from_VBG a_VBG patient_VBG with_VBG systemic_VBG glucocorticoid_VBG resistance_VBG and_VBG chronic_VBG lymphocytic_VBG leukemia_VBG ._VBG
Thymocytes_VBZ ,_VBG activated_VBG peripheral_VBG T_VBG lymphocytes_VBG ,_VBG or_VBG an_VBG activated_VBG T-cell_VBG clone_VBG were_VBG used_VBG as_VBG human_VBG partners_VBG ,_VBG respectively_VBG ,_VBG in_VBG three_VBG independent_VBG fusions_VBG ._VBG
The_DT findings_NNS presented_VBN here_VBP link_NN an_CC atheogenic_JJ lipoprotein_RB ,_VBG LDL_JJ ,_VBG with_CC the_DT induction_VBN of_VBG an_VBG adhesion_VBG molecule_VBG important_VBG in_VBG atherogenesis_VBG
c-jun_VBG mRNA_VBG levels_VBG were_VBG superinduced_VBG in_VBG cells_VBG treated_VBG with_VBG both_VBG okadaic_VBG acid_VBG and_VBG cycloheximide_VBG ,_VBG whereas_VBG inhibition_VBG of_VBG protein_VBG synthesis_VBG had_VBG little_VBG ,_VBG if_VBG any_VBG ,_VBG effect_VBG on_VBG okadaic_VBG acid-induced_VBG c-jun_VBG transcription_VBG ._VBG
HIV-1_NN harboring_VBG mutations_VBG within_VBG two_VBG sites_VBG were_VBG crippled_VBG in_VBG ability_VBG to_VBG replicate_VBG in_VBG U937_VBG promonocytic_VBG cells_VBG ,_VBG indicating_VBG that_VBG these_VBG sites_VBG are_VBG required_VBG for_VBG replication_VBG ._VBG
The_VBG approach_VBG was_VBG further_VBG extended_VBG to_VBG cell_VBG separation_VBG by_VBG the_VBG efficient_VBG recovery_VBG and_VBG elution_VBG of_VBG human_VBG CD37_VBG B_VBG lymphocytes_VBG from_VBG peripheral_VBG blood_VBG ._VBG
Transient_VBG overexpression_VBG of_VBG hTAFII105_VBG selectively_VBG squelches_VBG the_VBG transcription_VBG of_VBG some_VBG genes_VBG in_VBG B_VBG cells_VBG ._VBG
Previous_NN studies_NNS have_VBP suggested_JJ that_VBG gangliosides_VBG have_VBG an_VBG important_VBG role_VBG in_VBG cell_VBG signaling_VBG and_VBG recognition_VBG ._VBG
Both_JJ NK-_NN and_CC T-cell_NN subtypes_NN are_VBP closely_RB associated_JJ with_IN Epstein-Barr_JJ virus_NNS EBV_NN ._.
This_RB decrease_NN was_VBD seen_RB in_VBG patients_VBG who_VBG responded_VBG to_VBG the_VBG therapy_VBG as_VBG well_VBG as_VBG in_VBG those_VBG who_VBG did_VBG not_VBG ._VBG
In_VBG the_VBG present_VBG study_VBG ,_VBG corticosteroid_VBG Type_VBG I_VBG and_VBG Type_VBG II_VBG receptors_VBG in_VBG mononuclear_VBG leukocytes_VBG were_VBG measured_VBG in_VBG 10_VBG elderly_VBG subjects_VBG and_VBG in_VBG 9_VBG young_VBG adults_VBG ,_VBG before_VBG and_VBG after_VBG overnight_VBG DST_VBG 1_VBG mg_VBG ._VBG
Other_VBG studies_VBG have_VBG demonstrated_VBG that_VBG TPA-induced_VBG monocytic_VBG differentiation_VBG and_VBG expression_VBG of_VBG the_VBG c-jun_VBG and_VBG c-fos_VBG genes_VBG in_VBG myeloid_VBG leukemia_VBG cells_VBG are_VBG regulated_VBG by_VBG protein_VBG kinase_VBG C_VBG PKC_VBG ._VBG
Constitutive_PRP nuclear_JJ appearance_NN was_VBZ also_RB observed_JJ for_VBG ._.
To_VBG determine_VBG the_VBG E1A_VBG domain_VBG s_VBG responsible_VBG for_VBG these_VBG properties_VBG several_VBG cell_VBG lines_VBG were_VBG created_VBG by_VBG transforming_VBG baby_VBG rat_VBG kidney_VBG BRK_VBG cells_VBG with_VBG a_VBG set_VBG of_VBG plasmids_VBG expressing_VBG different_VBG hybrid_VBG E1A_VBG gene_VBG products_VBG ._VBG
Activation_IN of_VBG Stat_VBG 5b_VBG in_VBG erythroid_VBG progenitors_VBG correlates_VBG with_VBG the_VBG ability_VBG of_VBG ErbB_VBG to_VBG induce_VBG sustained_VBG cell_VBG proliferation_VBG ._VBG
A_VBG chimeric_VBG type_VBG II_VBG type_VBG I_VBG interleukin-1_VBG receptor_VBG can_VBG mediate_VBG interleukin-1_VBG induction_VBG of_VBG gene_VBG expression_VBG in_VBG T_VBG cells_VBG ._VBG
In_VBG contrast_VBG to_VBG inhibitory_VBG effects_VBG on_VBG cytokine_VBG expression_VBG ,_VBG GCS_VBG up-regulate_VBG cytokine_VBG receptor_VBG expression_VBG that_VBG correlates_VBG with_VBG enhanced_VBG cytokine_VBG effects_VBG on_VBG target_VBG cells_VBG ._VBG
The_DT translated_VBD protein_NN showed_VBD weak_NN DNA_NNS binding_VBG with_VBG a_VBG specificity_VBG for_VBG the_VBG kappa_VBG B_VBG binding_VBG motif_VBG ._VBG
Treatment_DT of_VBG Jurkat_VBG cells_VBG with_VBG mAb_VBG J393_VBG induced_VBG tyrosine_VBG phosphorylation_VBG of_VBG specific_VBG protein_VBG substrates_VBG that_VBG underwent_VBG hyperphosphorylation_VBG upon_VBG antigen_VBG receptor_VBG costimulation_VBG ._VBG
The_VBG effect_VBG appeared_VBG within_VBG 30_VBG min_VBG and_VBG returned_VBG to_VBG basal_VBG levels_VBG after_VBG 2_VBG h_VBG ._VBG
These_VBG factors_VBG are_VBG detected_VBG at_VBG the_VBG time_VBG the_VBG CD11b_VBG promoter_VBG is_VBG activated_VBG ._VBG
There_VBG were_VBG two_VBG main_VBG goals_VBG :_VBG 1_VBG to_VBG evaluate_VBG whether_VBG workers_VBG with_VBG a_VBG moderately_VBG increased_VBG burden_VBG 25-140_VBG ppt_VBG TCDD_VBG or_VBG 104-522_VBG ppt_VBG I-TE_VBG in_VBG blood_VBG fat_VBG exhibit_VBG changes_VBG in_VBG the_VBG surface_VBG receptors_VBG of_VBG white_VBG blood_VBG cells_VBG ,_VBG as_VBG observed_VBG in_VBG previous_VBG studies_VBG in_VBG non-human_VBG primates_VBG ,_VBG and_VBG 2_VBG to_VBG clarify_VBG whether_VBG persons_VBG at_VBG the_VBG upper_VBG range_VBG 10-23_VBG ppt_VBG TCDD_VBG or_VBG 30-90_VBG ppt_VBG I-TE_VBG in_VBG blood_VBG fat_VBG of_VBG the_VBG body_VBG burden_VBG reference_VBG values_VBG of_VBG a_VBG not_VBG particularly_VBG exposed_VBG population_VBG show_VBG detectable_VBG deviations_VBG in_VBG these_VBG immunological_VBG variables_VBG ,_VBG when_VBG compared_VBG with_VBG persons_VBG at_VBG the_VBG lower_VBG and_VBG medium_VBG range_VBG 1-3_VBG ppt_VBG TCDD_VBG or_VBG 9-29_VBG ppt_VBG I-TE_VBG of_VBG these_VBG body_VBG burden_VBG reference_VBG values_VBG ._VBG
Cyclosporin_DT A_VBG CsA_JJ and_CC FK506_NN rescued_VBN B104_NN cells_VBZ from_VBG death_VBG induced_VBG by_VBG anti-IgM_VBG Ab_VBG ,_VBG but_VBG did_VBG not_VBG affect_VBG the_VBG expression_VBG of_VBG Egr-1_VBG and_VBG c-fos_VBG mRNA_VBG ,_VBG showing_VBG that_VBG CsA_VBG and_VBG FK506_VBG affect_VBG signal_VBG transducers_VBG differently_VBG from_VBG or_VBG downstream_VBG to_VBG these_VBG molecules_VBG ._VBG
Signaling_VBG via_VBG IL-2_VBG and_VBG IL-4_VBG in_VBG JAK3-deficient_VBG severe_VBG combined_VBG immunodeficiency_VBG lymphocytes_VBG :_VBG JAK3-dependent_VBG and_VBG independent_VBG pathways_VBG ._VBG
1_CD ._RB The_VBG purpose_CD of_VBG these_VBG studies_VBG was_VBG to_VBG investigate_VBG the_VBG modulation_VBG of_VBG the_VBG proliferation_VBG of_VBG human_VBG T_VBG cells_VBG obtained_VBG from_VBG peripheral_VBG blood_VBG by_VBG dexamethasone_VBG DEX_VBG ,_VBG isoproterenol_VBG ISO_VBG ,_VBG and_VBG prostaglandin_VBG E2_VBG PGE2_VBG ._VBG
As_VBG the_VBG NF-kappa_VBG B_VBG transcription_VBG factor_VBG has_VBG a_VBG central_VBG role_VBG in_VBG the_VBG control_VBG of_VBG transcription_VBG of_VBG several_VBG genes_VBG involved_VBG in_VBG immune_VBG and_VBG inflammatory_VBG responses_VBG ,_VBG the_VBG authors_VBG have_VBG analysed_VBG the_VBG activation_VBG of_VBG NF-kappa_VBG B_VBG in_VBG human_VBG umbilical_VBG cord_VBG T_VBG lymphocytes_VBG ._VBG
Bcd_RB mRNA_NN transcripts_VBZ of_VBG or_CC 2.6_. kb_NN were_NN selectively_RB expressed_JJ in_VBG PBL_JJ and_CC testis_DT of_VBG healthy_JJ individuals_NNS ._.
In_VBG this_VBG review_VBG ,_VBG we_VBG summarize_VBG the_VBG current_VBG state_VBG of_VBG knowledge_VBG of_VBG the_VBG mechanism_VBG of_VBG action_VBG of_VBG GCS_VBG ,_VBG including_VBG the_VBG phenomenon_VBG of_VBG steroid-induced_VBG rebound_VBG ,_VBG which_VBG ensues_VBG upon_VBG GCS_VBG withdrawal_VBG ._VBG
The_DT activity_RB of_VBG the_DT CCAAT-box_NN binding_VBG factor_VBG NF-Y_VBG is_VBG modulated_VBG through_VBG the_VBG regulated_VBG expression_VBG of_VBG A_VBG subunit_VBG during_VBG monocyte_VBG to_VBG macrophage_VBG differentiation_VBG :_VBG regulation_VBG of_VBG tissue-specific_VBG genes_VBG through_VBG a_VBG ubiquitous_VBG transcription_VBG factor_VBG ._VBG
Early_VBG buds_VBG are_VBG characterized_VBG by_VBG a_VBG branching_VBG morphogenesis_VBG of_VBG the_VBG ductal_VBG epithelium_VBG from_VBG which_VBG endocrine_VBG and_VBG exocrine_VBG precursor_VBG cells_VBG bud_VBG to_VBG eventually_VBG form_VBG the_VBG two_VBG other_VBG compartments_VBG ._VBG
Substantial_VBG decreases_VBG of_VBG IL-2_VBG production_VBG were_VBG observed_VBG for_VBG cell_VBG cultures_VBG from_VBG 7_VBG of_VBG 12_VBG elderly_VBG individuals_VBG in_VBG response_VBG to_VBG the_VBG different_VBG stimuli_VBG ,_VBG whereas_VBG the_VBG levels_VBG of_VBG IL-2_VBG produced_VBG by_VBG stimulated_VBG T_VBG cells_VBG from_VBG other_VBG elderly_VBG individuals_VBG were_VBG equivalent_VBG to_VBG those_VBG observed_VBG for_VBG stimulated_VBG T_VBG cells_VBG of_VBG young_VBG subjects_VBG ._VBG
Half-maximal_VBG induction_VBG of_VBG GR_VBG mRNA_VBG and_VBG protein_VBG in_VBG 6TG1.1_VBG cells_VBG was_VBG observed_VBG between_VBG 10-100_VBG nM_VBG dexamethasone_VBG ,_VBG and_VBG inclusion_VBG of_VBG 1_VBG microM_VBG RU_VBG 38486_VBG completely_VBG blocked_VBG the_VBG effects_VBG of_VBG 100_VBG nM_VBG dexamethasone_VBG ,_VBG demonstrating_VBG that_VBG positive_VBG autoregulation_VBG of_VBG GR_VBG expression_VBG in_VBG 6TG1.1_VBG cells_VBG is_VBG a_VBG receptor-mediated_VBG response_VBG ._VBG
Taken_VBG together_VBG ,_VBG results_VBG suggest_VBG that_VBG OCA-B_VBG is_VBG a_VBG tissue-_VBG ,_VBG promoter-_VBG ,_VBG and_VBG factor-specific_VBG coactivator_VBG and_VBG that_VBG OCA-B_VBG may_VBG be_VBG a_VBG major_VBG determinant_VBG for_VBG B_VBG cell-specific_VBG activation_VBG of_VBG immunoglobulin_VBG promoters_VBG ._VBG
Constitutive_VBG binding_VBG of_VBG further_VBG factor_VBG proteins_VBG to_VBG DNA_VBG ,_VBG such_VBG as_VBG JunD_VBG ,_VBG c-Fos_VBG and_VBG FosB_VBG ,_VBG was_VBG detected_VBG in_VBG several_VBG patients_VBG whereas_VBG the_VBG localisation_VBG and_VBG DNA_VBG binding_VBG of_VBG other_VBG factors_VBG such_VBG as_VBG c-Jun_VBG ,_VBG and_VBG c-Rel_VBG was_VBG unaltered_VBG ._VBG
A_DT clone_CD of_VBG U937_NN cells_NN was_VBD selected_JJ which_WDT expressed_VBD Fc_NN receptor_CC I_NN Fc_NN gamma_NNS RI_NNS and_CC which_JJ ,_VBG after_DT incubation_NN with_IN IFN-gamma_NNS for_VBG 72_VBG h_JJ ,_VBG was_VBD capable_DT of_VBG generating_VBG high_VBG levels_VBG of_VBG lucigenin-enhanced_VBG CL_VBG ._VBG
Different_VBG amounts_VBG of_VBG the_VBG various_VBG isoforms_VBG are_VBG present_VBG within_VBG the_VBG same_VBG B-cell_VBG regardless_VBG of_VBG the_VBG developmental_VBG stage_VBG of_VBG B-cell_VBG differentiation_VBG and_VBG at_VBG least_VBG some_VBG of_VBG the_VBG isoforms_VBG are_VBG conserved_VBG between_VBG mouse_VBG and_VBG humans_VBG ._VBG
These_VBG blast_VBG cells_VBG express_VBG lineage-specific_VBG transcription_VBG factors_VBG such_VBG as_VBG GATA-1_VBG common_VBG to_VBG these_VBG lineages_VBG and_VBG frequently_VBG express_VBG erythroid-specific_VBG mRNAs_VBG such_VBG as_VBG gamma-globin_VBG and_VBG erythroid_VBG delta-aminolevulinate_VBG synthase_VBG ALAS-E_VBG ,_VBG indicating_VBG that_VBG most_VBG of_VBG the_VBG blasts_VBG in_VBG M7_VBG and_VBG TMD_VBG cases_VBG have_VBG erythroid_VBG and_VBG megakaryocytic_VBG phenotypes_VBG ._VBG
The_VBG structural_VBG classes_VBG of_VBG transcription_VBG factors_VBG are_VBG described_VBG and_VBG basic_VBG methods_VBG for_VBG detection_VBG and_VBG analysis_VBG of_VBG transcription_VBG factors_VBG are_VBG detailed_VBG ._VBG
Overexpression_IN of_VBG the_DT p50_CD ,_VBG p65_VBG and_VBG Rel_VBG proteins_VBG in_VBG these_VBG cells_VBG showed_VBG that_VBG significant_VBG activation_VBG of_VBG the_VBG IL-2R_VBG alpha_VBG kappa_VBG B_VBG site_VBG was_VBG observed_VBG only_VBG with_VBG Rel_VBG and_VBG Rel_VBG plus_VBG p65_VBG ._VBG
Three_PRP molecular_JJ clones_VBZ of_VBG HIV-1_NNS ,_VBG derived_JJ from_VBG a_VBG single_VBG isolate_VBG AL1_VBG ,_VBG exhibited_VBG distinct_VBG replicative_VBG and_VBG cytopathic_VBG properties_VBG during_VBG propagation_VBG in_VBG a_VBG human_VBG T_VBG cell_VBG line_VBG ._VBG
Okadaic_VBG acid_VBG was_VBG found_VBG to_VBG be_VBG a_VBG potent_VBG inducer_VBG of_VBG AP1_VBG ._VBG
It_DT is_VBZ assumed_JJ that_VBG pp56-LRB-lck-RRB-_NN acts_NN on_VBG these_DT processes_VBZ by_VBG phosphorylating_JJ substrates_NNS ._.
Instead_JJ ,_VBG ATF-2_NN and_IN Jun_NN proteins_NNS bind_CC to_VBG the_DT composite_VBP kappa_NN site_VBP and_CC NFATp_NN binds_NN to_VBG a_VBG newly_RB identified_VBN second_JJ NFAT_NN site_NN centered_VBN at_VBG -76_VBG nucleotides_VBG relative_VBG to_VBG the_VBG TNF-alpha_VBG transcription_VBG start_VBG site_VBG ._VBG
When_VBG endothelial_VBG cells_VBG are_VBG incubated_VBG with_VBG this_VBG lipoprotein_VBG in_VBG pathophysiologic_VBG amounts_VBG ,_VBG the_VBG cells_VBG are_VBG activated_VBG ._VBG
LPS_NNS binding_VBG to_VBG plasma_DT membrane_NN receptors_VBZ and_CC internalization_JJ of_VBG LPS_NNS into_VBG monocytes_VBG were_VBG not_VBG affected_VBG by_VBG lysoPC_VBG ._VBG
The_DT kappa_NNS B_NN sequence_VBP GGGACTTTCC_NN binds_IN a_VBG factor_RB ,_VBG NF-kappa_VBG B_VBG ,_VBG that_VBG is_VBG constitutively_VBG found_VBG in_VBG functional_VBG ,_VBG DNA_VBG binding_VBG form_VBG only_VBG in_VBG B_VBG lymphocytes_VBG ._VBG
We_VBG have_VBG isolated_VBG TFIIH_VBG from_VBG cells_VBG derived_VBG from_VBG a_VBG patient_VBG XP11BE_VBG who_VBG carries_VBG this_VBG frameshift_VBG mutation_VBG TFIIHmut_VBG and_VBG from_VBG the_VBG mother_VBG of_VBG this_VBG patient_VBG TFIIHwt_VBG to_VBG determine_VBG the_VBG biochemical_VBG consequences_VBG of_VBG the_VBG mutation_VBG ._VBG
Activation_IN of_VBG T_VBG cells_VBG results_VBG in_VBG a_VBG cascade_VBG of_VBG gene_VBG activation_VBG and_VBG subsequent_VBG proliferation_VBG and_VBG differentiation_VBG into_VBG effector_VBG phenotypes_VBG ._VBG
These_VBG findings_VBG provide_VBG direct_VBG in_VBG vivo_VBG evidence_VBG to_VBG strongly_VBG suggest_VBG that_VBG the_VBG modulation_VBG of_VBG X1_VBG and_VBG X2_VBG interactions_VBG is_VBG an_VBG important_VBG constituent_VBG of_VBG the_VBG interferon_VBG gamma_VBG induction_VBG pathway_VBG ._VBG
One_DT of_VBG the_DT factors_NN bound_VBD to_VBG a_VBG novel_JJ dyad_VBD symmetrical_JJ sequence_NN ._.
Recent_VBG work_VBG has_VBG shown_VBG that_VBG IL-10_VBG induces_VBG activation_VBG of_VBG the_VBG JAK-STAT_VBG signaling_VBG pathway_VBG ._VBG
Subsequently_RB binding_VBG sites_VBG have_VBG been_VBG demonstrated_VBG in_VBG the_VBG plasma_VBG membrane_VBG of_VBG human_VBG lymphocytes_VBG which_VBG show_VBG pharmacological_VBG aldosterone_VBG specificity_VBG and_VBG kinetic_VBG high_VBG turnover_VBG properties_VBG identical_VBG with_VBG those_VBG of_VBG the_VBG rapid_VBG aldosterone_VBG effects_VBG in_VBG the_VBG same_VBG cells_VBG ._VBG
TCF-1_NN contained_VBN a_VBG single_VBG DNA-binding_VBG HMG_VBG box_VBG most_VBG closely_VBG related_VBG to_VBG similar_VBG boxes_VBG in_VBG the_VBG putative_VBG mammalian_VBG sex-determining_VBG gene_VBG SRY_VBG and_VBG in_VBG the_VBG Schizosaccharomyces_VBG pombe_VBG Mc_VBG mating_VBG type_VBG gene_VBG ._VBG
The_VBG biochemical_VBG modifications_VBG responsible_VBG for_VBG the_VBG defect_VBG in_VBG transduction_VBG and_VBG execution_VBG of_VBG the_VBG proliferative_VBG signal_VBG are_VBG analyzed_VBG as_VBG a_VBG function_VBG of_VBG age_VBG ._VBG
Moreover_DT ,_VBG using_IN a_VBG heterologous_NNS promoter_NN herpes_VBZ thymidine_NN kinase_NN construct_NN containing_VBG the_VBG NF-kappa_VBG B_VBG consensus_VBG sequence_VBG ,_VBG it_VBG is_VBG shown_VBG that_VBG NF-kappa_VBG B_VBG binding_VBG by_VBG an_VBG IL-2-induced_VBG monocyte-derived_VBG nuclear_VBG protein_VBG confers_VBG reporter_VBG gene_VBG human_VBG growth_VBG hormone_VBG activity_VBG ._VBG
This_VBG study_VBG determined_VBG if_VBG the_VBG Ad5-induced_VBG inhibition_VBG of_VBG IFN-MCP_VBG was_VBG independent_VBG of_VBG adenovirus_VBG Ad_VBG infection_VBG and_VBG secondary_VBG only_VBG to_VBG the_VBG expression_VBG of_VBG the_VBG Ad_VBG early_VBG region_VBG 1A_VBG gene_VBG E1A_VBG ._VBG
Analysis_NNS of_VBG a_VBG series_VBZ of_VBG showed_JJ several_JJ peaks_VBZ of_VBG basal_CD and_CC PMA_NN induced_VBN activity_NN suggesting_JJ the_DT presence_CD of_VBG several_JJ positive_JJ and_NN negative_JJ regulatory_NN elements_NNS ._.
Thus_NNS ,_VBG this_VBG work_VBG presents_VBG the_VBG first_VBG detailed_VBG analysis_VBG of_VBG a_VBG naturally_VBG occurring_VBG mutation_VBG in_VBG a_VBG basal_VBG transcription_VBG factor_VBG and_VBG supports_VBG the_VBG concept_VBG that_VBG the_VBG combined_VBG clinical_VBG entity_VBG is_VBG actually_VBG the_VBG result_VBG of_VBG a_VBG combined_VBG deficiency_VBG ._VBG
Cortivazol_VBG is_VBG a_VBG phenylpyrazolo_VBG glucocorticoid_VBG of_VBG high_VBG potency_VBG and_VBG unusual_VBG structure_VBG ._VBG
This_DT indicated_JJ that_VBG the_DT dUTPase_JJ is_NN expressed_VBN during_JJ EBV_NN replication_NN and_NN reactivation_NN ._.
We_NN have_VBP therefore_RB investigated_VBP the_DT changes_VBZ in_VBG protein_VBG kinase_VBG C_VBG PKC_VBG activity_VBG upon_VBG exposure_VBG of_VBG monocytes_VBG to_VBG M-CSF_VBG ._VBG
These_NN studies_NNS suggest_VBD that_VBG ,_VBG by_VBG inhibiting_IN AP-1_NN activation_RB ,_VBG Nef_NN may_NN play_NN a_VBG role_VBP in_VBG regulating_VBG HIV-1_VBG gene_VBG expression_VBG in_VBG infected_VBG T-cells_VBG
As_DT a_VBG consequence_RB ,_VBG the_DT immune_CD response_NN developed_NN in_VBG senescent_JJ organisms_VBZ is_VBZ usually_RB inappropriate_VB ,_VBG often_VBG inefficient_VBG ,_VBG sometimes_VBG aberrant_VBG ,_VBG and_VBG potentially_VBG detrimental_VBG ._VBG
The_VBG regulatory_VBG mechanisms_VBG of_VBG the_VBG human_VBG and_VBG murine_VBG TNF_VBG genes_VBG are_VBG discussed_VBG ._VBG
Furthermore_PRP ,_VBG we_VBG present_VBG a_VBG new_VBG principle_VBG for_VBG searching_VBG Ag_VBG for_VBG potential_VBG amphipatic_VBG alpha-helical_VBG protein_VBG segments_VBG ._VBG
Mobility_VBG shift_VBG assays_VBG showed_VBG that_VBG the_VBG CLE0_VBG sequence_VBG has_VBG an_VBG AP1-binding_VBG site_VBG and_VBG is_VBG associated_VBG with_VBG an_VBG NF-AT-like_VBG factor_VBG ,_VBG termed_VBG NF-CLE0_VBG gamma_VBG ._VBG
Two_VBG homologues_VBG of_VBG the_VBG rhombotin_VBG gene_VBG have_VBG now_VBG been_VBG isolated_VBG ._VBG
Together_JJ ,_VBG this_VBG evidence_VBG strongly_VBG implicates_VBG BSAP_VBG in_VBG the_VBG regulation_VBG of_VBG the_VBG CD19_VBG gene_VBG ._VBG
The_DT numbers_VBZ of_VBG estrogen_VBN receptor_NN ER_JJ in_VBG human_VBG peripheral_VBG leucocytes_VBG in_VBG 22_VBG women_VBG with_VBG climacteric_VBG syndrome_VBG were_VBG measured_VBG by_VBG radioligand_VBG method_VBG ._VBG
Changes_DT in_VBG leucocytic_JJ estrogen_IN receptor_NN levels_VBZ in_VBG patients_VBG with_VBG climacteric_VBG syndrome_VBG and_VBG therapeutic_VBG effect_VBG of_VBG liuwei_VBG dihuang_VBG pills_VBG
The_VBG 70_VBG kDa_VBG heat_VBG shock_VBG protein_VBG Hsp70_VBG is_VBG a_VBG highly_VBG conserved_VBG ,_VBG ubiquitous_VBG protein_VBG involved_VBG in_VBG chaperoning_VBG proteins_VBG to_VBG various_VBG cellular_VBG organelles_VBG ._VBG
The_DT first_JJS male_JJ patient_JJ presented_VBN with_IN mild_NN hypertension_NN ._.
The_VBG endocrine_VBG events_VBG that_VBG are_VBG rapidly_VBG expressed_VBG seconds_VBG are_VBG due_VBG to_VBG a_VBG possible_VBG interaction_VBG with_VBG cellular_VBG membrane_VBG ._VBG
Elevated_VBG cAMP_VBG did_VBG not_VBG prevent_VBG nuclear_VBG translocation_VBG of_VBG and_VBG heterodimers_VBG ,_VBG decrease_VBG nuclear_VBG translocation_VBG of_VBG p65_VBG ,_VBG or_VBG significantly_VBG modify_VBG TNFalpha-induced_VBG phosphorylation_VBG of_VBG p65_VBG ._VBG
To_PRP analyze_VBP the_DT regulatory_JJ mechanisms_NN controlling_VBG p27Kip1_VBG gene_VBG expression_VBG ,_VBG we_VBG characterized_VBG the_VBG region_VBG from_VBG nt_VBG -1609_VBG to_VBG ._VBG
Various_VBG modes_VBG of_VBG basic_VBG helix-loop-helix_VBG protein-mediated_VBG regulation_VBG of_VBG murine_VBG leukemia_VBG virus_VBG transcription_VBG in_VBG lymphoid_VBG cell_VBG lines_VBG ._VBG
In_VBG contrast_VBG ,_VBG Spi-B_VBG is_VBG expressed_VBG exclusively_VBG in_VBG lymphoid_VBG cells_VBG and_VBG can_VBG be_VBG detected_VBG in_VBG early_VBG fetal_VBG thymus_VBG and_VBG spleen_VBG ._VBG
Whereas_VBZ the_DT hypercalcemic_JJ effect_NNS for_VBG ZK157202_VBG is_VBG also_VBG increased_VBG 10-fold_VBG ,_VBG ZK161422_VBG has_VBG the_VBG same_VBG calcium-mobilizing_VBG potency_VBG as_VBG VD_VBG ._VBG
The_DT responses_VBZ of_VBG lymphocytes_JJ to_VBG IL-2_VBG and_VBG IL-12_VBG ,_VBG involving_VBG proliferation_VBG ,_VBG differentiation_VBG ,_VBG and_VBG cytokine_VBG production_VBG ,_VBG are_VBG only_VBG partially_VBG overlapping_VBG ,_VBG and_VBG may_VBG depend_VBG on_VBG induced_VBG differential_VBG expression_VBG of_VBG specific_VBG sets_VBG of_VBG genes_VBG ._VBG
Serial_JJ sectioning_JJ of_VBG 6_VBG micrometer_IN was_VBD performed_VBN using_JJ a_VBG cryostat_RB ,_VBG and_CC samples_NNS were_VBP immunohistochemically_RB stained_JJ using_VBG the_VBG streptoavidin-biotin_VBG peroxidase_VBG method_VBG and_VBG a_VBG monoclonal_VBG antibody_VBG against_VBG c-fos_VBG ._VBG
Following_VBG irradiation_VBG ,_VBG transgenic_VBG mice_VBG ,_VBG as_VBG compared_VBG with_VBG controls_VBG ,_VBG more_VBG rapidly_VBG depressed_VBG peripheral_VBG white_VBG blood_VBG cell_VBG and_VBG granulocyte_VBG counts_VBG ._VBG
Furthermore_PRP ,_VBG an_DT inverse_JJ relationship_JJ was_NNS also_RB observed_JJ between_IN the_DT LDL_JJ receptor_NN gene_NN expression_JJ at_VBG the_VBG transcriptional_VBG level_VBG and_VBG the_VBG binding_VBG affinity_VBG of_VBG this_VBG 47_VBG kDa_VBG protein_VBG factor_VBG to_VBG the_VBG SRE_VBG sequence_VBG ._VBG
We_DT studied_VBD the_DT effect_NNS of_VBG interleukin-4_VBG IL-4_VBG on_VBG the_VBG lipopolysaccharide_VBG LPS_VBG induction_VBG of_VBG two_VBG immediate_VBG early_VBG genes_VBG c-fos_VBG and_VBG c-jun_VBG ._VBG
A_VBG similar_VBG half-life_VBG was_VBG determined_VBG in_VBG IM-9_VBG cells_VBG and_VBG was_VBG also_VBG unaffected_VBG by_VBG steroid_VBG treatment_VBG ._VBG
Human_VBG T-cell_VBG leukemia_VBG virus_VBG type_VBG I_VBG HTLV-I_VBG is_VBG the_VBG etiologic_VBG agent_VBG of_VBG the_VBG adult_VBG T-cell_VBG leukemia_VBG ,_VBG an_VBG aggressive_VBG and_VBG often_VBG fatal_VBG malignancy_VBG of_VBG activated_VBG human_VBG CD4_VBG T_VBG cells_VBG ._VBG
A_DT novel_RB HIV-1_NN isolate_NN containing_VBG alterations_NNS affecting_IN the_JJ NF-kappa_NN B_JJ element_NN ._.
TCF-1_NN alpha_IN is_VBZ currently_JJ unique_JJ among_NN the_DT newly_RB emerging_VBG family_VBG of_VBG DNA-binding_VBG regulatory_VBG proteins_VBG that_VBG share_VBG the_VBG HMG_VBG motif_VBG in_VBG that_VBG it_VBG is_VBG a_VBG highly_VBG tissue-specific_VBG RNA_VBG polymerase_VBG II_VBG transcription_VBG factor_VBG ._VBG
DNA-binding_VBG assays_VBG with_VBG cotranslated_VBG wild-type_VBG and_VBG truncated_VBG forms_VBG of_VBG EBF_VBG indicated_VBG that_VBG the_VBG protein_VBG interacts_VBG with_VBG site_VBG as_VBG a_VBG homodimer_VBG ._VBG
This_IN phenomenon_NN has_NNS been_VBN termed_VBN tolerance_NN ._.
Direct_VBG exposure_VBG to_VBG 2,3,7,8-tetrachlorodibenzo-p-dioxin_VBG TCDD_VBG increases_VBG infectivity_VBG of_VBG human_VBG erythrocytes_VBG to_VBG a_VBG malarial_VBG parasite_VBG ._VBG
Northern_NN analysis_NN using_IN a_VBG probe_IN encompassing_VBG a_VBG common_VBG region_VBG of_VBG both_VBG isoforms_VBG showed_VBG two_VBG mRNA_VBG species_VBG of_VBG 2.7_VBG and_VBG 4.5_VBG kilobase_VBG pairs_VBG ,_VBG while_VBG an_VBG NFATc.beta-specific_VBG probe_VBG detected_VBG only_VBG the_VBG 4.5-kilobase_VBG pair_VBG mRNA_VBG which_VBG was_VBG preferentially_VBG expressed_VBG in_VBG the_VBG spleen_VBG ._VBG
The_VBG rhombotin_VBG family_VBG of_VBG cysteine-rich_VBG LIM-domain_VBG oncogenes_VBG :_VBG distinct_VBG members_VBG are_VBG involved_VBG in_VBG T-cell_VBG translocations_VBG to_VBG human_VBG chromosomes_VBG 11p15_VBG and_VBG 11p13_VBG ._VBG
c-myc_JJ did_JJ not_RB correlate_JJ with_IN c-fos_NNS and_CC c-jun_IN protein_NN expression_NN ._.
Fas-mediated_VBG apoptosis_VBG plays_VBG an_VBG important_VBG role_VBG in_VBG regulating_VBG the_VBG immune_VBG response_VBG in_VBG peripheral_VBG T_VBG cells_VBG ._VBG
Importantly_IN ,_VBG culture_CD of_VBG MM_VBG cells_VBG with_VBG RB_VBG antisense_VBG ,_VBG but_VBG not_VBG RB_VBG sense_VBG ,_VBG oligonucleotide_VBG ODN_VBG triggered_VBG IL-6_VBG secretion_VBG and_VBG proliferation_VBG in_VBG MM_VBG cells_VBG ;_VBG however_VBG ,_VBG proliferation_VBG was_VBG only_VBG partially_VBG inhibited_VBG by_VBG neutralizing_VBG anti-IL-6_VBG monoclonal_VBG antibody_VBG MoAb_VBG ._VBG
Antigen_VBG receptor_VBG signals_VBG could_VBG be_VBG mimicked_VBG by_VBG suboptimal_VBG activation_VBG of_VBG protein_VBG kinase_VBG C_VBG PKC_VBG with_VBG phorbol_VBG esters_VBG in_VBG combination_VBG with_VBG calcium_VBG mobilization_VBG by_VBG an_VBG ionophore_VBG ._VBG
The_VBG P_VBG sequence_VBG does_VBG not_VBG share_VBG homology_VBG with_VBG the_VBG upstream_VBG sequence_VBG of_VBG the_VBG IL-2_VBG gene_VBG ,_VBG even_VBG though_VBG surrounding_VBG sequences_VBG of_VBG the_VBG IL-4_VBG gene_VBG share_VBG high_VBG homology_VBG with_VBG the_VBG IL-2_VBG gene_VBG ._VBG
An_JJ amino-terminal_JJ fragment_NNS of_VBG OCA-B_VBG binds_VBG the_VBG octamer_VBG site_VBG in_VBG the_VBG absence_VBG of_VBG a_VBG POU_VBG domain_VBG with_VBG the_VBG same_VBG sequence_VBG specificity_VBG ._VBG
The_DT GS_NN strain_IN transactivated_VBD the_DT promoter_VB in_VBG both_CC stimulated_VBD and_CC resting_NN T_NN cells_VBZ ,_VBG while_VBG the_VBG Z29_VBG strain_VBG increased_VBG HIV_VBG promoter_VBG activity_VBG only_VBG in_VBG stimulated_VBG T_VBG cells_VBG ._VBG
In_VBG contrast_VBG ,_VBG the_VBG human_VBG T_VBG cell_VBG line_VBG ,_VBG IARC_VBG 301_VBG ,_VBG expresses_VBG these_VBG two_VBG genes_VBG constitutively_VBG and_VBG we_VBG have_VBG previously_VBG demonstrated_VBG that_VBG growth_VBG depends_VBG on_VBG the_VBG autocrine_VBG production_VBG of_VBG this_VBG T_VBG cell_VBG growth_VBG factor_VBG and_VBG high_VBG affinity_VBG IL-2R_VBG ._VBG
However_DT ,_VBG longer_VBG periods_VBG of_VBG incubation_VBG were_VBG associated_VBG with_VBG a_VBG return_VBG to_VBG the_VBG distribution_VBG of_VBG PKC_VBG in_VBG control_VBG cells_VBG ._VBG
Reticuloendotheliosis_VBG virus_VBG long_VBG terminal_VBG repeat_VBG elements_VBG are_VBG efficient_VBG promoters_VBG in_VBG cells_VBG of_VBG various_VBG species_VBG and_VBG tissue_VBG origin_VBG ,_VBG including_VBG human_VBG lymphoid_VBG cells_VBG ._VBG
Currently_RB it_VBP is_VBZ accepted_JJ the_DT existence_VBP of_VBG a_VBG cytoplasmic_VBG nuclear_VBG receptor_VBG ,_VBG without_VBG explaining_VBG satisfactorily_VBG how_VBG the_VBG hormones_VBG come_VBG to_VBG the_VBG nucleus_VBG ._VBG
Infection_IN of_VBG target_VBG cells_VBG with_VBG cytopathic_VBG viruses_VBG inhibits_VBG IFN_VBG induction_VBG of_VBG cytolytic_VBG resistance_VBG to_VBG NK_VBG cell-mediated_VBG cytolysis_VBG IFN-mediated_VBG cytoprotection_VBG IFN-MCP_VBG ._VBG
We_VBG show_VBG that_VBG ATRA_VBG directly_VBG activates_VBG IRF-1_VBG gene_VBG expression_VBG ,_VBG followed_VBG by_VBG activation_VBG of_VBG IRF-2_VBG and_VBG oligoadenylate_VBG synthetase_VBG OAS_VBG gene_VBG expression_VBG with_VBG slower_VBG kinetics_VBG ._VBG
Here_DT we_PRP demonstrate_VBD that_VBG the_VBG human_VBG monocytic_VBG M-CSF_VBG receptor_VBG promoter_VBG directs_VBG reporter_VBG gene_VBG activity_VBG in_VBG a_VBG tissue-specific_VBG fashion_VBG ._VBG
Except_IN for_VBG PGF2_NN alpha_NNS ,_VBG HHT_VBG and_VBG 15-HETE_VBG no_VBG detectable_VBG quantities_VBG of_VBG eicosanoids_VBG were_VBG found_VBG in_VBG the_VBG non-tumor_VBG material_VBG ,_VBG whereas_VBG in_VBG the_VBG malignant_VBG tumor_VBG material_VBG substantial_VBG quantities_VBG of_VBG a_VBG number_VBG of_VBG eicosanoid_VBG metabolites_VBG were_VBG present_VBG ._VBG
This_NN study_NN examines_NNS the_DT regions_CD of_VBG the_VBG HIV_VBG promoter_VBG required_VBG for_VBG HHV-6_VBG transactivation_VBG in_VBG a_VBG heterogeneous_VBG population_VBG of_VBG primary_VBG human_VBG T_VBG lymphocytes_VBG with_VBG or_VBG without_VBG antigenic_VBG stimulation_VBG ._VBG
Biomarkers_VBG included_VBG DNA_VBG ploidy_VBG ,_VBG estrogen_VBG receptor_VBG ER_VBG ,_VBG and_VBG epidermal_VBG growth_VBG factor_VBG receptor_VBG EGFR_VBG ._VBG
Protective_VBG effects_VBG of_VBG notch-1_VBG on_VBG TCR-induced_VBG apoptosis_VBG ._VBG
We_DT previously_RB showed_VBP that_VBG granulocyte-macrophage_IN colony-stimulating_JJ factor_JJ GM-CSF_NN and_CC macrophage_NN colony-stimulating_VBG factor_VBG M-CSF_VBG stimulate_VBG the_VBG differentiation_VBG of_VBG human_VBG monocytes_VBG into_VBG two_VBG phenotypically_VBG distinct_VBG types_VBG of_VBG macrophages_VBG ._VBG
For_DT the_DT study_CD of_VBG the_DT changes_VBZ in_VBG plasma_RB interleukin-1_NN IL-1_CD and_CC possible_NN relationship_NN with_VBD the_DT changes_VBZ in_VBG glucocorticoid_VBN receptor_NN GR_JJ ,_VBG plasma_IN IL-1_NN and_CC GR_CD in_VBG peripheral_JJ blood_NN leukocytes_NN in_VBG aged_VBD long-distance_NN runner_JJR were_VBD measured_VBN simultaneously_RB ._.
Enhanced_VBG IL-2_VBG transcription_VBG correlates_VBG with_VBG increased_VBG c-fos_VBG synthesis_VBG and_VBG increased_VBG Fos_VBG content_VBG of_VBG AP-1_VBG ._VBG
In_NN clonogenetic_JJ fetal_NN calf_NN serum-supplemented_JJ or_CC -nonsupplemented_JJ FCS-_NN culture_NN treated_VBD with_IN saturating_VBG levels_VBG of_VBG interleukin-3_VBG IL-3_VBG granulocyte-macrophage_VBG colony-stimulating_VBG factor_VBG GM-CSF_VBG and_VBG erythropoietin_VBG Ep_VBG combined_VBG with_VBG c-kit_VBG ligand_VBG in_VBG FCS-LRB---RRB--culture_VBG conditions_VBG ,_VBG RA_VBG induces_VBG a_VBG dramatic_VBG dose-dependent_VBG shift_VBG from_VBG erythroid_VBG to_VBG granulomonocytic_VBG colony_VBG formation_VBG ,_VBG the_VBG latter_VBG colonies_VBG being_VBG essentially_VBG represented_VBG by_VBG granulocytic_VBG clones_VBG ._VBG
However_DT ,_VBG simultaneous_VBG incubation_VBG of_VBG RU_VBG 486_VBG with_VBG dexamethasone_VBG caused_VBG a_VBG distinct_VBG interference_VBG of_VBG RU_VBG 486_VBG with_VBG dexamethasone_VBG ._VBG
Proliferation_NN index_VBP as_VBG a_VBG prognostic_JJ marker_JJ in_VBG breast_JJS cancer_NN ._.
The_DT differentiating_VBG effects_VBG of_VBG the_VBG other_VBG C-11_VBG analogs_VBG on_VBG human_VBG promyeloid_VBG leukemia_VBG cells_VBG HL-60_VBG agreed_VBG well_VBG with_VBG bone-resorbing_VBG activity_VBG and_VBG receptor_VBG affinity_VBG ,_VBG but_VBG they_VBG demonstrated_VBG lower_VBG calcemic_VBG effects_VBG in_VBG vivo_VBG ._VBG
These_VBG results_VBG can_VBG not_VBG be_VBG explained_VBG by_VBG receptor_VBG down-regulation_VBG due_VBG to_VBG higher_VBG level_VBG of_VBG mineralocorticoids_VBG of_VBG the_VBG zona_VBG glomerulosa_VBG ._VBG
This_DT result_JJ indicates_NNS the_DT involvement_VBP of_VBG either_IN a_VBG B-cell-specific_VBG cofactor_VBG or_VBG a_VBG specific_VBG modification_VBG of_VBG a_VBG cofactor_VBG or_VBG the_VBG Oct2_VBG protein_VBG in_VBG Oct2-mediated_VBG enhancer_VBG activation_VBG ._VBG
Cyclosporin_DT A_VBG CsA_JJ and_CC FK506_NN inhibit_NN the_DT production_CD of_VBG IL-2_NNS in_VBG T_VBG lymphocytes_VBG at_VBG the_VBG level_VBG of_VBG gene_VBG transcription_VBG ._VBG
NF-kappa_NNS B_NN binding_VBG activity_VBG was_VBG inducible_VBG by_VBG tumor_VBG necrosis_VBG factor_VBG and_VBG phorbol_VBG myristate_VBG acetate_VBG in_VBG PLB-985_VBG ._VBG
Defective_VBG translocation_VBG of_VBG protein_VBG kinase_VBG C_VBG in_VBG multidrug-resistant_VBG HL-60_VBG cells_VBG confers_VBG a_VBG reversible_VBG loss_VBG of_VBG phorbol_VBG ester-induced_VBG monocytic_VBG differentiation_VBG ._VBG
Furthermore_PRP ,_VBG a_VBG significant_VBG decrease_VBG in_VBG the_VBG switch_VBG from_VBG the_VBG membrane_VBG forms_VBG of_VBG mu_VBG and_VBG gamma_VBG to_VBG respective_VBG secreted_VBG forms_VBG was_VBG noted_VBG in_VBG the_VBG presence_VBG of_VBG TGF-beta_VBG ._VBG
A_DT transcript_JJ of_VBG the_VBG ALAS_VBG IRE_VBG ,_VBG mutated_VBG in_VBG the_VBG conserved_VBG loop_VBG of_VBG the_VBG IRE_VBG ,_VBG did_VBG not_VBG readily_VBG form_VBG this_VBG protein-RNA_VBG complex_VBG ._VBG
Binding_DT of_VBG HIV-TF1_NNS to_VBG the_DT HIV_NN long_VBG terminal_VBG repeat_VBG LTR_VBG activated_VBG transcription_VBG from_VBG the_VBG HIV_VBG promoter_VBG in_VBG vitro_VBG ._VBG
Here_DT we_PRP examined_VBN the_DT activation_CD of_VBG NF-kB_JJ in_VBG human_JJ T_JJ cell_JJ thymic_JJ progenitors_NNS ._.
Because_IN of_VBG cell_NN type-specific_NN alternative_NN messenger_NN RNA_NNS splicing_VBG ,_VBG B-cell_VBG Fc_VBG gamma_VBG RII_VBG contains_VBG an_VBG insertion_VBG of_VBG 47_VBG amino_VBG acids_VBG that_VBG participates_VBG in_VBG determining_VBG receptor_VBG function_VBG in_VBG these_VBG cells_VBG ._VBG
We_NN have_VBP identified_VBN two_IN adjacent_JJ cis-acting_VBG regulatory_JJ elements_JJ ,_VBG both_NN of_VBG which_VBG are_VBG part_VBG of_VBG an_VBG Alu_VBG repeat_VBG ._VBG
We_NN then_RB generated_VBN new_DT donor_JJ T-cell_NN clones_NNS ._.
Therefore_PRP ,_VBG the_VBG high_VBG radiosensitivity_VBG of_VBG squamous_VBG cell_VBG carcinomas_VBG in_VBG samples_VBG could_VBG be_VBG explained_VBG by_VBG an_VBG overexpression_VBG of_VBG c-fos_VBG in_VBG the_VBG tumor-infiltrating_VBG lymphocytes_VBG induced_VBG by_VBG small_VBG doses_VBG of_VBG radiation_VBG therapy_VBG ,_VBG and_VBG these_VBG activated_VBG lymphocytes_VBG exerted_VBG a_VBG cytotoxic_VBG effect_VBG against_VBG the_VBG cancer_VBG cells_VBG ._VBG
Analysis_NNS of_VBG cytosolic_VBG extracts_VBG indicated_VBG that_VBG NF-kappa_VBG B_VBG levels_VBG were_VBG increased_VBG in_VBG HIV-infected_VBG cells_VBG ._VBG
In_VBG human_VBG histiocytic_VBG U937_VBG cells_VBG mRNA_VBG of_VBG clone_VBG pAT_VBG 133_VBG was_VBG constitutively_VBG expressed_VBG ,_VBG whereas_VBG mRNA_VBG of_VBG pAT_VBG was_VBG induced_VBG upon_VBG induction_VBG of_VBG terminal_VBG differentiation_VBG ._VBG
The_DT genes_NNS and_CC mechanisms_VBP that_VBG control_VBG programmed_VBG cell_VBG death_VBG are_VBG currently_VBG the_VBG subject_VBG of_VBG intense_VBG study_VBG ._VBG
Tyrosines_DT 113_VBG ,_VBG 128_VBG ,_VBG and_NN 145_VBG of_VBG SLP-76_VBG are_VBG required_VBG for_VBG optimal_VBG augmentation_VBG of_VBG NFAT_VBG promoter_VBG activity_VBG ._VBG
In_VBG contrast_VBG to_VBG the_VBG decrease_VBG in_VBG GR_VBG mRNA_VBG seen_VBG in_VBG IM-9_VBG cells_VBG after_VBG treatment_VBG with_VBG 1_VBG microM_VBG dexamethasone_VBG for_VBG 16-18_VBG h_VBG ,_VBG treatment_VBG of_VBG 6TG1.1_VBG cells_VBG resulted_VBG in_VBG an_VBG 8-fold_VBG increase_VBG in_VBG GR_VBG mRNA_VBG ,_VBG as_VBG determined_VBG by_VBG Northern_VBG blot_VBG and_VBG RNase_VBG protection_VBG analysis_VBG ,_VBG with_VBG a_VBG corresponding_VBG 3-_VBG to_VBG 4-fold_VBG increase_VBG in_VBG GR_VBG protein_VBG ._VBG
Unlike_JJ classical_JJ NFkappaB_NN sites_VBZ ,_VBG neither_JJ the_DT SNE_NN nor_CC the_DT SEE_NN motif_NN responded_VBD to_VBG phosphatase_VBG inhibition_VBG by_VBG okadaic_VBG acid_VBG ._VBG
While_VBG one_VBG of_VBG the_VBG twins_VBG was_VBG clinically_VBG affected_VBG ,_VBG the_VBG other_VBG was_VBG asymptomatic_VBG ._VBG
Another_VBG component_VBG of_VBG the_VBG AP-1_VBG transcription_VBG complex_VBG ,_VBG JunB_VBG ,_VBG is_VBG shown_VBG to_VBG inhibit_VBG activation_VBG mediated_VBG by_VBG JunD_VBG ._VBG
Expression_IN of_VBG Bcl-xL_NNS and_CC adenovirus_RB E1B_NN 19K_CD did_VBD not_RB interfere_VBN with_IN anti-Fas_NN killing_NN ._.
The_DT promoter_CD of_VBG the_VBG major_VBG histocompatibility_VBG class_VBG II_VBG gene_VBG DRA_VBG contains_VBG an_VBG octamer_VBG element_VBG ATTTGCAT_VBG that_VBG is_VBG required_VBG for_VBG efficient_VBG DRA_VBG expression_VBG in_VBG B_VBG cells_VBG ._VBG
ABSTRACT_NNS TRUNCATED_NN AT_CD 250_VBG WORDS_NN
It_DT is_VBZ becoming_JJ increasingly_RB apparent_NN that_VBG NF-kappa_NN B_NN plays_IN a_VBG critical_VBG role_VBG in_VBG regulating_VBG the_VBG inflammatory_VBG response_VBG ._VBG
S107_DT plasmacytoma_NN cells_VBZ ,_VBG which_VBG express_VBG CD40_VBG but_VBG are_VBG defective_VBG for_VBG the_VBG nuclear_VBG appearance_VBG of_VBG ,_VBG do_VBG not_VBG express_VBG RelB_VBG after_VBG CD40_VBG stimulation_VBG ._VBG
Interleukin_DT 6-induced_JJ differentiation_IN of_VBG a_VBG human_VBG B_VBG cell_VBG line_VBG into_VBG IgM-secreting_VBG plasma_VBG cells_VBG is_VBG mediated_VBG by_VBG c-fos_VBG ._VBG
Activation_IN of_VBG the_DT human_NN immunodeficiency_JJ virus_NN type_VBP 1_VBG enhancer_VBG is_VBG not_VBG dependent_VBG on_VBG NFAT-1_VBG ._VBG
In_VBG one_VBG patient_VBG ,_VBG transient_VBG reduction_VBG of_VBG aldosterone_VBG receptors_VBG could_VBG be_VBG documented_VBG ,_VBG while_VBG in_VBG the_VBG second_VBG patient_VBG the_VBG clinical_VBG and_VBG biochemical_VBG parameters_VBG were_VBG consistent_VBG with_VBG transient_VBG pseudohypoaldosteronism_VBG ._VBG
In_VBG the_VBG human_VBG leukemic_VBG cells_VBG studied_VBG here_VBG ,_VBG the_VBG ability_VBG to_VBG induce_VBG CD8_VBG antigen_VBG expression_VBG in_VBG a_VBG cells_VBG correlates_VBG with_VBG the_VBG ability_VBG to_VBG induce_VBG cell_VBG lysis_VBG in_VBG a_VBG glucocorticoid_VBG receptor_VBG positive_VBG cell_VBG population_VBG ._VBG
Corticosteroids_VBG are_VBG the_VBG preeminent_VBG antiinflammatory_VBG agents_VBG although_VBG the_VBG molecular_VBG mechanisms_VBG that_VBG impart_VBG efficacy_VBG have_VBG not_VBG been_VBG defined_VBG ._VBG
Finally_IN ,_VBG RNA_JJ from_VBG activated_VBG lymphocytes_VBG was_VBG amplified_VBG by_VBG polymerase_VBG chain_VBG reaction_VBG using_VBG oligonucleotide_VBG primers_VBG flanking_VBG the_VBG 196_VBG base_VBG pair_VBG long_VBG region_VBG encoding_VBG the_VBG DNA-binding_VBG domain_VBG of_VBG the_VBG human_VBG intestinal_VBG receptor_VBG ._VBG
Concerning_JJ tumor-infiltrating_VBG lymphocytes_VBG ,_VBG the_VBG rate_VBG of_VBG moderate_VBG or_VBG remarkable_VBG grades_VBG of_VBG c-fos-positive_VBG lymphocytes_VBG before_VBG radiotherapy_VBG and_VBG at_VBG radiation_VBG doses_VBG of_VBG 4_VBG ,_VBG 10_VBG ,_VBG and_VBG 20_VBG Gy_VBG was_VBG 8.0_VBG ,_VBG 29.2_VBG ,_VBG 4.8_VBG ,_VBG and_VBG 0_VBG ,_VBG respectively_VBG ._VBG
In_IN each_JJ cohort_JJ there_EX was_NNS only_RB one_IN case_NN with_CD a_VBG negative_VBG reaction_VBG of_VBG the_VBG primary_VBG tumor_VBG and_VBG a_VBG positive_VBG reaction_VBG with_VBG the_VBG isolated_VBG tumor_VBG cells_VBG from_VBG the_VBG pleural_VBG effusions_VBG ._VBG
When_VBG human_VBG monocytes_VBG were_VBG preincubated_VBG with_VBG dexamethasone_VBG for_VBG 1_VBG hour_VBG and_VBG then_VBG stimulated_VBG either_VBG with_VBG bacterial_VBG lipopolysaccharide_VBG or_VBG phorbol_VBG myristate_VBG ,_VBG it_VBG was_VBG found_VBG that_VBG dexamethasone_VBG inhibited_VBG the_VBG lipopolysaccharide-induced_VBG interleukin-1_VBG beta_VBG protein_VBG production_VBG ,_VBG but_VBG the_VBG phorbol_VBG myristate-induced_VBG production_VBG was_VBG increased_VBG 3-10_VBG fold_VBG ._VBG
In_VBG GH4C1_VBG pituitary_VBG cells_VBG ,_VBG T3SO4_VBG failed_VBG to_VBG displace_VBG -LCB-125I-RCB-T3_VBG from_VBG nuclear_VBG receptors_VBG in_VBG intact_VBG cells_VBG or_VBG soluble_VBG preparations_VBG ._VBG
Signal_VBG transduction_VBG through_VBG tyrosine_VBG kinase_VBG activation_VBG may_VBG lead_VBG to_VBG altered_VBG gene_VBG expression_VBG ,_VBG as_VBG ligation_VBG prompted_VBG decreases_VBG in_VBG the_VBG nuclear_VBG localization_VBG of_VBG the_VBG transcriptional_VBG regulatory_VBG protein_VBG NF-kappaB_VBG and_VBG proteins_VBG binding_VBG the_VBG interferon-inducible_VBG regulatory_VBG element_VBG ._VBG
Sjogren_VBG syndrome_VBG SS_VBG is_VBG characterized_VBG by_VBG lymphocytic_VBG infiltrates_VBG of_VBG exocrine_VBG glands_VBG ,_VBG remarkable_VBG B_VBG cell_VBG hyperreactivity_VBG and_VBG a_VBG strong_VBG predisposition_VBG to_VBG B_VBG cell_VBG neoplasia_VBG ._VBG
Remarkably_IN ,_VBG the_VBG expression_VBG of_VBG both_VBG genes_VBG is_VBG downmodulated_VBG during_VBG erythroid_VBG and_VBG megakaryocytic_VBG terminal_VBG maturation_VBG ._VBG
Unexpectedly_JJ ,_VBG in_VBG vivo_VBG studies_VBG also_VBG demonstrate_VBG that_VBG I_VBG kappa_VBG binds_VBG directly_VBG to_VBG NF-kappa_VBG B_VBG p50_VBG ._VBG
Rheumatoid_VBG arthritis_VBG is_VBG a_VBG multistep_VBG disorder_VBG associated_VBG with_VBG autoimmune_VBG features_VBG of_VBG yet_VBG unknown_VBG etiology_VBG ._VBG
Furthermore_PRP ,_VBG a_VBG truncated_VBG form_VBG of_VBG NFAT1_VBG acts_VBG as_VBG a_VBG dominant-negative_VBG ,_VBG reducing_VBG IL-4_VBG promoter_VBG activity_VBG in_VBG primed_VBG CD4_VBG T_VBG cells_VBG and_VBG confirming_VBG the_VBG importance_VBG of_VBG endogenous_VBG NFAT_VBG to_VBG increased_VBG IL-4_VBG gene_VBG expression_VBG by_VBG effector_VBG T_VBG cells_VBG ._VBG
Few_DT known_JJ genes_NNS IL-2_NNS ,_VBG members_VBZ of_VBG the_VBG IL-8_VBG family_VBG ,_VBG interferon-gamma_VBG are_VBG induced_VBG in_VBG T_VBG cells_VBG only_VBG through_VBG the_VBG combined_VBG effect_VBG of_VBG phorbol_VBG myristic_VBG acetate_VBG PMA_VBG and_VBG a_VBG ,_VBG and_VBG expression_VBG of_VBG only_VBG these_VBG genes_VBG can_VBG be_VBG fully_VBG suppressed_VBG by_VBG Cyclosporin_VBG A_VBG CyA_VBG ._VBG
Activation_IN of_VBG T_NN lymphocytes_NN induces_VBZ an_IN NF-kappa_NN B-like_JJ binding_VBG activity_VBG to_VBG the_VBG B2_VBG site_VBG ,_VBG concomitant_VBG with_VBG activation_VBG of_VBG the_VBG proenkephalin_VBG promoter_VBG ._VBG
Gel_JJ retardation_NN assays_IN ,_VBG using_IN a_VBG 32P-probe_JJ containing_VBG the_VBG HIV-1_VBG NF-kB_VBG probe_VBG and_VBG nuclear_VBG extracts_VBG from_VBG PMA-treated_VBG cells_VBG ,_VBG showed_VBG significantly_VBG reduced_VBG induction_VBG of_VBG nuclear_VBG NF-kB_VBG binding_VBG proteins_VBG in_VBG these_VBG two_VBG subclones_VBG compared_VBG with_VBG wild_VBG type_VBG CEM_VBG and_VBG a_VBG control_VBG subclone_VBG ._VBG
Severe_VBG combined_VBG immunodeficiency_VBG due_VBG to_VBG defective_VBG binding_VBG of_VBG the_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG in_VBG T_VBG lymphocytes_VBG of_VBG two_VBG male_VBG siblings_VBG ._VBG
In_NN these_DT studies_RB ,_VBG we_VBG have_VBG identified_VBG DNA_VBG sequences_VBG and_VBG specific_VBG protein_VBG interactions_VBG necessary_VBG for_VBG transcriptional_VBG regulation_VBG of_VBG the_VBG human_VBG prointerleukin_VBG 1_VBG beta_VBG proIL-1_VBG beta_VBG gene_VBG ._VBG
The_VBG closest_VBG match_VBG to_VBG the_VBG known_VBG SP-1_VBG consensus_VBG sequence_VBG within_VBG the_VBG respective_VBG region_VBG is_VBG a_VBG TCCCCTCCCCT_VBG motif_VBG ._VBG
An_VBG attempt_VBG was_VBG also_VBG undertaken_VBG to_VBG use_VBG a_VBG cell_VBG harvester_VBG for_VBG the_VBG separation_VBG of_VBG cells_VBG from_VBG unbound_VBG ligand_VBG ._VBG
Hypothetically_IN ,_VBG switches_VBZ of_VBG lineage-restricted_VBG transactivators_VBG may_VBG underlie_VBG the_VBG binary_VBG fate_VBG decisions_VBG of_VBG hematopoietic_VBG progenitors_VBG ._VBG
However_DT ,_VBG in_VBG either_VBG EL-4_VBG T_VBG cells_VBG or_VBG S194_VBG cells_VBG ,_VBG both_VBG lower-affinity_VBG sites_VBG can_VBG be_VBG significantly_VBG induced_VBG by_VBG the_VBG tax_VBG gene_VBG product_VBG of_VBG human_VBG T-cell_VBG leukemia_VBG virus_VBG type_VBG I_VBG ,_VBG showing_VBG that_VBG NF-kappa_VBG B_VBG activity_VBG can_VBG be_VBG modulated_VBG even_VBG in_VBG a_VBG B-cell_VBG line_VBG that_VBG constitutively_VBG expresses_VBG this_VBG factor_VBG ._VBG
In_VBG contrast_VBG ,_VBG NF-kappa_VBG B_VBG p50_VBG alone_VBG fails_VBG to_VBG stimulate_VBG kappa_VBG B-directed_VBG transcription_VBG ,_VBG and_VBG based_VBG on_VBG prior_VBG in_VBG vitro_VBG studies_VBG ,_VBG is_VBG not_VBG directly_VBG regulated_VBG by_VBG I_VBG kappa_VBG B_VBG ._VBG
Analogs_DT of_VBG 1_VBG alpha,25-dihydroxyvitamin_VBG D3_VBG 1_VBG alpha,25--LRB-OH-RRB-_VBG 2D3_VBG with_VBG substitutions_VBG on_VBG C-11_VBG were_VBG synthesized_VBG ._VBG
The_VBG lymphocyte-specific_VBG immunoglobulin_VBG mu_VBG heavy-chain_VBG gene_VBG intronic_VBG enhancer_VBG is_VBG regulated_VBG by_VBG multiple_VBG nuclear_VBG factors_VBG ._VBG
Specific_IN nuclear_JJ translocation_DT of_VBG was_VBG found_VBG to_VBG be_VBG time_VBG dependent_VBG reaching_VBG a_VBG maximum_VBG of_VBG approximately_VBG 2100_VBG binding_VBG after_VBG 3_VBG h_VBG of_VBG incubation_VBG in_VBG HL60_VBG cells_VBG ,_VBG whereas_VBG a_VBG maximum_VBG of_VBG approximately_VBG 310_VBG binding_VBG was_VBG found_VBG after_VBG 3_VBG h_VBG in_VBG PBL_VBG ._VBG
Group_VBG C_VBG ,_VBG adenovirus_VBG serotype_VBG 5_VBG Ad5_VBG infection_VBG inhibits_VBG both_VBG IFN-MCP_VBG and_VBG cellular_VBG protein_VBG synthesis_VBG ._VBG
These_VBG results_VBG demonstrate_VBG that_VBG CD40_VBG ,_VBG like_VBG sIg_VBG ,_VBG may_VBG employ_VBG PKC_VBG in_VBG producing_VBG select_VBG outcomes_VBG ,_VBG that_VBG individual_VBG B_VBG cell_VBG receptors_VBG may_VBG signal_VBG downstream_VBG events_VBG via_VBG both_VBG PKC-dependent_VBG and_VBG PKC-independent_VBG pathways_VBG ,_VBG and_VBG that_VBG multiple_VBG signal_VBG transduction_VBG pathways_VBG may_VBG be_VBG used_VBG to_VBG activate_VBG the_VBG expression_VBG of_VBG closely_VBG related_VBG genes_VBG ._VBG
The_VBG c-rel_VBG protooncogene_VBG product_VBG represses_VBG NF-kappa_VBG B_VBG p65-mediated_VBG transcriptional_VBG activation_VBG of_VBG the_VBG long_VBG terminal_VBG repeat_VBG of_VBG type_VBG 1_VBG human_VBG immunodeficiency_VBG virus_VBG ._VBG
As_IN with_IN egr-3_DT ,_VBG expression_DT of_VBG egr-2_VBG was_VBG blocked_VBG by_VBG cyclosporin_VBG A_VBG ._VBG
Furthermore_PRP ,_VBG we_PRP discuss_NNS recent_JJ advances_NN that_VBG have_VBG led_VBG to_VBG a_VBG better_VBG understanding_VBG of_VBG how_VBG cytokines_VBG elicit_VBG intracellular_VBG responses_VBG ,_VBG as_VBG well_VBG as_VBG role_VBG in_VBG normal_VBG lymphoid_VBG development_VBG ._VBG
The_VBG transcription_VBG factor_VBG as_VBG well_VBG as_VBG the_VBG closely_VBG related_VBG factor_VBG Spi-B_VBG bound_VBG to_VBG the_VBG PU-box_VBG in_VBG B-cells_VBG ._VBG
T_JJ cell_NN priming_VBG enhances_VBG IL-4_VBG gene_VBG expression_VBG by_VBG increasing_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG ._VBG
Similarly_IN ,_VBG interferons_VBG could_VBG act_VBG on_VBG APL_VBG cells_VBG ,_VBG alone_VBG or_VBG in_VBG combination_VBG with_VBG all-trans_VBG retinoic_VBG acid_VBG RA_VBG ,_VBG especially_VBG if_VBG the_VBG alpha_VBG fusion_VBG transcript_VBG that_VBG results_VBG from_VBG the_VBG t-LRB-15;_VBG 17-RRB-_VBG is_VBG induced_VBG by_VBG interferon_VBG ._VBG
The_DT induction_CD of_VBG tyrosine_VBG phosphorylation_VBG of_VBG p80c-rel_VBG was_VBG unique_VBG to_VBG G-CSF_VBG in_VBG that_VBG granulocyte-macrophage_VBG colony_VBG stimulating_VBG factor_VBG which_VBG also_VBG stimulates_VBG neutrophils_VBG and_VBG induces_VBG tyrosine_VBG phosphorylation_VBG does_VBG not_VBG result_VBG in_VBG tyrosine_VBG phosphorylation_VBG of_VBG p80c-rel_VBG ._VBG
Furthermore_PRP ,_VBG overexpression_JJ and_CC constitutive_VBP nuclear_JJ localization_NNS of_VBG NF-AT_JJ ,_VBG but_VBG not_VBG Jun_VBG ,_VBG Fos_VBG ,_VBG NF-kappaB_VBG ,_VBG Oct_VBG or_VBG Ets_VBG family_VBG members_VBG ,_VBG renders_VBG the_VBG interleukin-2_VBG enhancer_VBG in_VBG Jurkat_VBG T_VBG lymphocytes_VBG resistant_VBG to_VBG FK506_VBG and_VBG cyclosporin_VBG A_VBG ._VBG
The_VBG viral_VBG transcriptional_VBG pattern_VBG similar_VBG to_VBG that_VBG of_VBG nasopharyngeal_VBG carcinoma_VBG and_VBG Hodgkin_VBG disease_VBG suggests_VBG that_VBG EBV_VBG can_VBG exploit_VBG common_VBG regulatory_VBG mechanisms_VBG for_VBG gene_VBG transcription_VBG in_VBG diverse_VBG host_VBG cell_VBG types_VBG ._VBG
The_VBG type_VBG I_VBG interleukin-1_VBG receptor_VBG IL-1R_VBG is_VBG capable_VBG of_VBG transducing_VBG a_VBG signal_VBG resulting_VBG in_VBG promoter_VBG activation_VBG in_VBG T_VBG cells_VBG ._VBG
Pleural_VBG effusions_VBG from_VBG 20_VBG patients_VBG with_VBG breast_VBG cancer_VBG were_VBG tested_VBG ._VBG
Productive_VBG human_VBG immunodeficiency_VBG virus_VBG type_VBG 1_VBG HIV-1_VBG infection_VBG causes_VBG sustained_VBG NF-kappaB_VBG DNA-binding_VBG activity_VBG in_VBG chronically_VBG infected_VBG monocytic_VBG cells_VBG ._VBG
Interferon_VBG gamma_VBG induces_VBG class_VBG II_VBG expression_VBG in_VBG this_VBG glioblastoma_VBG cell_VBG line_VBG and_VBG ,_VBG in_VBG parallel_VBG ,_VBG up-regulates_VBG X1_VBG and_VBG X2_VBG box_VBG protein-DNA_VBG interactions_VBG ,_VBG while_VBG all_VBG other_VBG interactions_VBG remain_VBG unchanged_VBG ._VBG
EL-4_CD cells_NNS were_RB transfected_VBN with_DT a_VBG plasmid_VBN containing_VBG the_JJ IL-2_NN promoter_NN and_IN enhancer_JJ region_NN linked_JJ to_VBG the_DT chloramphenicol_NN acetyltransferase_IN CAT_NN reporter_CC gene_NN ._.
Cloning_JJ and_CC characterization_CD of_VBG NF-ATc_NNS and_CC NF-ATp_NNS :_VBG the_VBG cytoplasmic_VBG components_VBG of_VBG NF-AT_VBG ._VBG
We_VBG report_VBG here_VBG a_VBG simple_VBG and_VBG rapid_VBG strategy_VBG to_VBG detect_VBG the_VBG precise_VBG number_VBG of_VBG the_VBG CAGs_VBG ._VBG
Transfection_IN of_VBG an_NN expression_NN vector_CC containing_VBG ORF2_VBG but_VBG not_VBG full_VBG length_VBG cDNA_VBG was_VBG able_VBG to_VBG transform_VBG NIH3T3_VBG cells_VBG and_VBG induce_VBG tumors_VBG in_VBG nude_VBG mice_VBG ._VBG
Alternative_VBG mechanisms_VBG include_VBG the_VBG possibility_VBG that_VBG NF-ATc_VBG operates_VBG on_VBG some_VBG cytoplasmic_VBG anchor_VBG or_VBG that_VBG other_VBG proteins_VBG that_VBG are_VBG controlled_VBG by_VBG calcineurin_VBG carry_VBG out_VBG the_VBG nuclear_VBG import_VBG of_VBG NF-ATc_VBG ._VBG
We_JJ report_NN here_NN that_VBG PML_VBG is_VBG expressed_VBG at_VBG low_VBG levels_VBG or_VBG not_VBG expressed_VBG in_VBG normal_VBG circulating_VBG human_VBG monocytes_VBG ,_VBG lymphocytes_VBG ,_VBG and_VBG polymorphonucleate_VBG cells_VBG ,_VBG but_VBG is_VBG markedly_VBG induced_VBG by_VBG interferon_VBG ;_VBG that_VBG PML_VBG and_VBG alpha_VBG expression_VBG is_VBG augmented_VBG by_VBG interferon_VBG in_VBG the_VBG NB4_VBG APL_VBG cell_VBG line_VBG ,_VBG which_VBG carries_VBG the_VBG t-LRB-15;_VBG 17-RRB-_VBG ,_VBG and_VBG in_VBG APL_VBG blasts_VBG from_VBG patients_VBG ;_VBG that_VBG interferon_VBG inhibits_VBG growth_VBG and_VBG survival_VBG of_VBG NB4_VBG APL_VBG cells_VBG in_VBG cooperation_VBG with_VBG RA_VBG ;_VBG that_VBG interferons_VBG alone_VBG have_VBG minimal_VBG maturation_VBG effect_VBG on_VBG NB4_VBG cells_VBG ;_VBG and_VBG ,_VBG finally_VBG ,_VBG that_VBG interferon_VBG gamma_VBG ,_VBG but_VBG not_VBG alpha_VBG or_VBG beta_VBG ,_VBG induces_VBG maturation_VBG and_VBG growth_VBG suppression_VBG of_VBG NB4_VBG cells_VBG with_VBG de_VBG novo_VBG retinoid_VBG resistance_VBG ,_VBG and_VBG partially_VBG restores_VBG RA_VBG response_VBG ._VBG
Radiolabeled_VBG complexes_VBG of_VBG nuclei_VBG isolated_VBG from_VBG cells_VBG exposed_VBG for_VBG 3_VBG h_VBG to_VBG radiolabeled_VBG hormone_VBG --_VBG in_VBG contrast_VBG to_VBG identical_VBG experiments_VBG with_VBG intact_VBG cells_VBG --_VBG did_VBG not_VBG disappear_VBG from_VBG the_VBG nuclear_VBG compartment_VBG upon_VBG incubation_VBG of_VBG nuclei_VBG with_VBG identical_VBG concentrations_VBG of_VBG the_VBG unlabeled_VBG compound_VBG ._VBG
Peptide_JJ vaccination_NN can_MD lead_VBN to_VBG enhanced_VBN tumor_CC growth_NN through_DT specific_JJ T-cell_NN tolerance_JJ induction_NN ._.
In_VBG contrast_VBG to_VBG MEL_VBG cells_VBG ,_VBG however_VBG ,_VBG K562_VBG cells_VBG acquired_VBG a_VBG macrophage-like_VBG morphology_VBG and_VBG exhibited_VBG a_VBG complete_VBG failure_VBG to_VBG generate_VBG benzidine-positive_VBG cells_VBG ._VBG
The_DT loss_JJ of_VBG proliferative_VBG potential_VBG in_VBG response_VBG to_VBG antigenic_VBG challenge_VBG is_VBG a_VBG characteristic_VBG feature_VBG of_VBG immune_VBG senescence_VBG ._VBG
Nuclear_VBG run-on_VBG experiments_VBG demonstrated_VBG decreased_VBG transcription_VBG of_VBG kappa_VBG L_VBG chain_VBG ._VBG
A_VBG sequence_VBG is_VBG also_VBG present_VBG in_VBG the_VBG cytoplasmic_VBG domain_VBG of_VBG the_VBG Hodgkin_VBG disease_VBG marker_VBG ,_VBG CD30_VBG ,_VBG and_VBG binds_VBG TRAF3_VBG in_VBG vitro_VBG ._VBG
We_VBG show_VBG that_VBG in_VBG S194_VBG plasma_VBG cells_VBG the_VBG activity_VBG of_VBG each_VBG element_VBG correlates_VBG well_VBG with_VBG the_VBG relative_VBG affinity_VBG of_VBG B-cell-derived_VBG NF-kappa_VBG B_VBG for_VBG that_VBG element_VBG ._VBG
CD3-epsilon_VBG expression_VBG is_VBG controlled_VBG by_VBG a_VBG downstream_VBG T_VBG lymphocyte-specific_VBG enhancer_VBG element_VBG ._VBG
Finally_IN ,_VBG we_VBG show_VBG that_VBG one_VBG of_VBG the_VBG isoforms_VBG encodes_VBG the_VBG previously_VBG described_VBG lymphoid-specific_VBG Oct2B_VBG protein_VBG which_VBG has_VBG been_VBG suggested_VBG to_VBG be_VBG involved_VBG in_VBG the_VBG function_VBG of_VBG the_VBG octamer_VBG motif_VBG in_VBG the_VBG context_VBG of_VBG the_VBG immunoglobulin_VBG heavy-chain_VBG IgH_VBG enhancer_VBG ._VBG
Inhibition_IN of_VBG HIV-1_VBG latency_VBG reactivation_VBG by_VBG dehydroepiandrosterone_VBG DHEA_VBG and_VBG an_VBG analog_VBG of_VBG DHEA_VBG ._VBG
The_DT SS_NNS Oct-1_NN DNA-binding_VBG abnormality_VBG correlated_VBG significantly_VBG with_VBG an_VBG inability_VBG of_VBG cells_VBG to_VBG exit_VBG the_VBG cell_VBG cycle_VBG phase_VBG when_VBG stimulated_VBG in_VBG vitro_VBG ._VBG
Except_IN for_VBG a_VBG 4-hour_VBG advancement_VBG of_VBG the_VBG peak_VBG ,_VBG a_VBG similar_VBG circadian_VBG rhythm_VBG of_VBG hepatic_VBG GR_VBG was_VBG detected_VBG in_VBG rats_VBG reared_VBG under_VBG a_VBG reversed_VBG lighting_VBG regimen_VBG 12D_VBG :_VBG 12L_VBG ;_VBG lights_VBG on_VBG between_VBG 18:30_VBG and_VBG 06:30_VBG h_VBG ._VBG
Here_EX we_PRP report_VBD that_VBG this_VBG interference_VBG is_VBG cell_VBG specific_VBG ,_VBG as_VBG TPA_VBG augmented_VBG dexamethasone-induced_VBG transcriptional_VBG activation_VBG of_VBG the_VBG MMTV_VBG LTR_VBG in_VBG several_VBG T_VBG cell_VBG lines_VBG but_VBG was_VBG inhibitory_VBG in_VBG NIH-3T3_VBG fibroblasts_VBG ._VBG
This_VBG signal_VBG transduction_VBG is_VBG dependent_VBG on_VBG the_VBG cytoplasmic_VBG domain_VBG ,_VBG which_VBG consists_VBG of_VBG 213_VBG amino_VBG acids_VBG ._VBG
The_VBG results_VBG obtained_VBG suggest_VBG that_VBG two_VBG Ad12_VBG E1A_VBG domains_VBG are_VBG required_VBG to_VBG induce_VBG resistance_VBG of_VBG the_VBG cell_VBG lines_VBG to_VBG NK_VBG cells_VBG ._VBG
results_VBG therefore_VBG show_VBG that_VBG allele_VBG loss_VBG on_VBG chromosome_VBG 20q_VBG in_VBG polycythemia_VBG vera_VBG does_VBG not_VBG commonly_VBG involve_VBG mitotic_VBG recombination_VBG or_VBG chromosome_VBG loss_VBG and_VBG that_VBG microsatellite_VBG instability_VBG is_VBG a_VBG rare_VBG event_VBG in_VBG this_VBG disorder_VBG ._VBG
These_DT data_JJ are_VBP the_DT first_JJS to_VBG define_VBG the_VBG molecular_VBG weight_VBG of_VBG the_VBG membrane_VBG receptor_VBG for_VBG aldosterone_VBG ._VBG
Antisera_JJ to_VBG Fos_NN inhibits_VBZ NF-AT_JJ DNA_NN binding_VBG as_VBG does_NNS an_IN oligonucleotide_NN containing_VBG a_VBG binding_VBG site_VBG for_VBG AP1_VBG ._VBG
Using_VBG reverse-transcription_VBG PCR_VBG differential_VBG display_VBG ,_VBG we_VBG isolated_VBG an_VBG mRNA_VBG species_VBG expressed_VBG in_VBG IL-2-_VBG but_VBG not_VBG IL-12-stimulated_VBG NK_VBG cells_VBG ._VBG
HIV1_VBG infection_VBG of_VBG human_VBG monocytes_VBG and_VBG macrophages_VBG promotes_VBG induction_VBG or_VBG translocation_VBG of_VBG NF-KB-related_VBG factors_VBG ._VBG
Moreover_DT ,_VBG when_VBG introduced_VBG into_VBG murine_VBG pro-B_VBG lymphocytes_VBG ,_VBG the_VBG oncogenic_VBG E2A-HLF_VBG fusion_VBG protein_VBG reversed_VBG both_VBG interleukin-3-dependent_VBG and_VBG p53-mediated_VBG apoptosis_VBG ._VBG
The_DT rules_VBZ of_VBG assembly_IN of_VBG the_VBG cognate_VBG ligands_VBG of_VBG TF_VBG ,_VBG namely_VBG the_VBG zymogen_VBG plasma_VBG factors_VBG VII_VBG and_VBG the_VBG serine_VBG protease_VBG factor_VBG VIIa_VBG ,_VBG with_VBG the_VBG soluble_VBG surface_VBG domain_VBG of_VBG TF_VBG in_VBG free_VBG solution_VBG ,_VBG in_VBG the_VBG presence_VBG of_VBG phospholipid_VBG surfaces_VBG and_VBG cell_VBG surface_VBG and_VBG of_VBG the_VBG anchored_VBG TF_VBG molecule_VBG have_VBG been_VBG described_VBG ._VBG
Instead_JJ ,_VBG regulation_IN of_VBG activation_NN involved_VBD a_VBG region_CD of_VBG the_VBG cytoplasmic_VBG domain_VBG common_VBG to_VBG both_VBG the_VBG lymphocyte_VBG and_VBG macrophage_VBG receptor_VBG isoforms_VBG ._VBG
The_VBG glucocorticoid_VBG receptor_VBG levels_VBG in_VBG mononuclear_VBG leukocytes_VBG correlated_VBG with_VBG those_VBG in_VBG polymorphonuclear_VBG leukocytes_VBG ,_VBG and_VBG there_VBG was_VBG a_VBG linear_VBG relationship_VBG between_VBG the_VBG cellular_VBG glucocorticoid_VBG receptor_VBG levels_VBG and_VBG glucocorticoid-mediated_VBG inhibition_VBG of_VBG the_VBG uptake_VBG of_VBG 3-O-methyl-D-glucose_VBG in_VBG mononuclear_VBG leukocytes_VBG ._VBG
CsA_DT was_VBD found_VBN not_JJ to_VBG inhibit_VBG lck_VBG gene_VBG expression_VBG ,_VBG nor_VBG the_VBG activity_VBG of_VBG the_VBG lck_VBG gene_VBG product_VBG ._VBG
Plasma_IN cortisol_NN and_CC aldosterone_CD levels_NNS and_CC number_DT of_VBG related_VBG receptors_VBG in_VBG mononuclear_VBG leukocytes_VBG were_VBG measured_VBG in_VBG 49_VBG healthy_VBG aged_VBG subjects_VBG 62-97_VBG yr_VBG and_VBG in_VBG 21_VBG adult_VBG controls_VBG 21-50_VBG yr_VBG ._VBG
No_CD such_JJ increase_JJ was_VBD observed_VBD in_VBG control_VB U937_NN cells_NNS ._.
Pregnancy-induced_JJ hypertension_JJ PIH_NN is_IN a_VBG frequent_VBG cause_VBG of_VBG maternal_VBG and_VBG neonatal_VBG morbidity_VBG and_VBG mortality_VBG ._VBG
The_VBG functional_VBG significance_VBG of_VBG c-Rel_VBG involvement_VBG in_VBG the_VBG CD28-responsive_VBG complex_VBG is_VBG demonstrated_VBG by_VBG transient_VBG transfection_VBG analysis_VBG ,_VBG where_VBG cotransfection_VBG of_VBG c-Rel_VBG augments_VBG the_VBG level_VBG of_VBG expression_VBG of_VBG a_VBG chloramphenicol_VBG acetyltransferase_VBG reporter_VBG gene_VBG linked_VBG to_VBG the_VBG CD28-responsive_VBG element_VBG ._VBG
The_DT prevalence_NNS of_VBG aneuploidy_RB and_CC overexpressed_VBD EGFR_NN was_VBZ significantly_RB higher_IN in_VBG the_VBG high_VBG risk_VBG women_VBG than_VBG in_VBG the_VBG 25_VBG low_VBG risk_VBG controls_VBG p_VBG 0.002_VBG ,_VBG median_VBG 10_VBG year_VBG Gail_VBG risk_VBG was_VBG 0.7_VBG ._VBG
This_VBG dispersed_VBG localization_VBG of_VBG a_VBG group_VBG of_VBG functionally_VBG related_VBG gene_VBG provides_VBG insights_VBG into_VBG the_VBG molecular_VBG mechanism_VBG of_VBG human_VBG genome_VBG evolution_VBG and_VBG possible_VBG involvement_VBG in_VBG human_VBG diseases_VBG ._VBG
Indomethacin_DT blocked_VBD PGE2_NN release_VBP ,_VBG but_VBG had_VBG no_VBG influence_VBG on_VBG the_VBG observed_VBG effects_VBG of_VBG C3a_VBG ,_VBG suggesting_VBG that_VBG the_VBG effects_VBG of_VBG C3a_VBG on_VBG IL-6_VBG production_VBG are_VBG independent_VBG of_VBG PGE2_VBG formation_VBG by_VBG monocytes_VBG ._VBG
Neither_VBG deletion_VBG of_VBG NF_VBG kappa_VBG B_VBG nor_VBG deletion_VBG of_VBG NFAT-1_VBG decreased_VBG activation_VBG of_VBG viral_VBG replication_VBG by_VBG phorbol_VBG ester_VBG ._VBG
Deletion_IN of_VBG the_VBG glucocorticoid_VBG response_VBG elements_VBG located_VBG at_VBG ca._VBG bp_VBG -850_VBG upstream_VBG of_VBG Cp_VBG did_VBG not_VBG result_VBG in_VBG a_VBG significant_VBG loss_VBG in_VBG activity_VBG ._VBG
These_NN results_NNS suggest_VBD that_VBG CN_VBG is_VBG involved_VBG in_VBG the_VBG coordinated_VBG induction_VBG of_VBG the_VBG GM-CSF_VBG and_VBG IL-2_VBG genes_VBG and_VBG that_VBG the_VBG CLE0_VBG sequence_VBG of_VBG the_VBG GM-CSF_VBG gene_VBG is_VBG a_VBG functional_VBG analogue_VBG of_VBG the_VBG NF-AT-binding_VBG site_VBG in_VBG the_VBG IL-2_VBG promoter_VBG ,_VBG which_VBG mediates_VBG signals_VBG downstream_VBG of_VBG T_VBG cell_VBG activation_VBG ._VBG
Abnormalities_DT of_VBG p16_RB ,_VBG p15_VBG and_VBG CDK4_VBG genes_VBG in_VBG recurrent_VBG malignant_VBG astrocytomas_VBG ._VBG
Lymphocytes_DT from_VBG patients_VBG who_VBG have_VBG received_VBG anti-estrogen_VBG therapy_VBG show_VBG similar_VBG enhancement_VBG of_VBG Ig-secreting_VBG cells_VBG after_VBG PWM_VBG stimulation_VBG ._VBG
However_DT ,_VBG DCoH_NN did_NN not_RB confer_JJR transcriptional_JJ activation_VBN to_VBG the_DT GAL4_JJ DNA_NNS binding_VBG domain_NN ._.
Molecular_VBG genetic_VBG characterization_VBG of_VBG the_VBG variant_VBG allele_VBG can_VBG serve_VBG as_VBG a_VBG primary_VBG tool_VBG for_VBG diagnosis_VBG and_VBG subsequent_VBG therapy_VBG ,_VBG and_VBG can_VBG provide_VBG a_VBG basis_VBG for_VBG distinguishing_VBG heterozygous_VBG carriers_VBG in_VBG familial_VBG androgen_VBG resistance_VBG ._VBG
Treatment_DT of_VBG the_VBG mature_VBG B-cell_VBG line_VBG BAL-17_VBG with_VBG either_VBG anti-immunoglobulin_VBG M_VBG or_VBG phorbol_VBG 12-myristate_VBG 13-acetate_VBG leads_VBG to_VBG an_VBG increase_VBG in_VBG bcl-2_VBG expression_VBG that_VBG is_VBG mediated_VBG by_VBG the_VBG CRE_VBG site_VBG ._VBG
The_VBG apparent_VBG high_VBG frequency_VBG of_VBG IL-12-nonresponsive_VBG Th_VBG cells_VBG within_VBG the_VBG allergen-specific_VBG populations_VBG in_VBG atopic_VBG patients_VBG predicts_VBG a_VBG limited_VBG skewing_VBG potential_VBG of_VBG IL-12_VBG in_VBG the_VBG case_VBG of_VBG established_VBG Th2_VBG responses_VBG ,_VBG but_VBG only_VBG affecting_VBG newly_VBG recruited_VBG naive_VBG Th_VBG cells_VBG ._VBG
Serum_PRP response_NN factor_CC SRF_NN binds_FW to_VBG a_VBG site_VBG adjacent_VBG to_VBG the_VBG NF-kappa_VBG B_VBG site_VBG in_VBG the_VBG IL-2R_VBG enhancer_VBG ,_VBG and_VBG both_VBG sites_VBG together_VBG have_VBG strong_VBG transcriptional_VBG activity_VBG specifically_VBG in_VBG T_VBG cells_VBG ._VBG
These_NN ROI-induced_JJ effects_NNS can_JJ ,_VBG to_VBG a_VBG large_VBG extent_VBG ,_VBG be_VBG attributed_VBG to_VBG the_VBG activation_VBG of_VBG the_VBG transcription_VBG factor_VBG NF-kappaB_VBG ._VBG
Defective_VBG transcription_VBG of_VBG the_VBG IL-2_VBG gene_VBG is_VBG associated_VBG with_VBG impaired_VBG expression_VBG of_VBG c-Fos_VBG ,_VBG FosB_VBG ,_VBG and_VBG JunB_VBG in_VBG anergic_VBG T_VBG helper_VBG 1_VBG cells_VBG ._VBG
After_DT a_VBG 2-day_VBG incubation_VBG in_VBG LDL_VBG ,_VBG the_VBG binding_VBG of_VBG NF-kappa_VBG B_VBG ,_VBG which_VBG is_VBG believed_VBG to_VBG be_VBG a_VBG key_VBG oxidative-stress_VBG sensor_VBG for_VBG VCAM_VBG regulation_VBG ,_VBG remains_VBG at_VBG basal_VBG level_VBG ._VBG
Looking_DT at_VBG highly_VBG purified_VBG gangliosides_VBG ,_VBG GD3_VBG ,_VBG GD1a_VBG ,_VBG GM3_VBG ,_VBG GM2_VBG ,_VBG and_VBG GM1_VBG were_VBG all_VBG effective_VBG in_VBG reducing_VBG TNF_VBG production_VBG in_VBG PBMC_VBG ,_VBG and_VBG in_VBG Mono_VBG Mac_VBG 6_VBG by_VBG factor_VBG 10_VBG to_VBG 50_VBG ._VBG
MAbs_VBG against_VBG the_VBG dUTPase_VBG reacted_VBG with_VBG a_VBG protein_VBG of_VBG approximately_VBG 31_VBG kDa_VBG in_VBG 12-O-tetradecanoyl-phorbol-13-acetate_VBG TPA_VBG -stimulated_VBG B_VBG cells_VBG harbouring_VBG either_VBG type_VBG 1_VBG or_VBG type_VBG 2_VBG EBV_VBG ._VBG
Using_VBG this_VBG assay_VBG system_VBG ,_VBG we_VBG have_VBG evaluated_VBG the_VBG contributions_VBG of_VBG ligand_VBG binding_VBG and_VBG heat_VBG activation_VBG to_VBG DNA_VBG binding_VBG by_VBG these_VBG glucocorticoid_VBG receptors_VBG ._VBG
We_NN have_VBP defined_JJ the_DT mechanisms_CD of_VBG transactivation_JJ by_VBG NFAT1_NN ._.
Nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG contains_VBG Fos_VBG and_VBG Jun_VBG ._VBG
Increased_VBG Stat1_VBG and_VBG Stat3_VBG mRNA_VBG and_VBG protein_VBG levels_VBG were_VBG detected_VBG ,_VBG respectively_VBG 4_VBG and_VBG 24_VBG h_VBG after_VBG activation_VBG ._VBG
However_DT ,_VBG mutation_CD of_VBG the_JJ AP-1_NN site_NN markedly_MD diminished_VBN both_IN the_DT basal_NNS and_CC PMA-activated_NN promoter_NN activity_NN ._.
Ductal_DT cells_NNS were_RB obtained_VBN via_IN random_DT fine_NN needle_CD aspirations_NNS and_VBD cytologically_RB classified_VBN ._.
Although_VBG identical_VBG in_VBG composition_VBG and_VBG stoichiometry_VBG to_VBG TFIIHwt_VBG ,_VBG TFIIHmut_VBG shows_VBG a_VBG reduced_VBG XPB_VBG helicase_VBG activity_VBG ._VBG
Functional_VBG studies_VBG in_VBG extrarenal_VBG ,_VBG non-epithelial_VBG cells_VBG such_VBG as_VBG smooth_VBG muscle_VBG cells_VBG and_VBG more_VBG recently_VBG circulating_VBG human_VBG lymphocytes_VBG have_VBG provided_VBG increasing_VBG evidence_VBG that_VBG aldosterone_VBG produces_VBG not_VBG only_VBG classical_VBG genomic_VBG effects_VBG ,_VBG but_VBG also_VBG rapid_VBG ,_VBG non-genomic_VBG effects_VBG on_VBG transmembrane_VBG electrolyte_VBG movements_VBG ._VBG
However_DT ,_VBG while_VBG HUVECs_VBG contained_VBG endothelial_VBG NOS_VBG protein_VBG ,_VBG no_VBG inducible_VBG NOS_VBG was_VBG detected_VBG in_VBG either_VBG tolerant_VBG or_VBG nontolerant_VBG cells_VBG ._VBG
We_VBG demonstrated_VBG that_VBG the_VBG virus_VBG dUTPase_VBG isolated_VBG from_VBG EBV-infected_VBG cells_VBG is_VBG a_VBG phosphoprotein_VBG ._VBG
This_VBG HIV-mediated_VBG mechanism_VBG results_VBG in_VBG a_VBG self-perpetuating_VBG loop_VBG of_VBG NF-kappa_VBG B_VBG production_VBG ._VBG
Kappa_IN B_NN kappa_NN B_NN enhancer_NN binding_VBG proteins_NNS isolated_VBP from_VBG the_DT nuclei_JJ of_VBG activated_VBG human_VBG T_VBG cells_VBG produce_VBG two_VBG distinct_VBG nucleoprotein_VBG complexes_VBG when_VBG incubated_VBG with_VBG the_VBG kappa_VBG B_VBG element_VBG from_VBG the_VBG interleukin-2_VBG receptor-alpha_VBG IL-2R_VBG alpha_VBG gene_VBG ._VBG
In_VBG addition_VBG ,_VBG analysis_VBG of_VBG EBV_VBG protein_VBG expression_VBG by_VBG IH_VBG revealed_VBG a_VBG heterogeneous_VBG pattern_VBG of_VBG EBV_VBG gene_VBG expression_VBG at_VBG the_VBG single-cell_VBG level_VBG consisting_VBG of_VBG both_VBG and_VBG LMP1-_VBG tumour_VBG cells_VBG ,_VBG suggesting_VBG a_VBG mixture_VBG of_VBG latency_VBG I_VBG and_VBG II_VBG ._VBG
Thus_NNS ,_VBG select_IN genetic_JJ aberrations_IN in_VBG the_VBG apoptotic_VBG pathway_VBG reveal_VBG a_VBG cell_VBG autonomous_VBG coregulation_VBG of_VBG activation_VBG ._VBG
In_IN this_NNS study_IN the_DT effect_NNS of_VBG anti-estrogen_IN toremifene_NN therapy_IN on_VBG serum_VBG immunoglobulin_VBG IgA_VBG ,_VBG IgM_VBG ,_VBG IgG_VBG levels_VBG in_VBG breast_VBG cancer_VBG patients_VBG was_VBG investigated_VBG ._VBG
Although_VBG absent_VBG in_VBG nonexpressing_VBG erythroleukemia_VBG cell_VBG lines_VBG ,_VBG the_VBG DNase_VBG I_VBG site_VBG is_VBG present_VBG in_VBG uninduced_VBG myelomonocytic_VBG cell_VBG lines_VBG and_VBG is_VBG not_VBG changed_VBG after_VBG PMA_VBG induction_VBG ._VBG
Mildly_RB oxLDLs_IN 50_VBG and_JJ 100_VBG decreased_JJ the_DT number_JJ of_VBG lymphoblasts_NN and_CC the_DT level_CD of_VBG IL-2_VBG concentration_VBG in_VBG the_VBG culture_VBG supernatants_VBG after_VBG activation_VBG of_VBG lymphocytes_VBG by_VBG phytohaemagglutinin_VBG and_VBG ._VBG
Resting_DT monocytes_NNS contained_JJ nuclear_JJ factors_NNS binding_JJ to_VBG the_VBG AP-1_VBG element_VBG ,_VBG but_VBG stimulation_VBG of_VBG monocytes_VBG with_VBG LTB4_VBG induced_VBG greater_VBG AP-1-binding_VBG activity_VBG of_VBG nuclear_VBG proteins_VBG ._VBG
The_DT elevation_IN in_VBG intracellular_VBG calcium_VBG that_VBG is_VBG induced_VBG by_VBG interactions_VBG at_VBG the_VBG antigen_VBG receptor_VBG leads_VBG to_VBG the_VBG activation_VBG of_VBG the_VBG calcium-dependent_VBG phosphatase_VBG calcineurin_VBG ._VBG
These_VBG findings_VBG may_VBG have_VBG important_VBG implications_VBG for_VBG the_VBG design_VBG of_VBG alternative_VBG treatment_VBG approaches_VBG for_VBG recalcitrant_VBG asthma_VBG ._VBG
Increased_VBG proliferation_VBG ,_VBG cytotoxicity_VBG ,_VBG and_VBG gene_VBG expression_VBG after_VBG stimulation_VBG of_VBG human_VBG peripheral_VBG blood_VBG T_VBG lymphocytes_VBG through_VBG a_VBG surface_VBG ganglioside_VBG GD3_VBG published_VBG erratum_VBG appears_VBG in_VBG J_VBG Immunol_VBG 1994_VBG Jul_VBG 15_VBG ;_VBG 153_VBG 2_VBG :_VBG 910_VBG
Analysis_NNS of_VBG the_VBG accumulation_VBG of_VBG mRNA-encoding_VBG members_VBG of_VBG the_VBG AP-1_VBG transcription_VBG factor_VBG family_VBG demonstrated_VBG that_VBG c-fos_VBG and_VBG junB_VBG are_VBG also_VBG expressed_VBG upon_VBG stimulation_VBG of_VBG NK_VBG and_VBG T_VBG cells_VBG with_VBG IL-2_VBG ,_VBG but_VBG not_VBG IL-12_VBG ,_VBG whereas_VBG expression_VBG of_VBG c-jun_VBG and_VBG junD_VBG is_VBG not_VBG modified_VBG by_VBG either_VBG cytokine_VBG ._VBG
These_NN findings_NNS are_RB the_DT first_VBP to_VBG demonstrate_JJ membrane_NN binding_VBG of_VBG aldosterone_CD being_VBG compatible_VBG with_VBG major_VBG aspects_VBG of_VBG nongenomic_VBG effects_VBG ._VBG
Acute_VBG promyelocytic_VBG leukemia_VBG APL_VBG is_VBG a_VBG specific_VBG type_VBG of_VBG acute_VBG myeloid_VBG leukemia_VBG characterized_VBG by_VBG the_VBG morphology_VBG of_VBG the_VBG blast_VBG cells_VBG ,_VBG a_VBG specific_VBG t-LRB-15;17-RRB-_VBG translocation_VBG ,_VBG and_VBG risks_VBG of_VBG definite_VBG coagulopathy_VBG ._VBG
We_NN tested_VBD the_DT necessity_DT for_VBG appropriate_VBP spatial_JJ alignment_NNS of_VBG these_VBG elements_VBG by_VBG using_VBG mutated_VBG enhancers_VBG with_VBG altered_VBG spacings_VBG ._VBG
To_DT examine_NN the_DT mechanisms_JJ by_VBG which_VBG salicylates_VBG affect_VBG cytokine_VBG gene_VBG transcription_VBG ,_VBG the_VBG amount_VBG of_VBG active_VBG and_VBG inactive_VBG NF-kappa_VBG B_VBG and_VBG NF-kappa_VBG B_VBG mRNA_VBG ,_VBG in_VBG Porphyromonas_VBG gingivalis_VBG lipopolysaccharide-stimulated_VBG human_VBG monocytic_VBG cells_VBG was_VBG assessed_VBG ._VBG
It_DT is_VBZ directly_RB implicated_VBD in_VBG the_DT emergence_CD of_VBG the_DT age-related_VBN immune_NN deficiency_NN ._.
Multiple_DT prolactin-responsive_JJ elements_NNS mediate_CC G1_NN and_CC S_JJ phase_NN expression_VBP of_VBG the_DT interferon_JJ regulatory_JJ factor-1_JJ gene_NN ._.
Abnormalities_DT of_VBG retinoblastoma_VBG protein_VBG pRB_VBG and_VBG mutations_VBG of_VBG RB_VBG gene_VBG have_VBG been_VBG reported_VBG in_VBG up_VBG to_VBG 70_VBG of_VBG MM_VBG patients_VBG and_VBG 80_VBG of_VBG MM-derived_VBG cell_VBG lines_VBG ._VBG
In_VBG light_VBG of_VBG the_VBG evidence_VBG showing_VBG physical_VBG and_VBG functional_VBG interactions_VBG between_VBG Oct_VBG factors_VBG and_VBG OCA-B_VBG ,_VBG we_VBG propose_VBG a_VBG mechanism_VBG of_VBG action_VBG for_VBG OCA-B_VBG and_VBG discuss_VBG the_VBG implications_VBG of_VBG OCA-B_VBG for_VBG the_VBG transcriptional_VBG regulation_VBG of_VBG other_VBG tissue-specific_VBG promoters_VBG ._VBG
In_VBG contrast_VBG ,_VBG neither_VBG the_VBG RA-stimulated_VBG ,_VBG RARE-mediated_VBG transcription_VBG nor_VBG the_VBG induced_VBG RAR-beta_VBG expression_VBG was_VBG suppressed_VBG by_VBG VitD3_VBG ,_VBG suggesting_VBG that_VBG VitD3_VBG selectively_VBG inhibited_VBG the_VBG retinoid-induced_VBG differentiation_VBG program_VBG but_VBG not_VBG the_VBG RARE-mediated_VBG signal_VBG ._VBG
Such_JJ a_VBG diverse_VBG pathway_VBG of_VBG monocyte_VBG differentiation_VBG may_VBG constitute_VBG one_VBG of_VBG the_VBG basic_VBG mechanisms_VBG of_VBG immune_VBG regulation_VBG ._VBG
Role_CD of_VBG Egr-2_CD in_VBG up-regulation_IN of_VBG Fas_VBG ligand_VBG in_VBG normal_VBG T_VBG cells_VBG and_VBG aberrant_VBG double-negative_VBG lpr_VBG and_VBG gld_VBG T_VBG cells_VBG ._VBG
This_VBG activation_VBG differed_VBG substantially_VBG from_VBG that_VBG mediated_VBG by_VBG phorbol_VBG 12-myristate_VBG 13-acetate_VBG PMA_VBG and_VBG ionophore_VBG or_VBG produced_VBG by_VBG costimulation_VBG with_VBG antibodies_VBG against_VBG the_VBG T_VBG cell_VBG receptor-CD3_VBG complex_VBG and_VBG to_VBG CD28_VBG ._VBG
Electrophoretic_JJ mobility_NNS shift_VBP assays_IN and_CC Southwestern_JJ blotting_VBG experiments_VBG were_VBG used_VBG to_VBG detect_VBG the_VBG binding_VBG of_VBG cellular_VBG transactivation_VBG factor_VBG NF-KB_VBG to_VBG the_VBG double_VBG repeat-KB_VBG enhancer_VBG sequence_VBG located_VBG in_VBG the_VBG long_VBG terminal_VBG repeat_VBG ._VBG
E3_VBG transcripts_VBG are_VBG present_VBG in_VBG the_VBG myeloid_VBG ,_VBG B-lymphoid_VBG ,_VBG and_VBG erythroid_VBG lineages_VBG ,_VBG absent_VBG in_VBG nonhematopoietic_VBG cells_VBG ,_VBG and_VBG encode_VBG a_VBG highly_VBG hydrophobic_VBG ,_VBG potentially_VBG phosphorylated_VBG polypeptide_VBG of_VBG unknown_VBG function_VBG with_VBG significant_VBG homology_VBG to_VBG a_VBG putative_VBG protein_VBG expressed_VBG in_VBG myeloid_VBG cells_VBG ._VBG
Expression_IN of_VBG the_DT human_NN interleukin-2_JJ IL-2_NN receptor_JJ alpha_NN chain_MD gene_NN is_NNS potently_RB upregulated_VBD by_VBG own_VBG ligand_VBG ,_VBG IL-2_VBG ._VBG
We_VBG demonstrate_VBG that_VBG ,_VBG in_VBG normal_VBG human_VBG T_VBG cells_VBG ,_VBG an_VBG AP-1_VBG protein_VBG is_VBG a_VBG component_VBG of_VBG the_VBG NF-AT_VBG protein_VBG complex_VBG ._VBG
These_VBG results_VBG demonstrate_VBG a_VBG complex_VBG role_VBG for_VBG VitD3_VBG in_VBG modifying_VBG the_VBG retinoid_VBG differentiation_VBG pathway_VBG and_VBG may_VBG have_VBG implications_VBG for_VBG differentiation-inducing_VBG therapy_VBG of_VBG hematopoietic_VBG tumors_VBG ._VBG
In_VBG order_VBG to_VBG inquire_VBG into_VBG the_VBG functional_VBG state_VBG of_VBG adrenal_VBG cortex_VBG in_VBG patients_VBG with_VBG pulmonary_VBG heart_VBG disease_VBG ,_VBG the_VBG number_VBG of_VBG glucocorticoid_VBG receptors_VBG GCR_VBG of_VBG peripheral_VBG blood_VBG leukocytes_VBG in_VBG patients_VBG with_VBG chronic_VBG pulmonary_VBG heart_VBG disease_VBG was_VBG determined_VBG with_VBG radioligand-binding_VBG assay_VBG and_VBG the_VBG corresponding_VBG plasma_VBG cortisol_VBG levels_VBG were_VBG assessed_VBG with_VBG radioimmune_VBG assays_VBG ._VBG
We_VBG propose_VBG that_VBG direct_VBG interaction_VBG between_VBG the_VBG glucocorticoid_VBG receptor_VBG and_VBG nuclear_VBG factor-kappa_VBG B_VBG factors_VBG is_VBG at_VBG least_VBG a_VBG partial_VBG explanation_VBG for_VBG the_VBG effects_VBG of_VBG this_VBG hormone_VBG in_VBG inflammatory_VBG diseases_VBG ._VBG
This_VBG rise_VBG is_VBG due_VBG to_VBG increased_VBG mRNA_VBG stability_VBG ,_VBG which_VBG increased_VBG by_VBG almost_VBG twofold_VBG ,_VBG and_VBG to_VBG an_VBG overall_VBG increase_VBG in_VBG transcription_VBG ,_VBG which_VBG rises_VBG by_VBG more_VBG than_VBG sixfold_VBG ._VBG
A_DT fragment_NN extending_VBG from_VBG -643_NN to_VBG is_VBZ capable_VBN of_VBG controlling_VBG the_VBG tissue-specific_VBG expression_VBG of_VBG the_VBG CAT_VBG gene_VBG in_VBG transfection_VBG experiments_VBG ._VBG
We_PRP studied_VBN glucocorticosteroid_JJ receptor_NN density_NNS and_CC affinity_RB on_VBG peripheral_VBG blood_VBG mononuclear_VBG cells_VBG by_VBG the_VBG glucocorticosteroid_VBG binding_VBG assay_VBG in_VBG 33_VBG patients_VBG with_VBG SLE_VBG who_VBG had_VBG taken_VBG no_VBG glucocorticosteroid_VBG for_VBG the_VBG previous_VBG 6_VBG months_VBG and_VBG in_VBG 32_VBG healthy_VBG controls_VBG ._VBG
In_NN THP-1_NN cells_VBZ ,_VBG TPA_VBG also_VBG induced_VBG a_VBG new_VBG ,_VBG faster-migrating_VBG NF_VBG kappa_VBG B_VBG species_VBG not_VBG induced_VBG in_VBG monocytes_VBG ._VBG
Clinical_VBG remissions_VBG induced_VBG with_VBG all-trans_VBG retinoic_VBG acid_VBG RA_VBG treatment_VBG in_VBG acute_VBG promyelocytic_VBG leukemia_VBG are_VBG linked_VBG to_VBG expression_VBG in_VBG leukemic_VBG cells_VBG ._VBG
The_VBG results_VBG show_VBG for_VBG the_VBG first_VBG time_VBG that_VBG a_VBG DNA-binding_VBG protein_VBG can_VBG be_VBG used_VBG for_VBG affinity_VBG purification_VBG of_VBG fusion_VBG proteins_VBG as_VBG exemplified_VBG by_VBG the_VBG specific_VBG and_VBG gentle_VBG recovery_VBG of_VBG beta-galactosidase_VBG and_VBG alkaline_VBG phosphatase_VBG from_VBG bacterial_VBG lysates_VBG using_VBG immunomagnetic_VBG separation_VBG ._VBG
I_VBG kappa_VBG masks_VBG the_VBG nuclear_VBG localization_VBG signal_VBG of_VBG NF-kappa_VBG B_VBG p65_VBG and_VBG requires_VBG the_VBG transactivation_VBG domain_VBG to_VBG inhibit_VBG NF-kappa_VBG B_VBG p65_VBG DNA_VBG binding_VBG ._VBG
We_DT have_VBP shown_JJ that_VBG the_VBG Z_VBG gene_VBG product_VBG ,_VBG which_VBG binds_VBG to_VBG AP-1_VBG sites_VBG as_VBG a_VBG homodimer_VBG and_VBG has_VBG sequence_VBG similarity_VBG to_VBG c-Fos_VBG ,_VBG can_VBG efficiently_VBG activate_VBG the_VBG EBV_VBG early_VBG promoter_VBG ,_VBG BMRF1_VBG ,_VBG in_VBG certain_VBG cell_VBG types_VBG i.e._VBG ,_VBG HeLa_VBG cells_VBG but_VBG not_VBG others_VBG i.e._VBG ,_VBG Jurkat_VBG cells_VBG ._VBG
The_VBG data_VBG indicate_VBG that_VBG decrease_VBG of_VBG ER_VBG levels_VBG in_VBG cell_VBG may_VBG involve_VBG in_VBG the_VBG pathogenesis_VBG of_VBG climacteric_VBG syndrome_VBG ._VBG
They_PRP are_VBP composed_NN of_VBG different_VBG structural_VBG domains_VBG ,_VBG including_VBG distinct_VBG domains_VBG for_VBG DNA_VBG and_VBG ligand_VBG binding_VBG ._VBG
Mobility_VBG shift_VBG assays_VBG showed_VBG that_VBG addition_VBG of_VBG anti-AIM_VBG mAb_VBG to_VBG PMA-treated_VBG T_VBG lymphocytes_VBG markedly_VBG enhanced_VBG the_VBG binding_VBG activity_VBG of_VBG AP-1_VBG to_VBG cognate_VBG sequence_VBG ,_VBG the_VBG phorbol_VBG ester_VBG response_VBG element_VBG ._VBG
Chloramphenicol_NN acetyl_NN transferase_NN CAT_NNS assays_IN using_VBG the_IN HIV-1_NN -139_VBZ long_JJ terminal_JJ repeat-CAT_JJ construct_NN showed_VBD no_TO PMA_NN induction_CD of_VBG CAT_VBG activity_VBG in_VBG these_VBG subclones_VBG unlike_VBG the_VBG parental_VBG line_VBG and_VBG other_VBG subclones_VBG ._VBG
Stimulation_IN of_VBG human_VBG peripheral_VBG blood_VBG mononuclear_VBG cells_VBG by_VBG zinc_VBG and_VBG related_VBG cations_VBG ._VBG
Nevertheless_NNS ,_VBG the_VBG molecular_VBG mechanisms_VBG involved_VBG in_VBG BA-induced_VBG differentiation_VBG remain_VBG largely_VBG unknown_VBG ._VBG
Both_VBG canrenone_VBG and_VBG cortisol_VBG were_VBG inactive_VBG as_VBG ligands_VBG up_VBG to_VBG concentrations_VBG of_VBG 0.1_VBG microM_VBG ._VBG
Gel_VBG shift_VBG mobility_VBG assay_VBG showed_VBG stimulation_VBG of_VBG the_VBG AP-1_VBG and_VBG NF-kappaB_VBG contents_VBG in_VBG P-LPS-treated_VBG cells_VBG ._VBG
However_DT ,_VBG this_VBG apparent_VBG lack_VBG of_VBG response_VBG to_VBG the_VBG secosterol_VBG can_VBG be_VBG overcome_VBG by_VBG stimulation_VBG of_VBG B_VBG lymphocytes_VBG with_VBG a_VBG combination_VBG of_VBG these_VBG cellular_VBG activation_VBG signals_VBG ,_VBG which_VBG are_VBG sufficient_VBG to_VBG lead_VBG to_VBG G1_VBG cell_VBG cycle_VBG progression_VBG ._VBG
The_DT proximal_NN sequence_NN element_JJ PSE_NN -binding_VBG transcription_VBG factor_VBG PTF_VBG ,_VBG which_VBG binds_VBG the_VBG PSE_VBG of_VBG both_VBG RNA_VBG polymerase_VBG II-_VBG and_VBG RNA_VBG polymerase_VBG III-transcribed_VBG mammalian_VBG small_VBG nuclear_VBG RNA_VBG snRNA_VBG genes_VBG ,_VBG is_VBG essential_VBG for_VBG transcription_VBG ._VBG
Stimulation_IN of_VBG T_VBG cells_VBG with_VBG antigen_VBG results_VBG in_VBG activation_VBG of_VBG several_VBG kinases_VBG ,_VBG including_VBG protein_VBG kinase_VBG C_VBG PKC_VBG ,_VBG that_VBG may_VBG mediate_VBG the_VBG later_VBG induction_VBG of_VBG activation-related_VBG genes_VBG ._VBG
The_DT use_NNS of_VBG the_VBG protein_VBG tyrosine_VBG kinase_VBG PTK_VBG -specific_VBG inhibitor_VBG herbimycin_VBG A_VBG dramatically_VBG decreased_VBG cellular_VBG proliferation_VBG without_VBG altering_VBG the_VBG activity_VBG of_VBG the_VBG human_VBG immunodeficiency_VBG virus-1_VBG long_VBG terminal_VBG repeat_VBG HIV-1_VBG LTR_VBG ,_VBG a_VBG promoter_VBG largely_VBG dependent_VBG on_VBG the_VBG binding_VBG of_VBG nuclear_VBG factor_VBG kappa_VBG B_VBG NF-_VBG kappa_VBG B_VBG ._VBG
PMA_JJ induction_NN increases_NNS the_DT level_CD of_VBG a_VBG number_RB of_VBG specific_JJ binding_VBG complexes_VBG relative_VBG to_VBG the_VBG resting_VBG cells_VBG ._VBG
Problems_DT of_VBG antihypertensive_VBG therapy_VBG are_VBG discussed_VBG and_VBG the_VBG first_VBG results_VBG of_VBG a_VBG pilot_VBG study_VBG with_VBG Urapidil_VBG are_VBG presented_VBG ._VBG
Several_VBG methods_VBG for_VBG specific_VBG down-regulation_VBG of_VBG transcription_VBG factors_VBG are_VBG shown_VBG that_VBG may_VBG be_VBG relevant_VBG to_VBG treatment_VBG of_VBG human_VBG disease_VBG ._VBG
Proliferation_DT in_VBG response_VBP to_VBG TG_VBG was_VBG observed_VBG in_VBG T_VBG cells_VBG from_VBG only_VBG 1_VBG of_VBG 5_VBG Hashimoto_VBG patients_VBG ._VBG
The_VBG B_VBG family_VBG of_VBG transcription_VBG factors_VBG is_VBG composed_VBG of_VBG two_VBG distinct_VBG subgroups_VBG ,_VBG proteins_VBG that_VBG undergo_VBG proteolytic_VBG processing_VBG and_VBG contain_VBG repeats_VBG in_VBG carboxyl_VBG termini_VBG p105_VBG ,_VBG p98_VBG ,_VBG and_VBG those_VBG without_VBG such_VBG repeats_VBG that_VBG do_VBG not_VBG require_VBG processing_VBG p65_VBG ,_VBG c-Rel_VBG ,_VBG RelB_VBG ,_VBG and_VBG Dorsal_VBG ._VBG
Class_IN II_NN antigen_NN expressing_JJ T-cell_NN lines_NNS maintained_JJ contacts_NNS identical_VBP to_VBG B-cell_VBG lines_VBG ,_VBG while_VBG class_VBG II-negative_VBG T-cell_VBG lines_VBG exhibited_VBG no_VBG interactions_VBG ._VBG
In_VBG particular_VBG ,_VBG a_VBG high-affinity_VBG BSAP-binding_VBG site_VBG instead_VBG of_VBG a_VBG TATA_VBG sequence_VBG is_VBG located_VBG in_VBG the_VBG -30_VBG promoter_VBG region_VBG upstream_VBG of_VBG a_VBG cluster_VBG of_VBG heterogeneous_VBG transcription_VBG start_VBG sites_VBG ._VBG
This_VBG event_VBG is_VBG associated_VBG with_VBG induction_VBG of_VBG the_VBG c-jun_VBG early_VBG response_VBG gene_VBG and_VBG appearance_VBG of_VBG a_VBG monocytic_VBG phenotype_VBG ._VBG
Endothelial_DT cells_NNS EC_NN act_CC as_VBG APC_RB for_VBG resting_VBG PBL_VBG in_VBG vitro_VBG ,_VBG and_VBG may_VBG have_VBG important_VBG roles_VBG in_VBG vivo_VBG in_VBG the_VBG pathogenesis_VBG of_VBG allograft_VBG rejection_VBG and_VBG delayed_VBG hypersensitivity_VBG ._VBG
The_DT results_VBZ define_NN the_NN rhombotin_NN gene_NN family_IN as_VBG a_VBG class_CD of_VBG T-cell_NN oncogenes_VBZ with_IN duplicated_JJ cysteine-rich_JJ LIM_NN domains_NNS ._.
Thus_NNS ,_VBG p65_VBG and_VBG I_VBG kappa_VBG B_VBG are_VBG linked_VBG in_VBG an_VBG autoregulatory_VBG loop_VBG ,_VBG ensuring_VBG that_VBG NF-kappa_VBG B_VBG is_VBG held_VBG in_VBG the_VBG cytoplasm_VBG until_VBG cells_VBG are_VBG specifically_VBG induced_VBG to_VBG translocate_VBG it_VBG to_VBG the_VBG nucleus_VBG ._VBG
Agonist_VBG dexamethasone_VBG was_VBG slightly_VBG more_VBG effective_VBG in_VBG supporting_VBG specific_VBG DNA_VBG binding_VBG than_VBG antagonist_VBG RU486_VBG ._VBG
For_DT these_DT reasons_JJ ,_VBG the_VBG region_VBG of_VBG the_VBG GPIIb_VBG gene_VBG was_VBG used_VBG to_VBG identify_VBG the_VBG regions_VBG that_VBG interact_VBG with_VBG DNA-binding_VBG nuclear_VBG factors_VBG ._VBG
This_VBG defect_VBG was_VBG localized_VBG to_VBG T_VBG cells_VBG and_VBG reverted_VBG to_VBG normal_VBG after_VBG 48_VBG h_VBG in_VBG culture_VBG media_VBG ._VBG
The_DT protein_NNS Bcl-3_NN contains_NNS seven_RB so-called_VBN ankyrin_NN repeats_NNS ._.
Previous_VBG reports_VBG have_VBG shown_VBG that_VBG BA-induced_VBG overexpression_VBG of_VBG erythroid_VBG genes_VBG occurred_VBG at_VBG the_VBG transcriptional_VBG level_VBG ,_VBG suggesting_VBG the_VBG involvement_VBG of_VBG erythroid_VBG transcription_VBG factors_VBG ._VBG
In_VBG contrast_VBG ,_VBG mutations_VBG in_VBG the_VBG AP-1_VBG site_VBG located_VBG at_VBG -150_VBG bp_VBG almost_VBG completely_VBG abrogate_VBG induction_VBG of_VBG the_VBG IL-2_VBG promoter_VBG ,_VBG and_VBG appearance_VBG of_VBG an_VBG inducible_VBG nuclear_VBG factor_VBG binding_VBG to_VBG this_VBG site_VBG is_VBG sensitive_VBG to_VBG PKC_VBG depletion_VBG ._VBG
Finally_IN ,_VBG TFIIA_VBG facilitates_VBG Tax_VBG transactivation_VBG in_VBG vitro_VBG and_VBG in_VBG vivo_VBG ._VBG
In_DT each_JJ case_JJ the_DT allele_JJ loss_JJ was_VBD caused_VBD by_VBG an_JJ interstitial_JJ deletion_JJ because_VBG heterozygosity_RB at_VBG distal_VBG markers_VBG was_VBG retained_VBG and_VBG because_VBG quantitative_VBG Southern_VBG blotting_VBG demonstrated_VBG hemizygosity_VBG ._VBG
TF_IN antigen_NN expression_VBP as_VBG elicited_JJ by_VBG LPS_JJ was_VBD also_RB lowered_JJ by_VBG lysoPC_NN ._.
Interestingly_IN ,_VBG T3_VBG strongly_VBG enhanced_VBG the_VBG action_VBG of_VBG RA_VBG ,_VBG suggesting_VBG cooperative_VBG action_VBG of_VBG the_VBG two_VBG receptors_VBG in_VBG modulating_VBG erythroid_VBG differentiation_VBG ._VBG
However_DT ,_VBG compared_VBD to_VBG VD_VB ,_VBG antiproliferative_JJ effect_VBP is_VBZ up_RB to_VBG 30-fold_VBG higher_VBG on_VBG human_VBG peripheral_VBG blood_VBG mononuclear_VBG cells_VBG and_VBG even_VBG up_VBG to_VBG 300-fold_VBG higher_VBG on_VBG human_VBG breast_VBG cancer_VBG MCF-7_VBG cells_VBG ._VBG
A_DT 21.4-kb_CD DNA_NN clone_JJ ,_VBG pZVB70_NNS ,_VBG showed_JJ the_DT highest_JJ transactivating_VBG ability_VBG ,_VBG while_VBG two_VBG other_VBG DNA_VBG fragments_VBG ,_VBG pZVB10_VBG 6.2_VBG kb_VBG and_VBG pZVH14_VBG 8.7_VBG kb_VBG ,_VBG showed_VBG lower_VBG activity_VBG ._VBG
Inhibition_IN of_VBG transcription_VBG factor_VBG Stat1_VBG activity_VBG in_VBG mononuclear_VBG cell_VBG cultures_VBG and_VBG T_VBG cells_VBG by_VBG the_VBG cyclic_VBG AMP_VBG signaling_VBG pathway_VBG ._VBG
The_VBG active_VBG nuclear_VBG form_VBG of_VBG the_VBG NF-kappa_VBG B_VBG transcription_VBG factor_VBG complex_VBG is_VBG composed_VBG of_VBG two_VBG DNA_VBG binding_VBG subunits_VBG ,_VBG NF-kappa_VBG B_VBG p65_VBG and_VBG NF-kappa_VBG B_VBG p50_VBG ,_VBG both_VBG of_VBG which_VBG share_VBG extensive_VBG N-terminal_VBG sequence_VBG homology_VBG with_VBG the_VBG v-rel_VBG oncogene_VBG product_VBG ._VBG
Using_NN Western_NN blot_JJ analysis_NN with_VBP a_VBG monoclonal_NN antibody_NN recognizing_VBG a_VBG 17-amino_VBG acid_VBG epitope_VBG of_VBG the_VBG 1,25-dihydroxyvitamin_VBG D3_VBG 1,25-LRB-OH-RRB-2D3_VBG receptor_VBG ,_VBG we_VBG have_VBG detected_VBG two_VBG crossreacting_VBG proteins_VBG in_VBG activated_VBG normal_VBG human_VBG lymphocytes_VBG ._VBG
The_DT number_DT of_VBG glucocorticoid_VBG receptors_VBG was_VBG 63_VBG greater_VBG in_VBG the_VBG morning_VBG and_VBG 26_VBG greater_VBG in_VBG the_VBG afternoon_VBG in_VBG the_VBG patients_VBG with_VBG PTSD_VBG than_VBG in_VBG the_VBG normal_VBG subjects_VBG ._VBG
However_DT ,_VBG Nef_VBG does_VBG not_VBG affect_VBG the_VBG DNA-binding_VBG activity_VBG of_VBG other_VBG transcription_VBG factors_VBG implicated_VBG in_VBG HIV-1_VBG regulation_VBG ,_VBG including_VBG SP-1_VBG ,_VBG USF_VBG ,_VBG URS_VBG ,_VBG and_VBG NF-AT_VBG ._VBG
Pentoxifylline_DT for_VBG the_VBG treatment_VBG of_VBG infection_VBG with_VBG human_VBG immunodeficiency_VBG virus_VBG ._VBG
Here_PRP ,_VBG Stuart_DT Schreiber_NN and_CC Gerald_RB Crabtree_NN review_VBP recent_NN findings_NN that_VBG indicate_VBG CsA_VBG and_VBG FK506_VBG operate_VBG as_VBG prodrugs_VBG :_VBG they_VBG bind_VBG endogenous_VBG intracellular_VBG receptors_VBG ,_VBG the_VBG immunophilins_VBG ,_VBG and_VBG the_VBG resulting_VBG complex_VBG targets_VBG the_VBG protein_VBG phosphatase_VBG ,_VBG calcineurin_VBG ,_VBG to_VBG exert_VBG the_VBG immunosuppressive_VBG effect_VBG ._VBG
IL-4_VBG did_VBG not_VBG affect_VBG the_VBG stability_VBG of_VBG the_VBG c-fos_VBG and_VBG c-jun_VBG transcripts_VBG ._VBG
Since_VBG LPS_VBG and_VBG anti-IgM_VBG were_VBG unable_VBG to_VBG activate_VBG RelB_VBG ,_VBG CD40_VBG appears_VBG to_VBG trigger_VBG a_VBG special_VBG program_VBG of_VBG gene_VBG expression_VBG involved_VBG in_VBG the_VBG proliferation_VBG differentiation_VBG of_VBG B_VBG lymphocytes_VBG ._VBG
We_PRP further_VBP show_JJ that_VBG subdominant_VBG latent_VBG cycle_VBG reactivities_VBG to_VBG epitopes_VBG in_VBG the_VBG latent_VBG membrane_VBG protein_VBG LMP2_VBG ,_VBG though_VBG rarely_VBG undetectable_VBG in_VBG LCL-stimulated_VBG populations_VBG ,_VBG can_VBG be_VBG reactivated_VBG by_VBG DC_VBG stimulation_VBG and_VBG selectively_VBG expanded_VBG as_VBG polyclonal_VBG CTL_VBG lines_VBG ;_VBG the_VBG adoptive_VBG transfer_VBG of_VBG such_VBG preparations_VBG may_VBG be_VBG of_VBG value_VBG in_VBG targeting_VBG certain_VBG EBV-positive_VBG malignancies_VBG ._VBG
SCL_VBG protein_VBG production_VBG was_VBG examined_VBG in_VBG a_VBG variety_VBG of_VBG hemopoietic_VBG cell_VBG lines_VBG by_VBG immunoblotting_VBG using_VBG specific_VBG polyclonal_VBG antisera_VBG ._VBG
Epithelial_VBG cells_VBG are_VBG the_VBG major_VBG site_VBG of_VBG lytic_VBG EBV_VBG replication_VBG within_VBG the_VBG human_VBG host_VBG ,_VBG and_VBG viral_VBG reactivation_VBG occurs_VBG in_VBG EBV-associated_VBG nasopharyngeal_VBG carcinomas_VBG ._VBG
Unstimulated_VBG and_VBG T_VBG cells_VBG constitutively_VBG contained_VBG high_VBG levels_VBG of_VBG two_VBG proteins_VBG that_VBG bound_VBG to_VBG the_VBG FLRE_VBG ._VBG
Characterization_IN of_VBG the_DT murine_NN cyclin-dependent_NN kinase_NN inhibitor_JJ gene_JJ p27Kip1_NN ._.
Preincubation_IN of_VBG endothelial_JJ cells_NN with_IN endotoxin_DT lipopolysaccharide_NN LPS_CD ,_VBG 1_VBG led_VBD to_VBG a_VBG 4-fold_VBG increase_VBG in_VBG subsequent_VBG adherence_VBG of_VBG polymorphonuclear_VBG leukocytes_VBG P_VBG 0.0001_VBG ,_VBG n_VBG 10_VBG to_VBG endothelial_VBG cells_VBG ,_VBG an_VBG increase_VBG that_VBG was_VBG markedly_VBG attenuated_VBG when_VBG endothelial_VBG cells_VBG were_VBG treated_VBG with_VBG dexamethasone_VBG IC50_VBG 1_VBG nM_VBG ,_VBG P_VBG 0.0001_VBG ,_VBG n_VBG 6_VBG or_VBG 7_VBG during_VBG preincubation_VBG with_VBG LPS_VBG ._VBG
Circular_NN permutation_NN and_CC phasing_JJ analyses_NNS demonstrated_VBP that_VBG PU.1_CD binding_NN but_CC not_NN TFE3_NN or_JJ Ets-1_NN bends_NNS mu_MD enhancer_NN DNA_NNS toward_VBD the_DT major_MD groove_NN ._.
We_VBG find_VBG that_VBG in_VBG the_VBG absence_VBG of_VBG EKLF_VBG ,_VBG while_VBG human_VBG beta-globin_VBG expression_VBG is_VBG dramatically_VBG reduced_VBG ,_VBG gamma-globin_VBG transcripts_VBG are_VBG elevated_VBG approximately_VBG 5-fold_VBG ._VBG
In_VBG the_VBG cell_VBG types_VBG tested_VBG ,_VBG the_VBG LS_VBG mutations_VBG indicated_VBG an_VBG apparent_VBG requirement_VBG not_VBG only_VBG for_VBG the_VBG intact_VBG NF-kappa_VBG B_VBG and_VBG SP1-binding_VBG sites_VBG but_VBG also_VBG for_VBG several_VBG regions_VBG between_VBG -201_VBG and_VBG -130_VBG not_VBG previously_VBG associated_VBG with_VBG viral_VBG infectivity_VBG ._VBG
binds_IN to_VBG the_VBG response_VBG element_VBG by_VBG monomer_VBG or_VBG heterodimer_VBG with_VBG retinoid_VBG X_VBG receptor_VBG RXR_VBG ._VBG
The_VBG data_VBG presented_VBG below_VBG indicate_VBG that_VBG Notch-1_VBG expression_VBG provides_VBG significant_VBG protection_VBG to_VBG T_VBG cell_VBG lines_VBG from_VBG TCR-mediated_VBG apoptosis_VBG ._VBG
This_NNS protein-DNA_NN complex_NN comigrated_VBD with_IN the_DT complex_NN obtained_VBD with_JJ the_DT purified_JJ human_NN p65_NN NF-kappa_NNS B_NN subunit_CD and_CC binding_VBG was_VBG inhibited_VBG by_VBG I_VBG kappa_VBG B-alpha_VBG and_VBG -beta_VBG proteins_VBG ._VBG
Gangliosides_NNS appear_JJ to_VBG act_NN at_VBG an_VBG early_VBG step_VBG of_VBG activation_VBG in_VBG that_VBG TNF_VBG transcripts_VBG were_VBG reduced_VBG and_VBG the_VBG mobilization_VBG of_VBG the_VBG nuclear_VBG factor_VBG kappa_VBG B_VBG was_VBG blocked_VBG ._VBG
Surprisingly_IN ,_VBG although_VBG stimulation_VBG of_VBG Jurkat_VBG T_VBG cells_VBG with_VBG either_VBG CHO-CD80_VBG or_VBG anti-CD28_VBG mAb_VBG resulted_VBG in_VBG robust_VBG tyrosine_VBG phosphorylation_VBG of_VBG CD28_VBG itself_VBG ,_VBG ligation_VBG with_VBG CHO-CD86_VBG was_VBG unable_VBG to_VBG induce_VBG detectable_VBG CD28_VBG tyrosyl_VBG phosphorylation_VBG over_VBG a_VBG range_VBG of_VBG stimulation_VBG conditions_VBG ._VBG
Later_IN ,_VBG the_VBG expression_VBG of_VBG the_VBG BSAP_VBG gene_VBG shifts_VBG to_VBG the_VBG fetal_VBG liver_VBG where_VBG it_VBG correlates_VBG with_VBG the_VBG onset_VBG of_VBG B_VBG lymphopoiesis_VBG ._VBG
Within_DT this_DT region_RB ,_VBG single_VBP AP-2-_NN and_CC AP-1-like_JJ consensus_NNS sequences_NNS were_VBP noted_VBN ._.
The_DT effect_PRP is_VBZ mediated_VBD by_VBG the_VBG NF-kappa_VBG B_VBG transcription_VBG factor_VBG which_VBG is_VBG potently_VBG and_VBG rapidly_VBG activated_VBG by_VBG an_VBG H2O2_VBG treatment_VBG of_VBG cells_VBG from_VBG inactive_VBG cytoplasmic_VBG form_VBG ._VBG
However_DT ,_VBG neither_NN TNF_NN or_NN LPS_NN stimulated_VBN VCAM-1_NN expression_JJ in_VBG HUAECs_NNS ._.
Terminal_VBG differentiation_VBG of_VBG the_VBG leukemic_VBG cell_VBG lines_VBG U-937_VBG and_VBG HL-60_VBG by_VBG 12-O-tetradecanoylphorbol-13-acetate_VBG is_VBG accompanied_VBG by_VBG marked_VBG changes_VBG in_VBG gene_VBG expression_VBG ._VBG
The_VBG transcriptional_VBG activity_VBG of_VBG the_VBG NFAT_VBG binding_VBG site_VBG is_VBG mediated_VBG by_VBG a_VBG complex_VBG comprising_VBG a_VBG member_VBG of_VBG the_VBG NFAT_VBG group_VBG and_VBG AP-1_VBG family_VBG proteins_VBG ._VBG
Thus_NNS ,_VBG each_VBG factor_VBG may_VBG function_VBG as_VBG a_VBG novel_VBG negative_VBG regulator_VBG of_VBG transcription_VBG ._VBG
Therapy_IN with_IN dexamethasone_NN was_VBD successful_RB in_VBG female_DT patients_NNS with_IN acne_JJ and_CC hirsutism_RB ,_VBG as_VBG the_VBG secondary_VBG increase_VBG in_VBG the_VBG production_VBG of_VBG adrenal_VBG androgens_VBG was_VBG effectively_VBG controlled_VBG ._VBG
The_DT use_NNS of_VBG interferon-gamma-treated_VBD U937_NN cells_NN in_VBG chemiluminescence_NN assays_VBZ to_VBG detect_VBG red_VBG cell_VBG ,_VBG platelet_VBG and_VBG granulocyte_VBG antibodies_VBG of_VBG potential_VBG clinical_VBG significance_VBG ._VBG
Taken_VBG together_VBG ,_VBG data_VBG demonstrate_VBG that_VBG TNF_VBG gene_VBG expression_VBG in_VBG monocytes_VBG induced_VBG by_VBG different_VBG types_VBG of_VBG stimuli_VBG can_VBG be_VBG blocked_VBG by_VBG gangliosides_VBG at_VBG an_VBG early_VBG step_VBG of_VBG signal_VBG transduction_VBG ._VBG
This_VBG effect_VBG required_VBG surface_VBG expression_VBG of_VBG the_VBG CD45_VBG PTPase_VBG and_VBG was_VBG not_VBG observed_VBG in_VBG CD45-deficient_VBG variants_VBG of_VBG Jurkat_VBG cells_VBG ._VBG
The_DT transcription_NN and_IN transformation_NN activity_NNS of_VBG c-Jun_VBG is_VBG governed_VBG by_VBG a_VBG 27-amino_VBG acid_VBG regulatory_VBG motif_VBG ,_VBG labeled_VBG the_VBG delta-domain_VBG ,_VBG which_VBG is_VBG deleted_VBG in_VBG v-Jun_VBG ._VBG
Together_JJ ,_VBG these_VBG data_VBG suggest_VBG that_VBG EBF_VBG represents_VBG a_VBG novel_VBG regulator_VBG of_VBG B_VBG lymphocyte-specific_VBG gene_VBG expression_VBG ._VBG
Similar_JJ DNA_NNS binding_VBG activity_VBG was_VBG detected_VBG in_VBG a_VBG variety_VBG of_VBG virus-uninfected_VBG human_VBG T_VBG cell_VBG lines_VBG and_VBG HeLa_VBG cells_VBG by_VBG means_VBG of_VBG a_VBG gel_VBG mobility_VBG shift_VBG assay_VBG ._VBG
Optimal_VBG activation_VBG of_VBG T_VBG cells_VBG requires_VBG at_VBG least_VBG two_VBG signals_VBG ._VBG
However_DT ,_VBG a_VBG minority_NNS of_VBG LYSP100_JJ nuclear_JJ dots_NN exactly_RB colocalized_JJ with_IN PML_JJ and_CC SP100_NN ._.
and_CC related_VBN genes_NNS constitute_VB a_VBG family_VBG and_VBG the_VBG family_VBG consists_VBG of_VBG three_VBG subtypes_VBG ,_VBG named_VBG nur77_VBG alpha_VBG ,_VBG nur77_VBG beta_VBG ,_VBG nur77_VBG gamma_VBG ._VBG
We_VBG term_VBG the_VBG LYSP100_VBG structures_VBG LANDs_VBG ,_VBG for_VBG LYSP100-associated_VBG nuclear_VBG domains_VBG ._VBG
Cell_VBG cycle_VBG analysis_VBG of_VBG E2F_VBG in_VBG primary_VBG human_VBG T_VBG cells_VBG reveals_VBG novel_VBG E2F_VBG complexes_VBG and_VBG biochemically_VBG distinct_VBG forms_VBG of_VBG free_VBG E2F_VBG ._VBG
Human_DT peripheral_JJ blood_JJ monocytes_NNS Mo_NN constitutively_NN display_IN the_DT beta-chain_NNS of_VBG the_VBG receptor_VBG for_VBG IL-2_VBG ,_VBG whereas_VBG expression_VBG of_VBG the_VBG IL-2R_VBG alpha-chain_VBG is_VBG not_VBG constitutive_VBG but_VBG inducible_VBG with_VBG IL-2_VBG ._VBG
Suppression_IN of_VBG c-jun_JJ by_VBG antisense_JJ oligonucleotides_NNS inhibits_NNS cell_JJ adhesion_NN but_CC not_RB respiratory_VB burst_CC during_VBG phorbol_VBG ester-induced_VBG differentiation_VBG of_VBG U937_VBG human_VBG monoblastic_VBG cells_VBG ._VBG
LTB4_VBG increased_VBG the_VBG expression_VBG of_VBG the_VBG c-fos_VBG gene_VBG in_VBG a_VBG time-_VBG and_VBG concentration-dependent_VBG manner_VBG ._VBG
As_VBG expected_VBG ,_VBG nearly_VBG all_VBG control_VBG mice_VBG 94.4_VBG survived_VBG irradiation_VBG ,_VBG yet_VBG this_VBG irradiation_VBG was_VBG lethal_VBG to_VBG 45.8_VBG of_VBG transgenic_VBG mice_VBG ._VBG
Because_VBG the_VBG GATA-1_VBG gene_VBG is_VBG known_VBG to_VBG transactivate_VBG several_VBG genes_VBG specific_VBG for_VBG the_VBG erythroid_VBG ,_VBG megakaryocytic_VBG ,_VBG and_VBG lineages_VBG ,_VBG we_VBG studied_VBG GATA-1_VBG expression_VBG in_VBG these_VBG purified_VBG hematopoietic_VBG cells_VBG ._VBG
Reduced_VBG susceptibility_VBG to_VBG HIV-1_VBG infection_VBG of_VBG ethyl-methanesulfonate-treated_VBG CEM_VBG subclones_VBG correlates_VBG with_VBG a_VBG blockade_VBG in_VBG protein_VBG kinase_VBG C_VBG signaling_VBG pathway_VBG ._VBG
METHOD_NNS :_VBG They_NN measured_VBN the_DT number_JJ of_VBG lymphocyte_VBG cytosolic_VBG glucocorticoid_VBG receptors_VBG and_VBG plasma_VBG cortisol_VBG concentrations_VBG in_VBG 15_VBG consecutively_VBG admitted_VBG male_VBG combat_VBG Vietnam_VBG veterans_VBG with_VBG PTSD_VBG and_VBG in_VBG a_VBG normal_VBG comparison_VBG group_VBG of_VBG 11_VBG subjects_VBG ._VBG
The_DT SCMV_NNS SNE_NN sites_NNS contain_VBP potential_JJ overlapping_JJ core_NN recognition_NN binding_VBG motifs_VBG for_VBG SRF_VBG ,_VBG ,_VBG ETS_VBG ,_VBG and_VBG YY1_VBG class_VBG transcription_VBG factors_VBG but_VBG fail_VBG to_VBG respond_VBG to_VBG either_VBG serum_VBG or_VBG tumor_VBG necrosis_VBG factor_VBG alpha_VBG ._VBG
Here_DT we_PRP show_VBD that_VBG the_VBG response_VBG of_VBG the_VBG HIV-1_VBG LTR_VBG may_VBG be_VBG governed_VBG by_VBG two_VBG independent_VBG sequences_VBG located_VBG to_VBG the_VBG site_VBG of_VBG transcription_VBG initiation_VBG sequences_VBG that_VBG bind_VBG either_VBG NFAT-1_VBG or_VBG NF_VBG kappa_VBG B_VBG ._VBG
METHOD_NN ._.
The_DT expression_JJ of_VBG tissue_DT factor_NN TF_CD ,_VBG the_VBG principal_VBG initiator_VBG of_VBG coagulation_VBG ,_VBG is_VBG increased_VBG during_VBG inflammation_VBG and_VBG atherosclerosis_VBG ._VBG
These_VBG data_VBG suggest_VBG that_VBG NF-kappa_VBG B_VBG may_VBG be_VBG an_VBG important_VBG molecular_VBG mediator_VBG of_VBG Pb-induced_VBG immunotoxicity_VBG ._VBG
Aldosterone-specific_JJ membrane_JJ receptors_NN and_CC rapid_VBD non-genomic_JJ actions_IN of_VBG mineralocorticoids_NNS ._.
Cells_VBG with_VBG nuclear_VBG p50_VBG were_VBG negative_VBG for_VBG the_VBG CD38_VBG ,_VBG CD20_VBG and_VBG CD2_VBG markers_VBG ._VBG
The_VBG constitutive_VBG transcription_VBG factor_VBG SP1_VBG was_VBG unaffected_VBG by_VBG addition_VBG of_VBG TPA_VBG ._VBG
In_NN agreement_NN with_IN this_DT finding_VBG ,_VBG both_DT the_DT IL-2_NN and_CC IL-2-R_JJ alpha_NN promoters_NN are_VBP active_VBP in_VBG transient_IN transfection_NN assays_IN in_VBG IARC_NNS 301_VBG cells_NNS ._.
External_JJ stimuli_RB ,_VBG including_VBG those_VBP that_VBG activate_IN T_NN cells_VBZ ,_VBG result_VBP in_VBG nuclear_VBG translocation_VBG of_VBG active_VBG NF-kappa_VBG B_VBG ._VBG
The_DT development_NNS of_VBG functionally_RB responsive_NN T_NN cells_NNS ._.
Stronger_VBG c-myc_VBG mRNA_VBG expression_VBG was_VBG detected_VBG in_VBG labial_VBG salivary_VBG glands_VBG of_VBG patients_VBG with_VBG longer_VBG disease_VBG duration_VBG p_VBG less_VBG than_VBG or_VBG equal_VBG to_VBG 0.002_VBG and_VBG more_VBG intense_VBG T_VBG lymphocyte_VBG infiltrates_VBG p_VBG less_VBG than_VBG 0.05_VBG although_VBG these_VBG patients_VBG revealed_VBG no_VBG hypergammaglobulinemia_VBG ._VBG
We_VBG observed_VBG no_VBG change_VBG in_VBG membrane_VBG structural_VBG order_VBG with_VBG RU_VBG 486_VBG up_VBG to_VBG a_VBG concentration_VBG of_VBG 10-LRB--4-RRB-_VBG M_VBG ._VBG
Moreover_DT ,_VBG kappa_DT 1_VBG -_VBG kappa_VBG 3_VBG can_VBG each_VBG be_VBG deleted_VBG from_VBG the_VBG TNF-alpha_VBG promoter_VBG with_VBG little_VBG effect_VBG on_VBG the_VBG gene_VBG inducibility_VBG by_VBG PMA_VBG ._VBG
DNA_JJ sequence_NN homology_NNS of_VBG E1A_VBG genes_VBG between_VBG different_VBG Ad_VBG groups_VBG group_VBG A_VBG ,_VBG Ad12_VBG ;_VBG group_VBG C_VBG ,_VBG Ad5_VBG is_VBG limited_VBG almost_VBG entirely_VBG to_VBG three_VBG conserved_VBG regions_VBG located_VBG within_VBG the_VBG first_VBG exon_VBG of_VBG E1A_VBG ._VBG
The_VBG positive_VBG region_VBG can_VBG be_VBG divided_VBG into_VBG an_VBG upstream_VBG and_VBG a_VBG downstream_VBG regulatory_VBG region_VBG ._VBG
DNA_JJ from_VBG peripheral_VBG blood_VBG leukocytes_VBG of_VBG six_VBG patients_VBG from_VBG five_VBG families_VBG with_VBG various_VBG degrees_VBG of_VBG androgen_VBG insensitivity_VBG was_VBG studied_VBG ._VBG
These_PRP species_NNS showed_JJ different_JJ cell_JJ cycle_NN kinetics_NNS ._.
The_VBG NB4_VBG cell_VBG line_VBG ,_VBG which_VBG is_VBG derived_VBG from_VBG the_VBG bone_VBG marrow_VBG of_VBG a_VBG patient_VBG with_VBG APL_VBG during_VBG relapse_VBG ,_VBG can_VBG be_VBG used_VBG as_VBG a_VBG model_VBG system_VBG to_VBG study_VBG the_VBG growth_VBG and_VBG differentiation_VBG of_VBG APL_VBG cells_VBG ._VBG
Resting_RB T-cell_NN nuclear_CC extracts_NNS contained_IN homodimer_NN ._.
A_VBG region_VBG upstream_VBG to_VBG the_VBG first_VBG exon_VBG ,_VBG and_VBG highly_VBG conserved_VBG between_VBG mouse_VBG and_VBG man_VBG ,_VBG acts_VBG as_VBG an_VBG erythroid_VBG specific_VBG enhancer_VBG in_VBG transient_VBG assays_VBG ,_VBG if_VBG linked_VBG to_VBG the_VBG GATA-1_VBG or_VBG to_VBG the_VBG SV40_VBG promoter_VBG ._VBG
We_VBG show_VBG that_VBG JAK2_VBG kinase_VBG is_VBG rapidly_VBG phosphorylated_VBG and_VBG activated_VBG in_VBG response_VBG to_VBG IL-13_VBG ._VBG
Human_JJ tumor_NN necrosis_NNS factor_NN alpha_JJ gene_NN regulation_VBP in_VBG phorbol_NN ester_NN stimulated_VBN T_NN and_CC B_JJ cell_NN lines_NNS ._.
Further_RB studies_NNS indicated_VBN that_VBG inhibition_CD of_VBG GTP-cyclohydrolase_VBG I_VBG an_VBG enzyme_VBG involved_VBG in_VBG de_VBG novo_VBG synthesis_VBG of_VBG an_VBG important_VBG cofactor_VBG for_VBG NOS_VBG activity_VBG ,_VBG tetrahydrobiopterin_VBG prevented_VBG the_VBG generation_VBG of_VBG NO_VBG in_VBG cells_VBG ._VBG
Changes_DT in_VBG plasma_RB interleukin-1_NN and_CD possible_JJ relationship_NN with_CC the_DT changes_VBZ in_VBG glucocorticoid_VBG receptor_VBG in_VBG aged_VBG long-distance_VBG runner_VBG
These_VBG studies_VBG have_VBG been_VBG extended_VBG to_VBG show_VBG that_VBG i_VBG a_VBG mutant_VBG EBV_VBG strain_VBG lacking_VBG the_VBG gene_VBG encoding_VBG EBNA_VBG 2_VBG fails_VBG to_VBG switch_VBG from_VBG Wp_VBG to_VBG Cp_VBG usage_VBG in_VBG primary_VBG B_VBG lymphocytes_VBG ,_VBG although_VBG the_VBG virus_VBG contains_VBG a_VBG functional_VBG Cp_VBG ;_VBG ii_VBG a_VBG region_VBG from_VBG -429_VBG to_VBG -245_VBG base_VBG pairs_VBG upstream_VBG of_VBG Cp_VBG is_VBG essential_VBG for_VBG Cp_VBG activity_VBG in_VBG B_VBG lymphocytes_VBG ,_VBG but_VBG only_VBG in_VBG the_VBG context_VBG of_VBG upstream_VBG and_VBG downstream_VBG sequences_VBG ;_VBG iii_VBG this_VBG region_VBG contains_VBG an_VBG EBNA_VBG 2-dependent_VBG enhancer_VBG ;_VBG and_VBG iv_VBG DNase_VBG I_VBG protection_VBG employing_VBG nuclear_VBG extracts_VBG from_VBG B_VBG and_VBG T_VBG lymphocytes_VBG revealed_VBG a_VBG B-cell-specific_VBG footprint_VBG in_VBG the_VBG region_VBG of_VBG the_VBG EBNA_VBG 2-dependent_VBG enhancer_VBG ._VBG
Human_DT immunodeficiency_NN virus_NN type_CD 1_VBG Nef_VBG protein_VBG inhibits_VBG NF-kappa_VBG B_VBG induction_VBG in_VBG human_VBG T_VBG cells_VBG ._VBG
Purified_JJ human_JJ peripheral_JJ T_JJ cells_NNS or_VBP Jurkat_NN T_JJ cells_NNS were_RB stimulated_VBN with_IN Chinese_DT hamster_NN ovary_IN CHO_NN cells_NN expressing_VBG either_NN human_JJ CD80_NN CHO-CD80_JJ or_JJ human_JJ CD86_JJ CHO-CD86_NN or_NN with_IN anti-CD28_NN monoclonal_NN antibody_CC mAb_NN ._.
The_DT three_DT compartments_NNS are_VBP thought_VBN to_VBG be_DT of_VBG common_VBG endodermal_VBG origin_VBG ;_VBG in_VBG contrast_VBG to_VBG earlier_VBG hypotheses_VBG ,_VBG which_VBG suggested_VBG that_VBG the_VBG endocrine_VBG compartment_VBG was_VBG of_VBG neuroectodermal_VBG origin_VBG ._VBG
Thus_VBG these_VBG data_VBG suggest_VBG that_VBG the_VBG phorbol_VBG myristate-induced_VBG signal_VBG prolonged_VBG protein_VBG kinase_VBG C_VBG activation_VBG can_VBG not_VBG be_VBG inhibited_VBG by_VBG prior_VBG incubation_VBG with_VBG dexamethasone_VBG and_VBG it_VBG also_VBG protects_VBG the_VBG induced_VBG mRNA_VBG for_VBG the_VBG degradative_VBG action_VBG of_VBG dexamethasone_VBG ._VBG
The_DT loss_JJ of_VBG conventional_VBG responsiveness_VBG is_VBG probably_VBG caused_VBG by_VBG alterations_VBG at_VBG the_VBG level_VBG of_VBG signaling_VBG ,_VBG and_VBG may_VBG be_VBG a_VBG manifestation_VBG of_VBG the_VBG physiological_VBG state_VBG that_VBG is_VBG a_VBG precondition_VBG for_VBG selection_VBG ._VBG
A_VBG thymus-specific_VBG member_VBG of_VBG the_VBG HMG_VBG protein_VBG family_VBG regulates_VBG the_VBG human_VBG T_VBG cell_VBG receptor_VBG C_VBG alpha_VBG enhancer_VBG ._VBG
Both_VBG conditions_VBG are_VBG promoted_VBG by_VBG lysophosphatidylcholine_VBG lysoPC_VBG ._VBG
Over_PRP end_VBP ,_VBG it_VBG binds_VBG a_VBG factor_VBG that_VBG is_VBG ubiquitously_VBG and_VBG constitutively_VBG expressed_VBG ._VBG
We_VBG show_VBG that_VBG the_VBG constitutive_VBG expression_VBG of_VBG the_VBG T24_VBG Ha-ras_VBG oncogene_VBG in_VBG EBV-immortalized_VBG B_VBG lymphoblasts_VBG was_VBG associated_VBG with_VBG the_VBG induction_VBG of_VBG the_VBG interleukin_VBG 2_VBG receptor_VBG alpha_VBG subunit_VBG ,_VBG with_VBG an_VBG impaired_VBG immunoglobulin_VBG gene_VBG expression_VBG ,_VBG altered_VBG adhesion_VBG properties_VBG and_VBG increased_VBG survival_VBG in_VBG serum-free_VBG medium_VBG ._VBG
The_DT signaling_VBG events_NNS mediating_JJ this_DT effect_NN appeared_JJ to_VBG involve_JJ the_DT release_VBP of_VBG H2O2_NNS ,_VBG since_VBP LTB4_NN failed_JJ to_VBG induce_VBG NF-chi_VBG B_VBG or_VBG NF-IL6_VBG in_VBG the_VBG presence_VBG of_VBG the_VBG scavenger_VBG of_VBG H2O2_VBG ,_VBG N-acetyl-L-cysteine_VBG ._VBG
These_VBG data_VBG indicate_VBG specific_VBG modulation_VBG of_VBG the_VBG family_VBG of_VBG transcription_VBG factors_VBG by_VBG the_VBG CD2_VBG signalling_VBG pathway_VBG and_VBG suggest_VBG CD2_VBG receptor_VBG modulation_VBG of_VBG CRE-mediated_VBG transcription_VBG following_VBG ligand_VBG engagement_VBG e.g._VBG cell-to-cell_VBG contact_VBG ._VBG
These_PRP results_NNS are_VBP consistent_RB with_IN the_DT interpretation_VBP that_VBG glucocorticoid-mediated_VBG autoregulation_VBG of_VBG GR_VBG expression_VBG is_VBG a_VBG tissue-specific_VBG primary_VBG transcriptional_VBG response_VBG ._VBG
To_TO this_DT aim_JJ ,_VBG allergen-specific_DT T_NN cell_NN clones_NNS TCC_JJ were_VBD generated_VBD from_VBG the_VBG peripheral_VBG blood_VBG of_VBG three_VBG atopic_VBG patients_VBG ,_VBG and_VBG cytokine_VBG profiles_VBG were_VBG analyzed_VBG ._VBG
The_DT mechanism_CD of_VBG inhibition_VBG is_VBG related_VBG to_VBG the_VBG surface_VBG expression_VBG of_VBG several_VBG cell_VBG adhesion_VBG molecules_VBG ._VBG
The_VBG chemiluminescent_VBG CL_VBG response_VBG of_VBG interferon-gamma-treated_VBG U937_VBG IFN-U937_VBG cells_VBG to_VBG sensitized_VBG target_VBG cells_VBG has_VBG been_VBG used_VBG to_VBG detect_VBG red_VBG cell_VBG ,_VBG platelet_VBG and_VBG granulocyte_VBG antibodies_VBG ._VBG
Treatment_DT of_VBG SKW_VBG 6.4_VBG cells_VBG with_VBG IL_VBG 6_VBG induced_VBG a_VBG transient_VBG and_VBG early_VBG stimulation_VBG of_VBG c-fos_VBG sense_VBG mRNA_VBG expression_VBG ._VBG
LPS_JJ stimulation_NN did_JJ not_RB give_JJ rise_VBP to_VBG a_VBG persistent_VBG nuclear_VBG accumulation_VBG of_VBG RelB_VBG and_VBG c-Rel_VBG ,_VBG whereas_VBG nuclear_VBG c-Rel_VBG ,_VBG but_VBG not_VBG RelB_VBG ,_VBG accumulated_VBG after_VBG B_VBG cell_VBG receptor_VBG stimulation_VBG ._VBG
The_DT concentration_JJ of_VBG corticosteroid_JJ producing_VBG 50_VBG inhibition_JJ IC50_NN was_VBZ 600_VBG nM_JJ ,_VBG 70_VBG nM_RB ,_VBG and_CC 0.5_CD nM_JJ for_VBG hydrocortisone_CD ,_VBG methylprednisolone_JJ ,_VBG and_VBG dexamethasone_VBG ,_VBG respectively_VBG ,_VBG in_VBG monocytes_VBG from_VBG CS_VBG individuals_VBG ._VBG
The_DT algorithm_DT was_VBD constructed_VBD with_IN the_DT aim_NNS of_VBG identifying_VBG segments_VBG in_VBG Ag_VBG which_VBG are_VBG resistant_VBG to_VBG proteolytic_VBG degradation_VBG by_VBG the_VBG enzymes_VBG cathepsin_VBG B_VBG ,_VBG L_VBG ,_VBG and_VBG D_VBG ._VBG
The_VBG candidate_VBG oncogene_VBG bcl-3_VBG was_VBG discovered_VBG as_VBG a_VBG translocation_VBG into_VBG the_VBG immunoglobulin_VBG alpha-locus_VBG in_VBG some_VBG cases_VBG of_VBG B-cell_VBG chronic_VBG lymphocytic_VBG leukaemias_VBG ._VBG
Site-directed_VBG mutagenesis_VBG of_VBG the_VBG wild-type_VBG IL-2R_VBG alpha_VBG kappa_VBG B_VBG enhancer_VBG GGGGAATCTCCC_VBG has_VBG revealed_VBG that_VBG the_VBG binding_VBG of_VBG p50_VBG and_VBG p55_VBG B2_VBG complex_VBG is_VBG particularly_VBG sensitive_VBG to_VBG alteration_VBG of_VBG the_VBG triplet_VBG of_VBG deoxyguanosine_VBG residues_VBG ._VBG
Dendritic_DT cells_NNS DC_VBP are_VBP potent_RB APC_NN during_VBG primary_JJ and_CC secondary_JJ immune_NN responses_NNS ._.
Epstein-Barr_VBG virus_VBG EBV_VBG ,_VBG the_VBG causative_VBG agent_VBG of_VBG infectious_VBG mononucleosis_VBG ,_VBG is_VBG a_VBG human_VBG herpesvirus_VBG associated_VBG with_VBG epithelial_VBG cell_VBG malignancies_VBG nasopharyngeal_VBG carcinoma_VBG as_VBG well_VBG as_VBG B-cell_VBG malignancies_VBG ._VBG
Demonstration_IN of_VBG a_VBG 1,25-dihydroxyvitamin_VBG D3-responsive_VBG protein_VBG in_VBG human_VBG lymphocytes_VBG :_VBG immunologic_VBG crossreactivity_VBG and_VBG inverse_VBG regulation_VBG with_VBG the_VBG vitamin_VBG D_VBG receptor_VBG ._VBG
FK506_NNS and_CC ciclosporin_IN :_VBG molecular_JJ probes_VBZ for_VBG studying_NN intracellular_JJ signal_IN transduction_NN ._.
Cells_NNS need_JJ to_VBG distinguish_VBG between_VBG transient_VBG signals_VBG that_VBG induce_VBG events_VBG such_VBG as_VBG muscle_VBG contraction_VBG ,_VBG secretion_VBG ,_VBG adhesion_VBG and_VBG synaptic_VBG transmission_VBG ,_VBG and_VBG sustained_VBG signals_VBG that_VBG are_VBG involved_VBG in_VBG cell_VBG proliferation_VBG and_VBG differentiation_VBG ._VBG
This_NN multiple_JJ cytokine_VB production_NN deficiency_NN could_JJ not_RB be_VB restored_VBD by_VBG IL-2_VBG or_VBG co-stimulatory_VBG signals_VBG provided_VBG by_VBG antigen-presenting_VBG cells_VBG APC_VBG ._VBG
Although_RB the_DT -20_JJ GATA_NN binding_VBG site_VBG AGATAA_VBG is_VBG also_VBG a_VBG potential_VBG TFIID_VBG binding_VBG site_VBG ,_VBG it_VBG does_VBG not_VBG bind_VBG TFIID_VBG ._VBG
The_DT factor_NN responsible_VBP for_VBG this_VBG activity_VBG was_VBG designated_VBG Oct_VBG coactivator_VBG from_VBG B_VBG cells_VBG OCA-B_VBG ._VBG
The_VBG biological_VBG activity_VBG of_VBG 11_VBG alpha-methyl-1_VBG alpha,25--LRB-OH-RRB-2D3_VBG closely_VBG resembled_VBG that_VBG of_VBG the_VBG natural_VBG hormone_VBG on_VBG normal_VBG and_VBG leukemic_VBG cell_VBG proliferation_VBG and_VBG bone_VBG resorption_VBG ,_VBG whereas_VBG in_VBG vivo_VBG effect_VBG on_VBG calcium_VBG metabolism_VBG of_VBG the_VBG rachitic_VBG chick_VBG was_VBG about_VBG 50_VBG of_VBG that_VBG of_VBG 1_VBG alpha,25--LRB-OH-RRB-2D3_VBG ._VBG
Second_JJ ,_VBG T_VBG cells_VBG ,_VBG which_VBG lack_VBG CD45_VBG and_VBG can_VBG not_VBG signal_VBG via_VBG the_VBG TCR_VBG ,_VBG supported_VBG higher_VBG levels_VBG of_VBG viral_VBG replication_VBG and_VBG gene_VBG expression_VBG ._VBG
Thus_NNS ,_VBG stable_VBG expression_VBG of_VBG HB24_VBG confers_VBG an_VBG activation_VBG phenotype_VBG on_VBG a_VBG human_VBG T_VBG cell_VBG line_VBG ,_VBG implicating_VBG this_VBG gene_VBG as_VBG an_VBG important_VBG transcriptional_VBG factor_VBG during_VBG T_VBG cell_VBG activation_VBG and_VBG growth_VBG ._VBG
This_VBG result_VBG fits_VBG well_VBG into_VBG the_VBG general_VBG observation_VBG of_VBG stress-induced_VBG down-regulation_VBG of_VBG immune_VBG responses_VBG ._VBG
4_CD ._. It_PRP is_VBZ suggested_VBD that_VBG danazol_JJ has_VBZ an_IN anti-estrogenic_JJ action_VBN to_VBG the_VBG monocytes_VBG through_VBG the_VBG competition_VBG and_VBG suppression_VBG of_VBG estrogen_VBG binding_VBG sites_VBG as_VBG seen_VBG in_VBG the_VBG estrogen_VBG target_VBG organ_VBG ._VBG
These_NN transcripts_NNS initiate_JJ from_VBG one_JJ of_VBG two_VBG promoters_VBG ,_VBG Cp_VBG or_VBG Wp_VBG ,_VBG that_VBG function_VBG in_VBG a_VBG mutually_VBG exclusive_VBG fashion_VBG ._VBG
All_VBG groups_VBG contain_VBG cysteine-_VBG and_VBG histidine-rich_VBG putative_VBG zinc_VBG finger_VBG domains_VBG and_VBG a_VBG serine-phenylalanine_VBG SFS_VBG domain_VBG similar_VBG to_VBG part_VBG of_VBG the_VBG large_VBG subunit_VBG of_VBG eukaryotic_VBG RNA_VBG polymerase_VBG II_VBG ._VBG
Cotransfection_IN of_VBG an_VBG hGATA-3_VBG expression_VBG plasmid_VBG with_VBG a_VBG reporter_VBG plasmid_VBG transcription_VBG is_VBG directed_VBG by_VBG the_VBG HIV-1_VBG LTR_VBG resulted_VBG in_VBG 6-_VBG to_VBG 10-fold_VBG stimulation_VBG of_VBG LTR-mediated_VBG transcription_VBG ,_VBG whereas_VBG site_VBG specific_VBG mutation_VBG of_VBG these_VBG GATA_VBG sites_VBG resulted_VBG in_VBG virtual_VBG abrogation_VBG of_VBG the_VBG activation_VBG by_VBG hGATA-3_VBG ._VBG
Involvement_DT of_VBG NF-chi_VBG B_VBG and_VBG NF-IL6_VBG in_VBG induction_VBG of_VBG IL-6_VBG transcription_VBG by_VBG monocytes_VBG was_VBG demonstrated_VBG using_VBG deleted_VBG forms_VBG of_VBG the_VBG IL-6_VBG promoter_VBG ._VBG
p27Kip1_VBG directly_VBG inhibits_VBG the_VBG catalytic_VBG activity_VBG of_VBG cyclin-dependent_VBG kinase_VBG complexes_VBG interferes_VBG physically_VBG with_VBG activation_VBG by_VBG CAK_VBG ._VBG
A_DT human_NN putative_JJ lymphocyte_NN switch_VBD gene_NN containing_NN a_VBG CpG-rich_VBG island_VBG encodes_VBG a_VBG small_VBG basic_VBG protein_VBG with_VBG the_VBG potential_VBG to_VBG be_VBG phosphorylated_VBG ._VBG
The_VBG promoter_VBG region_VBG lacked_VBG a_VBG TATA_VBG box_VBG but_VBG contained_VBG potential_VBG binding_VBG sites_VBG for_VBG the_VBG transcriptional_VBG factors_VBG including_VBG two_VBG Sp1_VBG ,_VBG CRE_VBG ,_VBG Myb_VBG and_VBG NFkB_VBG located_VBG at_VBG positions_VBG -153_VBG ,_VBG -178_VBG ,_VBG -286_VBG ,_VBG -875_VBG ,_VBG and_VBG -1011_VBG ,_VBG respectively_VBG ._VBG
However_DT ,_VBG the_VBG molecular_VBG mechanisms_VBG involved_VBG in_VBG ATRA-dependent_VBG growth_VBG inhibition_VBG and_VBG cellular_VBG differentiation_VBG are_VBG not_VBG presently_VBG understood_VBG ._VBG
We_NN have_VBP previously_RB reported_VBP that_VBG the_VBG T_VBG lymphocytes_VBG of_VBG a_VBG child_VBG with_VBG severe_VBG combined_VBG immunodeficiency_VBG are_VBG defective_VBG in_VBG the_VBG transcription_VBG of_VBG several_VBG lymphokine_VBG genes_VBG that_VBG include_VBG IL2_VBG ,_VBG IL3_VBG ,_VBG IL4_VBG ,_VBG and_VBG IL5_VBG ,_VBG which_VBG encode_VBG interleukins_VBG 2_VBG ,_VBG 3_VBG ,_VBG 4_VBG ,_VBG and_VBG 5_VBG IL-2_VBG ,_VBG -3_VBG ,_VBG -4_VBG ,_VBG and_VBG -5_VBG ._VBG
CONCLUSIONS_NNS :_VBG These_VBG results_VBG provide_VBG further_VBG evidence_VBG for_VBG a_VBG dysregulation_VBG of_VBG the_VBG HPA_VBG axis_VBG in_VBG PTSD_VBG ._VBG
Female_PRP family_NN members_VBZ were_VBD also_RB studied_JJ to_VBG identify_IN heterozygote_JJ carriers_NNS ._.
ABSTRACT_NNS TRUNCATED_NN AT_CD 250_VBG WORDS_NN
The_VBG recent_VBG definition_VBG of_VBG a_VBG consensus_VBG DNA_VBG binding_VBG sequence_VBG for_VBG the_VBG Ets_VBG family_VBG of_VBG transcription_VBG factors_VBG has_VBG allowed_VBG the_VBG identification_VBG of_VBG potential_VBG Ets_VBG binding_VBG sites_VBG in_VBG the_VBG promoters_VBG and_VBG enhancers_VBG of_VBG many_VBG inducible_VBG T-cell_VBG genes_VBG ._VBG
Other_VBG studies_VBG further_VBG demonstrate_VBG that_VBG the_VBG jun-B_VBG and_VBG fra-1_VBG genes_VBG are_VBG induced_VBG by_VBG TPA_VBG in_VBG both_VBG and_VBG cells_VBG ,_VBG whereas_VBG c-fos_VBG expression_VBG is_VBG attenuated_VBG in_VBG the_VBG line_VBG ._VBG
The_VBG log10Kd_VBG increased_VBG 0.304_VBG 0.139_VBG p_VBG 0.04_VBG and_VBG the_VBG log10MBC_VBG increased_VBG 0.49_VBG 0.10_VBG p_VBG 0.001_VBG in_VBG the_VBG subjects_VBG compared_VBG to_VBG baseline_VBG ._VBG
As_DT a_VBG bioassay_RB for_VBG glucocorticoid_JJ action_NN we_IN also_RB measured_JJ dexamethasone_NN suppressibility_RB of_VBG mitogen-stimulated_VBG incorporation_VBG of_VBG -LCB-3H-RCB-thymidine_VBG in_VBG mononuclear_VBG leukocytes_VBG ._VBG
Sequence_VBG analysis_VBG of_VBG nine_VBG different_VBG 2.3-kb_VBG cDNA_VBG clones_VBG obtained_VBG from_VBG NK-derived_VBG RNA_VBG confirmed_VBG that_VBG they_VBG corresponded_VBG to_VBG an_VBG unrearranged_VBG TcR_VBG delta_VBG gene_VBG ._VBG
Constitutive_VBG expression_VBG of_VBG 1,25-LRB-OH-RRB-2D3_VBG receptor_VBG RNA_VBG was_VBG detected_VBG in_VBG various_VBG kinds_VBG of_VBG hematopoietic_VBG cells_VBG ,_VBG including_VBG macrophages_VBG and_VBG activated_VBG T_VBG lymphocytes_VBG ,_VBG as_VBG well_VBG as_VBG in_VBG cell_VBG lines_VBG KG-1_VBG myeloblasts_VBG ,_VBG HL-60_VBG promyelocytes_VBG ,_VBG ML-3_VBG myelomonoblasts_VBG ,_VBG U937_VBG ,_VBG THP-1_VBG monoblasts_VBG ,_VBG K562_VBG erythroblasts_VBG ,_VBG and_VBG S-LB1_VBG HTLV-1-transfected_VBG T_VBG lymphocytes_VBG ._VBG
After_VBG appropriate_VBG stimulation_VBG ,_VBG both_VBG NF-AT_VBG and_VBG AP-1_VBG are_VBG peculiarly_VBG sensitive_VBG to_VBG the_VBG protein_VBG synthesis_VBG inhibitor_VBG anisomycin_VBG ._VBG
We_NN have_VBP previously_RB shown_IN that_VBG a_VBG human_VBG B_VBG lymphoma_VBG cell_VBG line_VBG ,_VBG B104_VBG ,_VBG expressed_VBG surface_VBG IgM_VBG sIgM_VBG and_VBG surface_VBG IgD_VBG sIgD_VBG ,_VBG and_VBG that_VBG crosslinking_VBG of_VBG sIgM_VBG and_VBG sIgD_VBG by_VBG anti-IgM_VBG antibody_VBG Ab_VBG and_VBG anti-IgD_VBG Ab_VBG ,_VBG respectively_VBG ,_VBG induced_VBG influx_VBG to_VBG almost_VBG the_VBG same_VBG degree_VBG ,_VBG whereas_VBG only_VBG sIgM-crosslinking_VBG caused_VBG B104_VBG cell_VBG death_VBG ._VBG
We_NN have_VBP established_JJ the_DT essential_JJ nature_NNS of_VBG GATA-1_JJ during_IN both_CC primitive_NN and_CC definitive_NN erythropoiesis_NN ._.
Moreover_DT ,_VBG antisense_DT oligodeoxynucleotides_NNS targeting_VBG either_RB GATA-1_NN or_CC p45_RB NF-E2_NN proteins_NNS inhibited_VBN both_DT protein_NN expression_NN and_CC BA-induced_VBN differentiation_NN ._.
3_VBG ._VBG Although_VBG DEX_VBG and_VBG PGE2_VBG were_VBG equipotent_VBG in_VBG suppressing_VBG T-cell_VBG proliferation_VBG ,_VBG ISO_VBG was_VBG much_VBG less_VBG effective_VBG ._VBG
Dexamethasone_VBG markedly_VBG inhibited_VBG LPS-stimulated_VBG accumulation_VBG of_VBG mRNA_VBG for_VBG ELAM-1_VBG and_VBG expression_VBG of_VBG ELAM-1_VBG and_VBG ICAM-1_VBG IC50_VBG 10_VBG nM_VBG ,_VBG both_VBG P_VBG 0.001_VBG ,_VBG n_VBG 4-9_VBG ;_VBG inhibition_VBG of_VBG expression_VBG by_VBG dexamethasone_VBG was_VBG reversed_VBG by_VBG RU-486_VBG both_VBG P_VBG 0.005_VBG ,_VBG n_VBG 4-6_VBG ._VBG
Furthermore_PRP ,_VBG the_DT ability_CD of_VBG these_DT complexes_NN to_VBG regulate_VBG gene_VBG expression_VBG is_VBG demonstrated_VBG by_VBG increased_VBG transcription_VBG from_VBG an_VBG AP-1_VBG driven_VBG reporter_VBG construct_VBG and_VBG marked_VBG increases_VBG in_VBG the_VBG expression_VBG of_VBG endogenous_VBG AP-1_VBG regulated_VBG genes_VBG ._VBG
We_VBG found_VBG that_VBG GIG18_VBG was_VBG rapidly_VBG induced_VBG to_VBG comparable_VBG levels_VBG by_VBG both_VBG AR_VBG and_VBG GR_VBG ,_VBG demonstrating_VBG that_VBG AR_VBG can_VBG indeed_VBG function_VBG as_VBG a_VBG transcriptional_VBG activator_VBG in_VBG S49_VBG cells_VBG and_VBG ,_VBG moreover_VBG ,_VBG that_VBG GIG18_VBG induction_VBG may_VBG be_VBG a_VBG marker_VBG of_VBG early_VBG apoptotic_VBG events_VBG in_VBG steroid-treated_VBG cells_VBG ._VBG
LDP_VBG not_VBG only_VBG increases_VBG plasma_VBG estradiol_VBG levels_VBG ,_VBG but_VBG also_VBG increases_VBG the_VBG leucocytic_VBG ER_VBG levels_VBG ._VBG
These_VBG data_VBG show_VBG that_VBG this_VBG technique_VBG is_VBG useful_VBG for_VBG the_VBG identification_VBG of_VBG minimal_VBG residual_VBG disease_VBG in_VBG patients_VBG with_VBG APL_VBG and_VBG that_VBG cytotoxic_VBG chemotherapy_VBG following_VBG ATRA_VBG therapy_VBG is_VBG required_VBG for_VBG the_VBG elimination_VBG of_VBG APL_VBG cells_VBG ._VBG
The_DT HIV-TF1-binding_VBG site_VBG in_VBG HIV_VBG LTR_VBG was_VBG similar_VBG to_VBG the_VBG site_VBG recognized_VBG by_VBG upstream_VBG stimulatory_VBG factor_VBG USF_VBG in_VBG the_VBG adenovirus_VBG major_VBG late_VBG promoter_VBG ._VBG
Here_DT we_PRP show_VBD that_VBG priming_CD of_VBG CD4_VBG T_VBG cells_VBG selectively_VBG enhances_VBG IL-4_VBG expression_VBG relative_VBG to_VBG IL-2_VBG expression_VBG by_VBG a_VBG transcriptional_VBG mechanism_VBG involving_VBG nuclear_VBG factor_VBG of_VBG activated_VBG T_VBG cells_VBG NFAT_VBG proteins_VBG ._VBG
Recently_VBG it_VBG has_VBG become_VBG clear_VBG that_VBG these_VBG cytokines_VBG activate_VBG a_VBG number_VBG of_VBG important_VBG intracellular_VBG signaling_VBG molecules_VBG ,_VBG including_VBG the_VBG Janus_VBG kinases_VBG JAK1_VBG and_VBG JAK3_VBG and_VBG members_VBG of_VBG the_VBG transcription_VBG factor_VBG family_VBG of_VBG signal_VBG transducers_VBG and_VBG activators_VBG of_VBG transcription_VBG STATs_VBG ._VBG
